Protein crystal structure

ABSTRACT

Disclosed is a crystal comprising at least a catalytically active portion of a SET 7/9 histone methyltransferase, and various uses thereof, and ligands for SET 7/9.

FIELD OF THE INVENTION

This invention relates to a protein crystal structure, various methods of utilising the structure and/or information derivable therefrom, and altered proteins.

BACKGROUND OF THE INVENTION

In eukaryotic cells, DNA is maintained in a highly ordered and condensed in association with small, basic histone proteins. This packaged DNA is termed chromatin. Generally speaking, there are two forms of chromatin: heterochromatin which is tightly compacted and highly refractory to processes such as gene transcription; and euchromatin, which has a more open conformation and tends to be amenable to transcription.

The basic unit of chromatin is the nucleosome, which consists of approximately two turns of DNA around a histone core octamer comprising two monomers each of histones H2A, H2B, H3 and H4. The N terminal tails of the core histones protrude out of the core structure and make contact with adjacent nucleosomes.

The basic N terminal tails of the core histones are known to be subject to many different covalent modifications including acetylation and, in particular, methylation of lysine residues.

It is generally believed that modification of the histone tails affects chromatin structure and thereby has an impact on expression of genes within the DNA in the modified nucleosome. Thus it is widely held that histone modification provides a layer of epigenetic control of gene expression, although the details of the mechanisms involved have not yet been fully elucidated.

A number of enzymes which methylate histones (histone methyltransferases, or HMTs) are known. They tend to be highly specific e.g. a particular HMT will normally methylate only a particular lysine residue of a particular histone molecule (say, for example, the lysine residue at position 9 of histone H3). HMTs almost exclusively belong to the “SET” family of proteins, that is they contain a conserved methyltransferase domain called a SET domain (so called because the domain was first identified in the Drosophila protein Suvar)3-9, (Enhancer-of-zeste, Ttrithorax); (Su(var) is an abbreviation for “suppressor of variegation”).

It has been postulated that deregulation of SET domain function in SET proteins may be involved in the causation of many types of cancer (Schneider et al, 2002 TRENDS in Biochemical Sciences 27, 396-402) and, given the likely role of HMTs in regulation of gene expression, one can appreciate the basis for such a postulation.

The first example of an enzyme that specifically methylates lysine-4 of histone H3 in humans was independently characterised by two groups and separately named SET7 (Wang et al, 2001 Mol. Cell. 8, 1207-1217) and SET9 (Nishioka et al, 2002 Genes Dev. 16, 479-489). Accordingly the protein is now known as SET 719). This protein is among the smallest shown to possess HMTase activity and it also lacks SET domain-associated cysteine-rich regions.

The results of X-ray crystallographic analysis of the enzyme in isolation, or in complex with a reaction product, have been published (Wilson et al, 2002 Cell 777, 105-115; Jacobs et al, 2002 Nat. Struct. Biol. 9, 833-838). However; the crystal used for analysis by Wilson et al lacked a C-terminal segment of the enzyme (which is critical for catalytic activity) since no useful crystals could be obtained of the complete enzyme, due to the flexibility of the C terminal.

The SET 7/9 HMT comprises a conserved SET domain (i.e. the SET 7/9 domain) and flanking pre- and post-SET domains. Analysis by Rea et al, (2000 Nature 406, 593-599) suggested that, at least for SuV39H1, both the pre-SET and post-SET domains were required for HMTase activity. However, the function of the pre-SET and post-SET domains is still unclear. A variety of different sequences are found adjacent to the C terminus of SET domains across the family of HMTs, and this might reflect important differences in the precise specificity of the various enzymes.

The present inventors have now been able to prepare a crystal of a catalytically competent portion of the enzyme, in a complex with both its co-factor and a lysine-containing peptide substrate. This complex has allowed determination of the structure of the SET domain, including the essential C-terminal segment, to a surprisingly high resolution.

This information has, in turn, led the inventors to make a number of other inventions, described and exemplified below.

SUMMARY OF THE INVENTION

In a first aspect the invention provides a crystal comprising at least a catalytically active portion of a SET 7/9 histone methyltransferase (HMT). In a preferred embodiment the crystal comprises SET 7/9 HMT in complex with a lysine-containing protein or peptide substrate and/or a methyl group-donating co-factor. It should be noted that the crystal complex may be formed before or (more preferably) after the enzyme-catalysed methylation reaction takes place, so the co-factor, if present, may be methylated or demethylated and, conversely, the substrate (if present) may be unmethylated or methylated.

In a preferred embodiment the invention provides a crystal comprising SET 7/9 HMT, optionally in a complex with a lysine-containing substrate and/or a (methyl group-donating) co-factor, which diffracts X-rays so as to allow for the determination of atomic co-ordinates of SET 7/9 HMT to a resolution of 1.7 Å or better.

A crystal in accordance with the invention typically has the space group P2₁, and unit cell dimensions of a=52.7 Å, b=75.4 Å, c=69.1 Å and β=94.2°.

In particular, a crystal in accordance with the invention comprises at least residues 117-366 of SET 7/9 HMT, which portion is catalytically active.

One crystal in accordance with the invention has the relative atomic co-ordinates set out in Annex 1, and these will generally be applicable for other crystals in accordance with the invention. However, those skilled in the art will appreciate that minor deviation from these precise co-ordinates will not significantly affect the structure, either in terms of its dominant characteristics or its usefulness in, for example, rational drug design (as discussed further below). Accordingly, for the purposes of the present specification, a crystal having a structure in which the atomic co-ordinates set out in Annex 1 may vary by up to 0.2 Å (more preferably no more than 0.1 Å) in any direction is considered as being a crystal in accordance with the present invention.

By way of explanation, Annex 1 shows (from left to right): the atom number and type, the residue type and number, the x, y and z co-ordinates of the atom (in Å); “OCC” is the occupancy and B is the B factor (in Å²). Atoms 1-3813 belong to the SET 7/9 domain. Atoms 3814-3855 belong to the S-AdoHomocysteine cofactor. Atoms 3859-4039 belong to the substrate peptide.

Using the data provided by the atomic co-ordinates, the inventors have identified residues of the SET 7/9 domain which are believed to interact with residues of the substrate. Thus in one particular embodiment the invention provides a crystal comprising a complex of SET 7/9 with a lysine-containing substrate peptide comprising at least the amino acid sequence ARTKQT, and wherein the complex involves one or more (preferably two or more, more preferably three or more, and most preferably four or more) of the interactions set out in Table 1 below. (The relative substrate residue numbering makes the lysine residue to be methylated position 0, with residues to the N terminal side being negative and residues to the C terminal side being positive): TABLE 1 SET 7/9 Residue interacts with: Relative Substrate Residue Trp 260 −3 (e.g. Ala) His 252 −2 (e.g. Arg) Asp 256 −2 (e.g. Arg) Ser 268 −1 (e.g. Thr) Thr 266 Lys 0 Ser 268 Lys 0 Ser 268 +1 (e.g. Gln) Val 355 +1 (e.g. Gln) Lys 317 +2 (e.g. Thr)

Those skilled in the art will readily appreciate that determination of the three dimensional ternary structure of SET 7/9 HMT in complex with its cofactor and/or a substrate provides the basis for the rational design of molecules which interact specifically with SET 7/9 HMT (alone, or in complex with its cofactor and/or a substrate). Such molecules may be referred to, for present purposes, as ligands. Of particular interest are ligands which will modulate the methyltransferase activity of SET 7/9 HMT. Such modulation may include inhibiting or enhancing the methylstransferase activity, altering its substrate specificity, and stabilising or destabilising the interaction between SET 7/9 HMT and its cofactor and/or a histone substrate. For present purposes, “destabilising” encompasses inhibition of the formation of a complex of SET 7/9 HMT with a substrate and/or its cofactor.

By way of explanation, SET 7/9 HMT requires a source of methyl groups for transfer to the lysine residue of the substrate to be methylated. The source of methyl groups is provided by a methyl group-donating cofactor. The natural cofactor for SET 7/9 is referred to as S-AdoMet (or AdoMet), in essence an adenosinylated methionine molecule. During the SET 7/9 HMT-catalysed reaction, the methyl group is transferred from S-AdoMet to the lysine residue of the substrate. The resulting demethylated cofactor is referred to as S-AdoHomocysteine (abbreviated as S-AdoHcy or AdoHcy). The structures of AdoMet and AdoHcy are shown in FIGS. 1 a and 1 b respectively.

In particular, there are several computer modelling packages commercially available which can facilitate the rational design of ligand molecules which are likely to modulate the methyltransferase activity of SET 7/9 HMT. Examples include computer programs such as GRAM, DOCK and AUTODOCK (Walters et al, 1998 Drug Discovery Today 3, 160-178; Dunbrack et al, 1997 Folding and Design 2, 2742) which can be employed, with knowledge of the ternary structure a complex comprising SET 7/9, to design potential reversible or irreversible SET 7/9 HMT inhibitors.

Alternatively a computer program may be employed to analyse the active site of SET 7/9 HMT and predict the structure of chemical moieties which will interact with the active site. An example of one such program is GRID (described by Goodford, 1985 J. Med. Chem. 28, 849-857).

In addition, the likely forces of attraction and repulsion, and the degree of any steric hindrance, between SET 7/9 HMT and a prospective ligand, can be estimated using computer programs. In general, the greater the forces of attraction (and the lower the forces of repulsion), the closer the fit and the fewer the number of steric hindrances, the tighter will be the interaction between SET 7/9 HMT and the ligand. In addition, the greater the specificity of binding of the ligand, the lower the likelihood of any adverse reactions from undesired interactions with other proteins.

Thus, in a further aspect, the invention provides a method of selecting or designing a ligand for SET 7/9, which method comprises use of at least part of the atomic co-ordinate data contained in Annex 1 (preferably a substantial part of the data i.e. the data relating to at least 50% of the atoms identified in Annex 1, more preferably most of the data i.e. the data relating to at least 75% of the atoms, and most preferably substantially all of the data i.e. the data relating to at least 95% of the atoms), or data derivable therefrom. Data derivable from the atomic co-ordinate data presented in Annex 1 include structure factor data (see Blundell et al, in “Protein Crystallography” Academic Press, New York, London and San Francisco (1976)). Where less than the complete data set is used for the modelling or designing method of the invention, it is preferred at least to include data relating to that part of the SET domain which constitutes the active site. In particular the inventors believe the following residues to be important to the catalytic activity of the SET 7/9 HMT:

Tyr 245, His 252, Hsp 256, Asn 263, Gly 264, Thr 266, Leu 267, Ser 268, Gly 292, His 293, Ala 295, Tyr 305, Lys 317, Tyr 335, and Tyr 337.

Accordingly, preferred methods of selecting or designing potential ligands will typically comprise use of atomic co-ordinate data for at least some of the atoms present in one or more (preferably most, more preferably all) of the residues identified immediately above.

Typically the method of this aspect of the invention comprises the step of modelling all or part of the structure of SET 7/9 HMT using a computer and identifying a potential ligand by designing or selecting a molecule based on its likely ability to interact with the modeled structure.

A potential ligand may be a new chemical entity, although this has the disadvantage that a method of synthesising the entity must be devised if the compound is to be tested in vitro. More preferably therefore, the potential ligand is a compound which is already available. Commercially available libraries of compound structures, such as the Cambridge Structural Database, allow for computer-based high throughput screening of compounds in order to identify and select potential ligands.

Potential ligands which have been designed or selected on the basis of computer modelling or otherwise may then be synthesised or, more preferably, obtained from commercial sources for in vitro testing. The potential ligand may be tested, for example, for any enhancing or inhibitory effect on the methyltransferase activity of SET 7/9 HMT. An assay of HMT activity is described herein and may readily be modified to investigate the effect of the ligand e.g. by contacting a preparation comprising SET 7/9 HMT with a suitable lysine-containing peptide or protein substrate and a suitable cofactor in the presence or absence of the potential ligand.

An assay of methyltransferase activity has the advantage of indicating not only whether a ligand binds to SET 7/9 HMT but also whether such binding has a modulating effect on the catalytic activity of the enzyme. However, other in vitro screening or analytical methods might usefully be employed as an alternative or as an adjunct to enzyme activity assays.

For example, the potential ligand could be labelled, conveniently with a fluorophore. Many suitable fluorophores are commercially available and include inter alia, fluorescein and rhodamine. Binding of the labelled potential ligand to SET 7/9 (alone or in complex with a substrate and/or cofactor) could then be readily detected and assayed (e.g. in a fluorescence polarization assay—see, for instance, Sokham et al, 1999 Anal. Biochem. 275, 156-161).

If desired, any complex resulting from interaction of the potential ligand with SET 7/9 HMT can be analysed to obtain detailed structural information about the binding of the (potential) ligand to SET 7/9. This allows for the structure of the selected or designed ligand to be altered in a rational way in order to optimise affinity and/or specificity of binding of the ligand to SET 7/9. In particular, if desired, a complex comprising SET 7/9 HMT and the ligand may be crystallised and subject to X-ray crystallography in order to obtain data to “fine tune” the interaction between the ligand and SET 7/9 HMT. The interaction may be optimised, for example, by adding or removing groups from the ligand, substituting groups or otherwise altering the overall shape of the ligand.

It will be appreciated that the process of computer modelling and in vitro testing and/or analysis could be performed in an iterative manner, if desired.

In another aspect the invention provides a computer readable medium comprising either (a) at least part of the atomic co-ordinate data contained within Annex 1, or (b) structure factor data derivable from at least part of the atomic co-ordinate data contained within Annex 1.

The invention also provides a computer system for the purpose of modelling structures and/or performing rational drug design of a potential ligand for the SET 7/9 HMT (alone or in complex with a substrate and/or cofactor), the system comprising either (a) at least part of the atomic co-ordinate data contained within Annex 1, or (b) structure factor data derivable from at least part of the atomic co-ordinate data contained within Annex 1.

Preferably the computer readable medium and/or computer system comprises positional data relating to, or derivable from, at least 50%, more preferably at least 75%, and most preferably at least 95% of the atoms detailed in Annex 1.

In yet another aspect the invention provides a method of obtaining a crystal comprising at least a catalytically active portion of a SET 7/9 domain, the method comprising the steps of:

-   (i) forming a complex comprising at least a catalytically active     portion of a SET 7/9 domain with a lysine-containing substrate     peptide or protein, and/or with a cofactor; and -   (ii) forming a crystal comprising the complex.

More especially, the inventors have surprisingly found that optimal results are obtained if the lysine residue of the substrate which interacts with the active site of the SET 7/9 domain in the complex is methylated (especially, mono-methylated), and such represents a preferred feature of the invention. In addition, it is also preferred that the cofactor, if present in the complex, is in unmethylated form (e.g. AdoHcy).

The inventors have found that, in preferred embodiments, a crystal may be formed from a complex of a methylated lysine-containing substrate peptide or protein, a SET 7/9 domain, and an unmethylated cofactor (such as AdoHcy), which crystal diffracts X-rays so as to allow determination of the atomic co-ordinates of the SET 7/9 domain to a resolution of 1.7 Å or better.

In yet another aspect the invention provides a method of obtaining a crystal comprising at least a catalytically active portion of a SET 7/9 domain, the method comprising the steps of:

-   (i) forming a complex comprising at least a catalytically active     portion of a SET 7/9 domain and a ligand therefor (the ligand being     an inhibitor of SET 7/9 HMT activity); and -   (ii) forming a crystal comprising the complex.

In the crystal-forming method aspects of the invention, the complex will typically comprise at least residues 108-366 of the SET domain, which portion is catalytically active.

In a further aspect, the invention provides a ligand for a SET 7/9 domain which modulates the methyltransferase activity thereof, said ligand having been selected or designed by analysis or modelling using at least part of the atomic co-ordinate data contained within Annex 1 or structure factor data obtainable therefrom. More specifically the ligand is typically selected or designed by analysis or modelling using data from at least 50%, more preferably at least 75% and most preferably at least 95% of the atoms detailed in Annex 1.

The ligand may, for example, be one which interacts with one or more of the residues of the SET 7/9 domain which the inventors believe to be important for the HMTase activity of the SET 7/9 domain, namely:

Tyr 245, His 252, Hsp 256, Asn 263, Gly 264, Thr 266, Leu 267, Ser 268, Gly 292, His 293, Ala 295, Tyr 305, Lys 317, Tyr 335, and Tyr 337.

Alternatively, or additionally the ligand may interact with one or more of the SET 7/9 residues identified in Table 1 above as interacting with the substrate. Preferred ligands will comprise or consist of a hydrophobic moiety which can occupy the highly hydrophobic lysine access channel, identified by the inventors in the SET 7/9 domain. Some examples of suitable ligands are given in Example 3.

Once ligands have been identified with acceptable binding specificity and affinity, they can be investigated for use as potential drugs as modulators of SET HMT activity (particularly as inhibitors). Thus, in a further aspect the invention provides a pharmaceutical composition comprising a modulator of SET HMT activity in admixture with a physiologically acceptable diluent, excipient or carrier, the modulator being a compound in accordance with general formula I or II (defined in Example 3) and/or being a modulator selected or designed by analysis or modelling using at least part of the atomic co-ordinate data contained within Annex 1 or structure factor data obtainable therefrom.

The invention also provides for use of a ligand molecule e.g. in accordance with general formula I or II, and/or selected or designed by the method of the invention as a modulator of SET HMT activity, (particularly as an inhibitor thereof). The invention additionally provides for use of a modulator of SET HMT activity to prepare a pharmaceutical composition for modulating the methylation of histones.

In addition, the data obtained by the inventors has enabled identification of key amino acid residues in the SET HMT protein which are essential to the histone methyltransferase activity of the enzyme or its specificity. Alteration of one or more of these key residues may affect the HMT properties in a useful way.

Those skilled in the art are readily able to make point mutations in proteins, provided the relevant nucleic acid sequencing encoding the protein to be mutated is available. Thus, for example, site directed mutagenesis and/or PCR could be used to introduce one or more mutations into the SET HMT protein at desired locations. Particular residues which are susceptible to mutation so as to alter HMTase activity include residues 245, 305 and 335 of the SET domain. The invention thus affords a method providing SET HMTases with altered enzyme activity, and altered SET HMTases obtained by the method.

The invention will now be further described by way of illustrative example and with reference to the accompanying drawings in which:

FIGS. 1A and 1B illustrate the structure of the SET 7/9 cofactor in its methylated (S-AdoMet) and demethylated (S-AdoHcy) states respectively;

FIG. 2 a(i) and 2 a(ii) are two orthogonal views of the ternary structure of the SET 7/9 domain in complex with AdoHcy and a substrate peptide;

FIG. 2 b(i) and 2 b(ii) are two views of the SET domain using surface representation (views (i) and (ii) are related by a two-fold rotation about a vertical axis);

FIG. 2 c(i)-(iv) are stereographic representations of selected active site residues of the SET 7/9 domain;

FIG. 2 d(i) and (ii) are two representations of the electron density (2fo-2fc) over a small part of the active site of the SET 7/9 domain;

FIG. 3 is a bar chart showing the results of HMT assays of SET 7/9 and two point mutants thereof, for unmethylated or monomethylated lysine-containing peptide substrates;

FIG. 4 a is a schematic representation of various interactions made by the histone substrate peptide in complex with SET 7/9;

FIG. 4 b shows the sequence of various portions of histone proteins which are known to be subject to methylation, aligned according to the position of the target lysine residues. The numbers at the top refer to the relative position of the residues with respect to the target lysine (K) residue. The numbers at the sides are the absolute positions of the residues within the various histone proteins;

FIGS. 5 and 6 show examples of the structure of potential ligands for SET 7/9 proposed by the inventors; and

FIG. 7 is a schematic representation of a proposed synthesis scheme for preparing a further ligand of SET 7/9.

EXAMPLES Example 1.1

Protein Constructs

A truncated form of the SET 7/9 HMT protein lacking the first 51 residues of the N terminal portion, referred to as ΔSET7/9 (residues 52-366), was expressed as a GST-fusion in pGEX 6P1 in E. coli BL21. The GST was removed by overnight treatment with PreScission™ Protease (Amersham) prior to gel filtration. Preparation of ΔSETT7/9 in D₂O for nmr studies resulted in a series of N-terminal degradation products which were still catalytically active. Subsequently a further truncated form of the protein, ΔΔSET7/9 (residues 108-366), was prepared as above and found to be stable for growth in D₂O and was consequently used for further nmr and crystallography experiments. Site-directed alanine mutations were introduced using the Stratagene Quikchange Mutagenesis kit, mutations were confirmed by DNA sequencing and electrospray mass spectrometry. Synthetic peptides were prepared using conventional in vitro techniques. AdoHcy was obtained from Fluka, Switzerland.

Example 1.2

HMTase Activity Measurements

The methyltransferase activity of SET7/9 and the various mutant constructs described in the text were determined in a reaction volume of 20 μl containing 3 μM AdoMet supplemented with [methyl-³H] AdoMet (4 μCi) (Amersham Biosciences, UK) and 750 μM purified methylase in reaction buffer (50 mM Tris pH 8.5, 100 mm NaCl, 1 mM EDTA, 1 mM DTT) with 50 μM histone peptide (see below). Following incubation at 37° C. for 60 min the reaction was vacuum blotted onto membrane (Hybond-C, Amersham Biosciences, UK) washed and activity measured by scintillation counting.

Example 1.3

Analytical Analysis of Histone Methylation

The histone methyltransferase assay for analytical purposes was carried out under slightly different conditions than those described in Example 1.2. For analytical purposes the reaction was performed at 37° C. in 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, 1 mM DTT, with 300 μM AdoMet (Fluka, Switzerland), 100 μM H3 20mer peptide (ARTKQTARKSTGGKAPRKQY), and with 1.5 μM enzyme. At desired time intervals an aliquot of the reaction was removed and quenched in 8 M urea and acidified with glacial acetic acid. The reaction products were separated by reverse phase HPLC (Jasco (UK) Ltd) on a Zorbax 300SB-C18 column (Rockland Technologies, Inc. USA) using a gradient from 0 to 40% acetonitrile in the presence of 0.05% trifluoroacetic acid at 55° C. Fractions from the peptide peak were analysed using a Reflex III MALDI time-of-flight mass spectrometer (Bruker Daltonik, GmbH, Germany) to obtain positive ion mass spectra.

Example 1.4

NMR

NMR spectra were recorded at 25° C. on a Varian Inova spectrometer operating at ¹H frequencies of 600 MHz and 800 MHz. Protein samples, 0.5 nM, were prepared in 50 mM Tris-HCl, 0.2 mM TCEP (Trialkylphosphine Tris (2-carboxyethyl)phosphine—a reducing agent), 10% D₂O, pH 6.5.

Example 1.5

Crystallography

Protein stock solution was prepared at 100 mg/ml in 50 mM Tris, pH 7.0, 100 mM NaCl, and then incubated with a two-fold molar excess of mono-methylated Lys-410-mer peptide (ARTKQTARKS) and AdoHcy. Crystals were grown by vapour diffusion at room temperature as hanging drops. Drops were prepared by mixing equal volumes of protein complex with reservoir solution containing 0.1M Tris, pH 7.8 and 22% PEG3350.

Crystals were first transferred into mother liquor augmented with an additional 5% PEG 400, prior to plunging into liquid nitrogen. Data were collected from flash cooled crystals at 100K on an Raxis-II detector mounted on a Rigaku RU200 generator. Diffraction data were integrated and scaled using DENZO and SCALEPACK (Otwinoski & Minor in “Data Collection and Processing” (eds. Sawyer, Isaacs & Bailey) p 556-562 (SERC Daresbury Laboratory, Warrington 1993)). The crystals belong to the spacegroup P2₁, with a=52.7 Å, b=75.4 Å, c=69.1 Å and β=94.2°. The upper resolution of data collection was limited only by the minimum crystal-detector distance, for all data 20-1.75 Å the merging R factor is 0.052 with 90% completeness (0.20 and 52% for the bin, 1.8-1.75 Å); overall the data is 1-fold redundant. The structure was solved by molecular replacement using our previous model (1H3I.brk) with AMORE. Subsequent refinement was done using REFMAC5 (1994, Collaborative Computational Project 4, Acta Crystallogr. D50 p 760-763) and manual model building in 0 (Jones et al, 1991 Acta Crystallogr. A47 p 110-119). The final model comprises one AdoHcy molecule and residues 117-366 of the protein for both complexes in the asymmetric unit, for the A molecule residues 1-6 of the peptide are ordered while all 10 residues are ordered in the B molecule because of the contacts with another molecule in the lattice. At the current stage of refinement, using all data from 20-1.75 Å, there are 480 water molecules and R_(work)=0.21, R_(free)=0.24 and rms bonds=0.008.

Example 2 Example 2.1

Preliminary NMR Studies

Preliminary studies were performed using a complex comprising an unlabelled SET 7/9 domain (residues 52-366 of SET 7/9HMT) and a 20 amino acid residue peptide corresponding to the N terminal of histone H3, specifically labelled with ¹³C and ¹⁵N terminal of histone H3, specifically labelled with ¹³C and ¹⁵N in the lysine residue at position 4. Slightly sub-stoichiometric amounts (0.8 equivalents) of labelled peptide were used. Spectra were recorded at 25° C. using a Varian Inova spectrometer operating at ¹H frequency of 600 MHz. Studies were performed with or without overnight incubation with 5.0 equivalents of AdoMet cofactor, so as to allow comparison of methylated product and unmethylated substrate complexes.

The spectrum of the methylated product complex (data omitted for brevity) exhibited marked differences from that of the unmodified peptide, most notably a reversal of the relative populations of the Lysine-4 side-chain conformers. The relative intensities of the new peaks appearing on methylation (at 2.87, 51.4 and 2.63, 42.0 ppm) indicated that the methylated peptide is more stably bound than the unmethylated substrate and the predominant species (>90%) appeared to have an environment dissimilar to that of the free peptide. A small proportion of the H3 peptide remained unmodified.

Example 2.2

Structural Determinations

Since the preliminary NMR studies suggested that a histone peptide containing monomethylated lysine-4 was better ordered in complex with SET 7/9 than unmodified peptide, the inventors used the products of the normal HMT reaction for crystallisation experiments (methylated lysine peptide and AdoHcy). In particular the inventors used a catalytically active construct that contains the complete C-terminal segment of the SET 7/9 domain. Well-ordered crystals of the ternary complex of SET 7/9 were obtained (using the methodology described in Example 1 and by Wilson et al, 2002 Cell 111, 105-115) that diffracted to at least 1.7 Å spacing and the structure was readily solved by molecular replacement. The C-terminal segment, the AdoHcy cofactor and most of the substrate peptide are well defined in the resulting electron density maps, as are all the important residues around the active site. The overall structure of the ternary complex of SET 7/9 is shown in two orthogonal views in FIG. 2 a (i) and (ii).

FIG. 2 a shows two orthogonal views [(i) and (ii)] of the SET 7/9 ternary complex using ribbon representation. The N- and C-terminals of the SET 7/9 domain are labelled “N-term” and “C-term” respectively. The side chain of the methylated lysine residue at position 4 in the substrate peptide is labelled with reference numeral 2. The demethylated AdoHcy cofactor is labelled with reference numeral 4. Elements of the secondary structure of the SET 7/9 domain are labelled (β16 etc). FIG. 2 b shows two views [(I) and (ii)] of the SET 7/9 domain using surface representation, and the circular inset panel (iii) shows a magnified view of the lysine access channel (see description below) accommodating the methylated lysine side chain, as seen from the AdoHcy binding site.

FIG. 2 b(i) shows the AdoHcy cofactor (2), and FIG. 2 b(ii) shows the substrate peptide (4). FIG. 2 b(iii) shows the lysine access channel, labelled with reference numeral 6, accommodating the lysine side chain.

The most stirring feature of the catalytic structure is that the AdoHcy and the peptide substrate are located on opposite sides of the SET domain and that there is a narrow channel (the “lysine access channel”) passing through the enzyme that connects the peptide and cofactor binding surfaces. The target lysine residue of the substrate (Lys-4) is inserted into this channel so that its amine can access the methyl donor (AdoMet). The packing of the C-terminal segment against the SET domain is required to form the lysine access channel explaining why this feature has not been observed in previous HMTase structures which did not include the C terminal segment of the SET domain (Wilson et al, 2002 Cell 111, 105-115).

The C-terminal segment (residues 345-366) is organised into two structural features; residues 337-349, belonging mainly to the SET domain, form an approximate β-hairpin structure that protrudes at a right angle to the surface of the enzyme. This is followed by three residues that accommodate a sharp bend in the polypeptide chain before the final stretch of the protein which adopts an α-helical conformation (FIG. 2 a). Tyr-335 and Tyr-337, located just before the C-segment, are both important for the formation of the lysine access channel. The arrangements of the P-hairpin is such that it stabilises the conformation of these two tyrosine residues whilst also contributing to one of the sides of the groove into which the peptide binds. The second side of the peptide-binding groove is made up by residues 255-268 (including β-17). The α-helix at the end of the C-terminal segment packs against P-19, particularly Phe-299 (located just beyond the conserved NHS signature motif (Rea et al, 2000 Nature 406, 593-599), and makes hydrophobic packing interactions with the AdoHcy cofactor through Trp-352.

The mode of cofactor binding in the present structure is such that the methyl group to be transferred from the AdoMet to the amine is pointing into the lysine binding channel (see FIG. 2 b). At the peptide binding site, the channel surface is largely made up by the side chains of Leu-267 and tyrosine residues -305-335 and -337 (FIGS. 2 c and 2 d). The alkyl component of the lysine side-chain therefore inhabits a hydrophobic environment.

The other end of the channel, where it opens onto the cofactor binding surface, is dominated by four phenoxyl hydorixdes (Tyr-245, and Tyr-305, -335, -337) and five main-chain carbonyl groups, all approximately oriented towards the lysine amine group. There are also several well defined water molecules in the vicinity of the active site, although only one is close to the lysine amine.

FIG. 2C, panels (i)-(iv), are stereographic representations of selected active site residues. The upper panels (i), (ii), show the AdoHcy and residues forming the channel occupied by the alkyl portion of the lysine side-chain. The lower panels (iii), (iv) show the arrangement of five main chain carbonyl groups around the amine group of the lysine side chain.

The arrangement is such that, along most of its length, the lysine access channel is highly hydrophobic, and thus insertion of the alkyl portion of the lysine side-chain into the channel is, energetically, very favourable. In contrast, at the far (co-factor) end, the channel is, relatively speaking, moderately hydrophilic due to the presence of the 5 carbonyl groups and this allows for accommodation of the polar amino group at the end of the lysine side-chain.

The structure, with its catalytic and binding surfaces, explains at last the role of a number of invariant residues, whose mutation to alanine has been shown to essentially abolish HMTase activity without significantly affecting the affinity for substrate or cofactor binding. The aromatic ring of Tyr-335 forms a significant part of the binding cavity for the alkyl portion of the Lys-4 residue while its hydroxyloxygen makes a single hydrogen bond to the main-chain carbonyl of residue 295. The importance of the correct positioning of this tyrosine residue is underscored by the observation that His-297 (of the NHS signature) acts to stabilise its conformation by acting as a hydrogen bond acceptor to its main-chain amide (FIG. 2 c).

The electron density for the methyl-Lys-4 is very well defined and clearly shows the location of the single methyl group, FIG. 2 d(i) and (ii). Examination of the active site also reveals that the lysine amine group donates hydrogen bonds to both the invariant Tyr-245 and to a tightly bound water molecule (W1). The lysine appears to be acting as a hydrogen bond donor in both cases because of the nature of the other hydrogen bonds made by Tyr-335 and W1 (FIG. 2 c). The orientation of the lysine amine group is such that the amine-methyl bond is aligned towards the sulfur atom of the AdoHcy. Moreover, it is directed at sulfur along the tetrahedral vector corresponding to the (S) location of the methyl group in AdoMet (Hoffmann, 1986 Biochemistry 25, 4444-49).

FIG. 2 e shows a schematic representation of the proposed reaction scheme. The structure clearly shows that the lysine has been stripped of all solvent molecules except for the one water used as a hydrogen bond acceptor to orient the amino group. This desolvation will lower the pKa of the lysine amino group and also enhance its nucleophilicity. At the same time, the local orientation of the dipoles of four main-chain carbonyl groups towards the nitrogen will stabilise the developing positive charge on that atom as the methylation reaction proceeds. There is no proximate proton acceptor to provide general base catalysis for the nucleophilic nitrogen. Mechanistically, it thus seems likely that the lysine sidechain enters the active site with difficulty in its protonated form, the passage of this cation through the channel being facilitated by the faces of the flanking tyrosines. In the active site, the desolvated lysine is deprotonated, possibly to one of the flanking tyrosine oxygens. Thereafter the methylation reaction proceeds without general base catalysis, facilitated simply by orientation of orbitals, by desolvation and by stabilisation of charge reorganisation.

The present inventors have further analysed the methylation reaction. Reaction mixtures were set up with unmodified peptide and AdoMet and conditions found where the reaction was driven essentially to completion. HPLC separation of the reaction products (results omitted for brevity) gave a peak which eluted at a different position to the unmodified peptide and MALDI analysis of this material revealed only mono-methylated peptide. These results strongly support the conclusion that SET 7/9 catalyses the addition of a single methyl group to its target lysine. The reason for SET 7/9 acting as a mono-methyltransferase is readily apparent from the crystal structure now presented. The peptide used for crystallization was synthesised using mono-methylated lysine at position 4. In the crystal structure there is very well defined electron density for this methyl group in just one position. The arrangement of the two hydrogen bond acceptor groups (for the lysine amine) provides an immediate explanation for the lack of rotation about the CE-NZ bond; Tyr-245 and W1 not only make favourable interactions that stabilise the observed rotamer, but they also preclude, on steric grounds, a methyl group in any other position. Thus the structure shows that the arrangement of protein side-chains and, indirectly, water molecules at the active site of SET 7/9 is such that it can only catalyse the addition of a single methyl group to the lysine amine.

In the light of the present findings, comparison of the sequence of other SET proteins (Lachner & Jenuwein 2002, Curr. Opinion in Cell Biol. 14, 286-298), in the vicinity of the active site, suggests why many of these enzymes catalyse di- or tri-methylation of their target lysines. Only Tyr-245 and Tyr-335 are invariant across the SET family, many other residues are highly variable. So, for example, Tyr-305 is substituted for a valine residue in SUV39H1 (a tri-methylase) and a proline in G9a (a di-methylase). Both of these substitutions would seem likely to produce a cavity at the active site that could accommodate a methyl substituent on the lysine amine.

It has previously been reported that the Y245>A mutation in SET 7/9 leads to a dramatic reduction in HMTase activity (Wilson et al, 2002 cited above). The inventors have now surprisingly found that although this mutant has greatly reduced activity with respect to an unmodified lysine substrate, it has substantial activity if assayed with mono-methylated Lys-4 substrate (see FIG. 3). All of these results taken together, suggest that it will be possible both to predict from the primary structure whether a particular SET protein has mono-, di- or tri-methylase activity and to engineer altered functionality into these enzymes.

FIG. 3 shows the results of a Histone methyltransferase assay of SET 7/9, and SET 7/9 with either of the point mutations Y245→F, using histone H3 peptide substrate either unmodified or with monomethylation of the lysine residue at position 4.

The histone peptide binds in a largely extended conformation into a shallow groove (as shown in FIG. 2 b). The binding is mediated by a network of hydrogen and salt bonds involving both the main-chain and side-chains of the peptide (FIG. 4 a). The target Lys-4 residue is located approximately at the centre of the defined peptide and the interactions of non-conserved SET 7/9 residues with the peptide seems to account for the enzyme's specificity. Arg(−2)_(PEP) (substrate residues are numbered relative to the target lysine) makes a salt bridge with Asp-256 and a hydrogen bond with His-252. Thr(−1)_(PEP) and Gln(+1)_(PEP) both form hydrogen bonds with Ser-268, and Thr(+2) hydrogen bonds to the side-chain of Lys-317. Arg(−2)_(PEP) therefore seems to play a particularly important role in mediating substrate specificity. Moreover, inspection of the various histone target sequences (FIG. 4 b) shows that only Lys-4 of histone H3 contains a basic residue in this (−2) position. The others all have a basic residue either at the (−1) or )+1) position. Both activity measurements and peptide affinity measurements, using a peptide in which Arg(−2)_(PEP) is mutated to an alanine (data not shown), support the notion that this arginine residue contributes significantly to peptide binding to SET 7/9. The structure of the ternary complex of SET 7/9 disclosed herein will provide a good model for assessing the likely substrate specificity of other SET proteins from their primary sequence.

Example 3

Rational Design of Ligands for SET 7/9

The determination of the structure of the SET 7/9 domain (in complex with its substrate) as disclosed herein has allowed the present inventors to identify a number of compounds which may act as ligands for the SET 7/9 domain and thus modulate the methyltransferase activity of HMTs containing the SET 7/9 domain.

In particular the inventors have identified (i) potential ligands which may bind to the SET domain ether in isolation or when the protein is in complex with a histone substrate; (ii) a second group of potential ligands which will bind to the SET domain only when the protein is in isolation. Potential ligands may be envisaged which will bind to the SET domain exclusively by covalent binding, or exclusively by non-covalent binding, or by a mixture of both covalent and non-covalent interactions.

In general, potential ligands may have some elements of structure which are analogous to the AdoMet cofactor. However, detailed knowledge of the SET structure has enabled the inventors to propose specific modifications which should improve binding affinity and/or specificity.

In general it will be desirable for the potential ligand to have a stabilised 5′ thioadenosine moiety. This can be achieved, for example, by replacing the S atom of AdoMet with N.

Such a molecule, AzaAdoMet, has been synthesized previously (1999 J. Org. Chem. 64, 7467). In addition, or as an alternative it may be advantageous to derivatise atoms which (in AdoMet) do not strongly interact with the SET protein. Examples include the 3′-OH of the ribosyl moiety and the —NH₂ group at position 4 of the adenyl moiety. Substitutions at one or more of these positions are likely to have beneficial effects on pharmacokinetics in general and on metabolic stability and/or bioavailability in particular. Examples of potential ligands may conform to the general formula I,

wherein R¹, R¹ and R³ are, independently: H, alkyl, haloakyl, aralkyl, acyl, cycloalkyl, alkenyl, or oxa-alkyl and wherein n=0, 1 or 2.

Preferred ligands however will comprise a hydrophobic moiety (e.g. a substituted or unsubstituted alkyl or alkenyl group) which will occupy the lysine access channel normally occupied by the side chain of the lysine residue of the substrate. Occupancy of the lysine access channel by a hydrophobic moiety of a ligand would allow for multiple strong hydrophobic interactions, providing a large binding energy for formation of the ligand/protein complex, which should be reflected in a high binding affinity. The lysine access channel is about 8 Å in diameter and, in principle, any hydrophobic moiety of suitable size might be useful for inclusion in a ligand to make use of this unusual feature of the SET 7/9 domain. Ligands of this type may, for example, conform to the general formula II,

wherein R¹-R³ and are as in general formula I, and wherein R⁴ may be selected from any of the following: a linear, cyclic or branched alkyl group comprising 2 or more carbon atoms (preferably 2-6 carbon atoms, more preferably 2-5 carbon atoms); an alkenyl group having one or more double bonds; the alkyl or alkenyl group optionally being substituted at one or more positions (e.g. hydroxylated, halogenated, or aminated) and optionally comprising one or more oxa- aza- or thia-replacements of CH₂ groups.

In particular, potential ligands which might occupy the lysine access channel, and therefore bind to SET-domain containing proteins with high affinity might include 1,1′-bis [2,2,2]-bicyclooctane or 1,4-diphenyl moieties. The structures of proposed sample ligands is shown in FIGS. 5 and 6. For the diphenyl-based ligand (FIG. 6) R¹-R⁴ must be small in size, so that the diphenyl moiety can still be inserted into the lysine access channel. R¹, R¹, R³ and R⁴ will typically therefore each comprise a single atom or a small group. For example R₁-R₄ may be, independently, any one of H, F, Cl, Br, OH, methyl, Omethyl or ethyl.

A further family of potential ligands relate to an 5′-aziridinyl adenosine alkylating agent that becomes activated in the bound state as a result of protonation. The parent aziridine nucleoside has been exemplified for underivatised adenosines by E. Weinhold et al (Angew. Chem. Int. Ed., 1998, 37, 2888). An outline synthetic scheme is shown in FIG. 7. Starting from the compound (1) described in the prior art, desirable modifications (R¹, R²) could be introduced to generate species (2). Next, addition of a modified or alternated “homocysteine” group would require the previous introduction of an aziridine generating group on the 5′-nitrogen (as illustrated in species (3), where X is P, Cl, Br or Omes for example). Lastly, incorporation of the aziridine in the “homocysteine” moiety would restore the concept of drug activation by N-protonation following binding the SET-domain containing HMT. In all cases, one would expect that such a ligand would alkylate the terminal amino group of the lysine side chain of the substrate histone, “locking” it into the active site and causing essentially irreversible inhibition of the HMT.

Ligands which fill the hydrophobic lysine access channel of the SET 7/9 domain may well exhibit binding which is highly specific for histone methyltransferases and exhibiting very little, if any, binding affinity for other methyltransferases which do not possess a similar substrate access channel. Consequently, drugs based on such ligands should be similarly specific.

An alternative (and less preferred) approach would be to try to block or fill the lysine access channel from the “cofactor side” of the SET 7/9 protein, by marketing use of protein/protein interactions (e.g. by using a peptide mimetic approach), based on knowledge of the flanking amino acid residues surrounding the opening of the channel. Such peptides are readily synthesized in vitro in large quantities. Conceivably it might be possible to combine the two approaches by using a peptide mimetic with a hydrophobic moiety to be inserted into the lysine access channel—although this would need to allow for the relatively polar nature of the channel at the co-factor end. Annex 1 HEADER  TRANSFERASE                   18-DEC-02  1O9S TITLE  CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF THE HUMAN HISTONE TITLE  2 METHYLTRANSFERASE SET7/9 COMPND  MOL_ID; 1; COMPND  2 MOLECULE: HISTONE-LYSINE N-METHYLTRANSFERASE, H3 LYSINE-4 COMPND  3 SPECIFIC; COMPND  4 SYNONYM: HISTONE H3-K4 METHYLTRANSFERASE, H3-K4-HMTASE; COMPND  5 CHAIN: A; COMPND  6 FRAGMENT: N-DOMAIN, SET-DOMAIN, RESIDUES 108-366; COMPND  7 EC: 2.1.1.43; COMPND  8 ENGINEERED: YES; COMPND  9 MOL_ID: 2; COMPND 10 MOLECULE: GENE FRAGMENT FOR HISTONE H3; COMPND 11 CHAIN: K; COMPND 12 FRAGMENT: RESIDUES 2-11; COMPND 13 ENGINEERED: YES SOURCE  MOL_ID: 1; SOURCE  2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE  3 ORGANISM_COMMON: HUMAN; SOURCE  4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE  5 MOL_ID: 2; SOURCE  6 SYNTHETIC: YES; SOURCE  7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE  8 ORGANISM_COMMON: HUMAN KEYWDS  METHYLATION, HISTONE H3, METHYLTRANSFERASE, TRANSFERASE EXPDTA  X-RAY DIFFRACTION AUTHOR  B. XIAO, C. JING, J. R. WILSON, P. A. WALKER, N. VASISHT, G. KELLY, AUTHOR  2 S. HOWELL, I. A. TAYLOR, G. M. BLACKBURN, S. J. GAMBLIN REVDAT  1  19-DEC-02 1O9S   0 JRNL   AUTH B. XIAO, C. JING, J. R. WILSON, P. A. WALKER, N. VASISHT, JRNL   AUTH 2 G. KELLY, S. HOWELL, I. A. TAYLOR, G. M. BLACKBURN, JRNL   AUTH 3 S. J. GAMBLIN JRNL   TITL STRUCTURE AND CATALYTIC MECHANISM OF THE HUMAN JRNL   TITL 2 HISTONE METHYLTRANSFERASE SET7/9 JRNL   REF  TO BE PUBLISHED JRNL   REFN REMARK  2 RESOLUTION. 1.75 ANGSTROMS. REMARK E 501 SAH S-Adenosyl-homocyteine CRYST1  52.690  75.438  69.099  90.00  94.16  90.00  P 1 21 1   4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018979 0.000000 0.001380 0.00000 SCALE2 0.000000 0.013256 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014510 0.00000 No. Type Residue X Y Z Occ. B ATOM 1 N GLY A 117 31.852 −2.694 2.451 1.00 13.90 N ATOM 3 CA GLY A 117 30.788 −1.711 2.826 1.00 13.55 C ATOM 6 C GLY A 117 30.367 −1.598 4.276 1.00 13.14 C ATOM 7 O GLY A 117 29.481 −0.788 4.552 1.00 14.03 O ATOM 10 N VAL A 118 30.820 −2.492 5.146 1.00 11.64 N ATOM 12 CA VAL A 118 30.552 −2.429 6.568 1.00 10.23 C ATOM 14 CB VAL A 118 31.408 −3.477 7.277 1.00 10.37 C ATOM 16 CG1 VAL A 118 30.860 −3.776 8.647 1.00 10.40 C ATOM 20 CG2 VAL A 118 31.444 −4.758 6.440 1.00 10.29 C ATOM 24 C VAL A 118 30.691 −1.045 7.215 1.00 9.12 C ATOM 25 O VAL A 118 31.738 −0.387 7.133 1.00 8.38

ATOM 26 N CYS A 119 29.609 −0.620 7.860 1.00 7.88

ATOM 28 CA CYS A 119 29.560 0.642 8.582 1.00 7.63

ATOM 30 CB CYS A 119 28.553 1.595 7.946 1.00 7.90

ATOM 33 SG CYS A 119 28.136 3.044 8.935 1.00 8.87

ATOM 34 C CYS A 119 29.191 0.387 10.047 1.00 7.19

ATOM 35 O CYS A 119 28.248 −0.351 10.346 1.00 6.63

ATOM 36 N TRP A 120 29.963 0.979 10.949 1.00 6.31

ATOM 38 CA TRP A 120 29.692 0.897 12.381 1.00 6.30

ATOM 40 CB TRP A 120 30.960 0.559 13.183 1.00 6.44

ATOM 43 CG TRP A 120 31.500 −0.810 12.987 1.00 6.89

ATOM 44 CD1 TRP A 120 32.219 −1.265 11.920 1.00 7.26

ATOM 46 NE1 TRP A 120 32.574 −2.580 12.117 1.00 8.17

ATOM 48 CE2 TRP A 120 32.088 −2.997 13.327 1.00 8.70

ATOM 49 CD2 TRP A 120 31.416 −1.902 13.908 1.00 7.94

ATOM 50 CE3 TRP A 120 30.827 −2.073 15.164 1.00 8.69

ATOM 52 CZ3 TRP A 120 30.926 −3.312 15.792 1.00 9.60

ATOM 54 CH2 TRP A 120 31.604 −4.378 15.188 1.00 9.83

ATOM 56 CZ2 TRP A 120 32.196 −4.240 13.963 1.00 9.55

ATOM 58 C TRP A 120 29.190 2.262 12.847 1.00 6.01

ATOM 59 O TRP A 120 29.838 3.279 12.602 1.00 5.78

ATOM 60 N ILE A 121 28.033 2.284 13.495 1.00 5.92

ATOM 62 CA ILE A 121 27.493 3.517 14.047 1.00 6.04

ATOM 64 CB ILE A 121 26.105 3.817 13.469 1.00 6.35

ATOM 66 CG1 ILE A 121 26.154 3.835 11.936 1.00 6.79

ATOM 69 CD1 ILE A 121 24.786 4.013 11.282 1.00 7.65

ATOM 73 CG2 ILE A 121 25.600 5.165 13.962 1.00 6.50

ATOM 77 C ILE A 121 27.420 3.373 15.574 1.00 5.80

ATOM 78 O ILE A 121 26.590 2.634 16.101 1.00 5.54

ATOM 79 N TYR A 122 28.304 4.064 16.278 1.00 5.71

ATOM 81 CA TYR A 122 28.300 4.007 17.733 1.00 5.65

ATOM 83 CB TYR A 122 29.719 4.092 18.288 1.00 5.69

ATOM 86 CG TYR A 122 30.466 2.790 18.211 1.00 5.87

ATOM 87 CD1 TYR A 122 31.219 2.470 17.089 1.00 6.06

ATOM 89 CE1 TYR A 122 31.900 1.285 17.007 1.00 6.49

ATOM 91 CZ TYR A 122 31.842 0.396 18.055 1.00 6.75

ATOM 92 OH TYR A 122 32.531 −0.783 17.973 1.00 9.10

ATOM 94 CE2 TYR A 122 31.106 0.683 19.184 1.00 6.65

ATOM 96 CD2 TYR A 122 30.420 1.877 19.257 1.00 5.78

ATOM 98 C TYR A 122 27.479 5.132 18.319 1.00 5.62

ATOM 99 O TYR A 122 27.680 6.304 17.993 1.00 6.01

ATOM 100 N TYR A 123 26.551 4.773 19.190 1.00 5.73

ATOM 102 CA TYR A 123 25.770 5.769 19.901 1.00 6.09

ATOM 104 CB TYR A 123 24.457 5.180 20.405 1.00 6.43

ATOM 107 CG TYR A 123 23.532 4.727 19.308 1.00 7.37

ATOM 108 CD1 TYR A 123 23.343 3.381 19.055 1.00 8.49

ATOM 110 CE1 TYR A 123 22.488 2.952 18.050 1.00 8.58

ATOM 112 CZ TYR A 123 21.815 3.883 17.284 1.00 9.47

ATOM 113 OH TYR A 123 20.969 3.448 16.296 1.00 11.11

ATOM 115 CE2 TYR A 123 21.984 5.234 17.515 1.00 8.85

ATOM 117 CD2 TYR A 123 22.840 5.648 18.528 1.00 8.33

ATOM 119 C TYR A 123 26.603 6.258 21.080 1.00 5.50

ATOM 120 O TYR A 123 27.512 5.561 21.556 1.00 5.44

ATOM 121 N PRO A 124 26.303 7.453 21.564 1.00 5.04

ATOM 122 CA PRO A 124 27.026 8.012 22.709 1.00 4.56

ATOM 124 CB PRO A 124 26.311 9.349 22.970 1.00 4.62

ATOM 127 CG PRO A 124 25.365 9.565 21.870 1.00 5.23

ATOM 130 CD PRO A 124 25.265 8.357 21.059 1.00 5.10

ATOM 133 C PRO A 124 26.979 7.113 23.955 1.00 3.98

ATOM 134 O PRO A 124 27.880 7.201 24.781 1.00 3.93

ATOM 135 N ASP A 125 25.966 6.257 24.066 1.00 3.55

ATOM 137 CA ASP A 125 25.821 5.359 25.207 1.00 3.08

ATOM 139 CB ASP A 125 24.365 4.953 25.422 1.00 2.63

ATOM 142 CG ASP A 125 23.731 4.358 24.181 1.00 2.85

ATOM 143 OD1 ASP A 125 24.275 3.374 23.635 1.00 2.64

ATOM 144 OD2 ASP A 125 22.675 4.814 23.706 1.00 3.02

ATOM 145 C ASP A 125 26.691 4.110 25.104 1.00 3.21

ATOM 146 O ASP A 125 26.774 3.342 26.056 1.00 2.98

ATOM 147 N GLY A 126 27.320 3.888 23.955 1.00 3.70

ATOM 149 CA GLY A 126 28.228 2.756 23.814 1.00 3.59

ATOM 152 C GLY A 126 27.684 1.636 22.955 1.00 3.82

ATOM 153 O GLY A 126 28.433 0.769 22.515 1.00 3.55

ATOM 154 N GLY A 127 26.371 1.642 22.718 1.00 3.88 N ATOM 156 CA GLY A 127 25.761 0.659 21.840 1.00 4.21

ATOM 159 C GLY A 127 26.096 1.018 20.395 1.00 4.61

ATOM 160 O GLY A 127 26.593 2.109 20.109 1.00 4.48

ATOM 161 N SER A 128 25.825 0.110 19.470 1.00 5.37

ATOM 163 CA SER A 128 26.140 0.372 18.070 1.00 5.88

ATOM 165 CB SER A 128 27.619 0.028 17.808 1.00 6.36

ATOM 168 OG SER A 128 27.904 −1.320 18.139 1.00 6.52

ATOM 170 C SER A 128 25.253 −0.376 17.094 1.00 6.17

ATOM 171 O SER A 128 24.612 −1.363 17.446 1.00 5.68

ATOM 172 N LEU A 129 25.203 0.150 15.870 1.00 6.68

ATOM 174 CA LEU A 129 24.546 −0.488 14.742 1.00 7.41

ATOM 176 CB LEU A 129 23.546 0.469 14.084 1.00 7.78

ATOM 179 CG LEU A 129 22.059 0.098 14.150 1.00 10.11

ATOM 181 CD1 LEU A 129 21.609 −0.271 15.535 1.00 11.82

ATOM 185 CD2 LEU A 129 21.209 1.256 13.588 1.00 10.96

ATOM 189 C LEU A 129 25.678 −0.852 13.776 1.00 7.31

ATOM 190 O LEU A 129 26.581 −0.041 13.520 1.00 7.01

ATOM 191 N VAL A 130 25.652 −2.075 13.256 1.00 7.45

ATOM 193 CA VAL A 130 26.715 −2.540 12.373 1.00 7.62

ATOM 195 CB VAL A 130 27.722 −3.377 13.136 1.00 7.81

ATOM 197 CG1 VAL A 130 28.953 −3.618 12.265 1.00 7.47

ATOM 201 CG2 VAL A 130 28.079 −2.689 14.417 1.00 8.87

ATOM 205 C VAL A 130 26.200 −3.410 11.245 1.00 7.84

ATOM 206 O VAL A 130 25.346 −4.265 11.448 1.00 8.27

ATOM 207 N GLY A 131 26.740 −3.196 10.055 1.00 7.83

ATOM 209 CA GLY A 131 26.349 −3.988 8.903 1.00 7.72

ATOM 212 C GLY A 131 26.744 −3.336 7.597 1.00 8.01

ATOM 213 O GLY A 131 27.115 −2.155 7.536 1.00 6.88

ATOM 214 N GLU A 132 26.693 −4.139 6.545 1.00 8.56

ATOM 216 CA GLU A 132 26.931 −3.650 5.207 1.00 9.76

ATOM 218 CB GLU A 132 26.773 −4.795 4.209 1.00 10.61

ATOM 221 CG GLU A 132 28.057 −5.375 3.662 1.00 12.77

ATOM 224 CD GLU A 132 27.834 −6.071 2.335 1.00 14.90

ATOM 225 OE1 GLU A 132 26.692 −6.069 1.849 1.00 17.36

ATOM 226 OE2 GLU A 132 28.804 −6.614 1.768 1.00 16.80

ATOM 227 C GLU A 132 25.855 −2.630 4.884 1.00 9.88

ATOM 228 O GLU A 132 24.685 −2.877 5.150 1.00 10.33

ATOM 229 N VAL A 133 26.231 −1.495 4.310 1.00 10.07

ATOM 231 CA VAL A 133 25.234 −0.516 3.848 1.00 10.25

ATOM 233 CB VAL A 133 25.797 0.910 3.870 1.00 10.52

ATOM 235 CG1 VAL A 133 26.278 1.237 5.252 1.00 10.72

ATOM 239 CG2 VAL A 133 26.920 1.082 2.851 1.00 10.68

ATOM 243 C VAL A 133 24.729 −0.853 2.433 1.00 10.42

ATOM 244 O VAL A 133 25.398 −1.575 1.695 1.00 9.26

ATOM 245 N ASN A 134 23.541 −0.339 2.077 1.00 10.94

ATOM 247 CA ASN A 134 22.936 −0.558 0.756 1.00 11.92

ATOM 249 CB ASN A 134 21.446 −0.102 0.768 1.00 11.89

ATOM 252 CG AASN A 134 20.496 −1.066 0.269 0.50 13.75

ATOM 253 CG BASN A 134 21.305 1.409 0.958 0.50 12.62

ATOM 254 OD1 AASN A 134 20.857 −2.146 −0.162 0.50 15.50

ATOM 255 OD1 BASN A 134 22.289 2.136 1.015 0.50 13.62

ATOM 256 ND2 AASN A 134 19.235 −0.632 0.183 0.50 14.57

ATOM 257 ND2 BASN A 134 20.070 1.880 1.015 0.50 13.29

ATOM 262 C ASN A 134 23.704 0.253 −0.293 1.00 12.39

ATOM 263 O ASN A 134 24.599 1.030 0.041 1.00 11.91

ATOM 264 N GLU A 135 23.340 0.089 −1.563 1.00 13.28

ATOM 266 CA GLU A 135 23.973 0.862 −2.630 1.00 14.12

ATOM 268 CB GLU A 135 23.433 0.475 −4.026 1.00 14.45

ATOM 271 CG GLU A 135 21.955 0.726 −4.294 1.00 15.44

ATOM 274 CD GLU A 135 21.568 0.407 −5.735 1.00 16.94

ATOM 275 OE1 GLU A 135 22.468 0.069 −6.538 1.00 17.74

ATOM 276 OE2 GLU A 135 20.366 0.501 −6.085 1.00 17.47

ATOM 277 C GLU A 135 23.812 2.368 −2.347 1.00 14.41

ATOM 278 O GLU A 135 24.527 3.190 −2.918 1.00 14.88

ATOM 279 N ASP A 136 22.890 2.713 −1.446 1.00 14.52

ATOM 281 CA ASP A 136 22.604 4.105 −1.083 1.00 14.64

ATOM 283 CB ASP A 136 21.090 4.344 −1.066 1.00 14.86

ATOM 286 CG ASP A 136 20.460 4.271 −2.443 1.00 15.26

ATOM 287 OD1 ASP A 136 21.185 4.369 −3.456 1.00 15.80

ATOM 288 OD2 ASP A 136 19.233 4.120 −2.607 1.00 15.74

ATOM 289 C ASP A 136 23.153 4.501 0.291 1.00 14.53

ATOM 290 O ASP A 136 22.784 5.548 0.825 1.00 14.88

ATOM 291 N GLY A 137 24.008 3.666 0.876 1.00 14.11

ATOM 293 CA GLY A 137 24.585 3.960 2.179 1.00 13.69

ATOM 296 C GLY A 137 23.634 3.851 3.361 1.00 13.26

ATOM 297 O GLY A 137 23.916 4.401 4.427 1.00 13.56

ATOM 298 N GLU A 138 22.520 3.142 3.197 1.00 12.56

ATOM 300 CA GLU A 138 21.573 2.951 4.302 1.00 12.13

ATOM 302 CB GLU A 138 20.132 3.043 3.807 1.00 12.20

ATOM 305 CG GLU A 138 19.762 4.404 3.243 1.00 13.10

ATOM 308 CD GLU A 138 18.564 4.341 2.320 1.00 14.32

ATOM 309 OE1 GLU A 138 18.166 3.219 1.942 1.00 15.05

ATOM 310 OE2 GLU A 138 18.026 5.410 1.957 1.00 15.58

ATOM 311 C GLU A 138 21.793 1.602 4.988 1.00 11.37

ATOM 312 O GLU A 138 22.238 0.648 4.354 1.00 11.03

ATOM 313 N MET A 139 21.489 1.528 6.285 1.00 10.72

ATOM 315 CA MET A 139 21.592 0.284 7.038 1.00 10.35

ATOM 317 CB MET A 139 21.672 0.584 8.529 1.00 11.29

ATOM 320 CG MET A 139 22.928 1.315 8.887 1.00 14.10

ATOM 323 SD MET A 139 24.340 0.197 8.839 1.00 20.90

ATOM 324 CE MET A 139 24.057 −0.735 10.285 1.00 20.60

ATOM 328 C MET A 139 20.399 −0.617 6.787 1.00 9.24

ATOM 329 O MET A 139 19.541 −0.779 7.652 1.00 8.26

ATOM 330 N THR A 140 20.360 −1.203 5.592 1.00 8.20

ATOM 332 CA THR A 140 19.276 −2.065 5.171 1.00 7.66

ATOM 334 CB THR A 140 18.526 −1.378 4.024 1.00 7.49

ATOM 336 OG1 THR A 140 18.095 −0.077 4.443 1.00 7.44

ATOM 338 CG2 THR A 140 17.242 −2.114 3.657 1.00 7.50

ATOM 342 C THR A 140 19.836 −3.369 4.643 1.00 7.44

ATOM 343 O THR A 140 20.634 −3.367 3.717 1.00 7.48

ATOM 344 N GLY A 141 19.409 −4.482 5.222 1.00 7.61

ATOM 346 CA GLY A 141 19.866 −5.789 4.789 1.00 7.57

ATOM 349 C GLY A 141 19.420 −6.844 5.782 1.00 7.70

ATOM 350 O GLY A 141 18.803 −6.509 6.800 1.00 7.59

ATOM 351 N GLU A 142 19.767 −8.102 5.513 1.00 7.72

ATOM 353 CA GLU A 142 19.361 −9.232 6.356 1.00 8.07

ATOM 355 CB GLU A 142 19.056 −10.442 5.475 1.00 8.60

ATOM 358 CG GLU A 142 17.878 −10.230 4.541 1.00 10.48

ATOM 361 CD GLO A 142 16.545 −10.378 5.242 1.00 12.69

ATOM 362 OE1 GLU A 142 16.516 −10.311 6.485 1.00 14.31

ATOM 363 OE2 GLU A 142 15.527 −10.561 4.545 1.00 14.94

ATOM 364 C GLU A 142 20.414 −9.641 7.367 1.00 7.91

ATOM 365 O GLU A 142 20.180 −10.523 8.193 1.00 7.61

ATOM 366 N LYS A 143 21.576 −9.010 7.288 1.00 7.58

ATOM 368 CA LYS A 143 22.684 −9.353 8.160 1.00 7.56

ATOM 370 CB LYS A 143 23.808 −9.985 7.341 1.00 7.63

ATOM 373 CG LYS A 143 23.429 −11.335 6.723 1.00 7.75

ATOM 376 CD LYS A 143 24.554 −11.902 5.871 1.00 8.89

ATOM 379 CE LYS A 143 24.185 −13.242 5.262 1.00 10.51

ATOM 382 NZ LYS A 143 25.306 −13.829 4.466 1.00 11.82

ATOM 386 C LYS A 143 23.183 −8.116 8.892 1.00 7.45

ATOM 387 O LYS A 143 24.385 −7.887 8.988 1.00 7.79

ATOM 388 N ILE A 144 22.256 −7.316 9.407 1.00 7.24 N ATOM 390 CA ILE A 144 22.617 −6.111 10.157 1.00 7.37 C ATOM 392 CB ILE A 144 21.758 −4.926 9.725 1.00 7.95 C ATOM 394 CG1 ILE A 144 22.066 −4.586 8.260 1.00 9.50 C ATOM 397 CD1 ILE A 144 21.303 −3.432 7.744 1.00 10.75 C ATOM 401 CG2 ILE A 144 21.998 −3.722 10.610 1.00 7.98 C ATOM 405 C ILE A 144 22.461 −6.412 11.643 1.00 7.00 C ATOM 406 O ILE A 144 21.740 −7.333 12.008 1.00 6.71 C ATOM 407 N ALA A 145 23.161 −5.675 12.505 1.00 6.55 N ATOM 409 CA ALA A 145 23.060 −5.947 13.924 1.00 6.38 C ATOM 411 CB ALA A 145 24.182 −6.892 14.344 1.00 6.56 C ATOM 415 C ALA A 145 23.103 −4.720 14.822 1.00 6.21 C ATOM 416 O ALA A 145 23.744 −3.709 14.515 1.00 6.27 O ATOM 417 N TYR A 146 22.397 −4.821 15.935 1.00 5.83 N ATOM 419 CA TYR A 146 22.567 −3.855 16.991 1.00 5.75 C ATOM 421 CB TYR A 146 21.278 −3.491 17.680 1.00 5.65 C ATOM 424 CG TYR A 146 21.556 −2.722 18.955 1.00 5.17 C ATOM 425 CD1 TYR A 146 21.855 −1.366 18.922 1.00 4.51 C ATOM 427 CE1 TYR A 146 22.124 −0.661 20.096 1.00 4.27 C ATOM 429 CZ TYR A 146 22.107 −1.322 21.306 1.00 4.15 C ATOM 430 OH TYR A 146 22.373 −0.623 22.469 1.00 3.48 O ATOM 432 CE2 TYR A 146 21.825 −2.671 21.359 1.00 4.42 C ATOM 434 CD2 TYR A 146 21.566 −3.364 20.193 1.00 4.81 C ATOM 436 C TYR A 146 23.451 −4.543 18.015 1.00 5.68 C ATOM 437 O TYR A 146 23.214 −5.695 18.365 1.00 5.97 O ATOM 438 N VAL A 147 24.458 −3.845 18.509 1.00 5.56 N ATOM 440 CA VAL A 147 25.326 −4.434 19.509 1.00 5.28 C ATOM 442 CB VAL A 147 26.791 −4.503 19.025 1.00 5.60 C ATOM 444 CG1 VAL A 147 27.644 −5.214 20.036 1.00 5.40 C ATOM 448 CG2 VAL A 147 26.869 −5.217 17.673 1.00 6.04 C ATOM 452 C VAL A 147 25.213 −3.592 20.781 1.00 4.80 C ATOM 453 O VAL A 147 25.357 −2.370 20.735 1.00 4.27 O ATOM 454 N TYR A 148 24.933 −4.249 21.902 1.00 4.48 N ATOM 456 CA TYR A 148 24.817 −3.575 23.194 1.00 4.13 C ATOM 458 CB TYR A 148 24.291 −4.555 24.243 1.00 3.94 C ATOM 461 CG TYR A 148 22.795 −4.859 24.136 1.00 3.58 C ATOM 462 CD1 TYR A 148 22.327 −5.880 23.325 1.00 3.66 C ATOM 464 CE1 TYR A 148 20.983 −6.167 23.248 1.00 4.23 C ATOM 466 CZ TYR A 148 20.076 −5.422 23.975 1.00 3.79 C ATOM 467 OH TYR A 148 18.740 −5.721 23.900 1.00 4.39 O ATOM 469 CE2 TYR A 148 20.515 −4.400 24.791 1.00 3.42 C ATOM 471 CD2 TYR A 148 21.869 −4.132 24.865 1.00 3.02 C ATOM 473 C TYR A 148 26.181 −2.994 23.603 1.00 3.93 C ATOM 474 O TYR A 148 27.193 −3.334 22.992 1.00 4.16 O ATOM 475 N PRO A 149 26.216 −2.117 24.614 1.00 3.52 N ATOM 476 CA PRO A 149 27.463 −1.488 25.059 1.00 3.71 C ATOM 478 CB PRO A 149 26.999 −0.534 26.166 1.00 3.63 C ATOM 481 CG PRO A 149 25.556 −0.323 25.932 1.00 3.10 C ATOM 484 CD PRO A 149 25.068 −1.619 25.385 1.00 3.36 C ATOM 487 C PRO A 149 28.520 −2.429 25.607 1.00 3.72 C ATOM 488 O PRO A 149 29.644 −1.979 25.827 1.00 3.15 O ATOM 489 N ASP A 150 28.195 −3.698 25.820 1.00 4.10 N ATOM 491 CA ASP A 150 29.219 −4.647 26.257 1.00 4.16 C ATOM 493 CB ASP A 150 28.632 −5.834 27.034 1.00 4.16 C ATOM 496 CG ASP A 150 27.697 −6.702 26.218 1.00 4.50 C ATOM 497 OD1 ASP A 150 27.395 −6.381 25.041 1.00 4.01 O ATOM 498 OD2 ASP A 150 27.199 −7.741 26.711 1.00 4.84 O ATOM 499 C ASP A 150 30.088 −5.102 25.073 1.00 4.57 C ATOM 500 O ASP A 150 31.110 −5.769 25.277 1.00 4.32 O ATOM 501 N GLU A 151 29.710 −4.680 23.863 1.00 4.71 N ATOM 503 CA GLU A 151 30.388 −5.043 22.617 1.00 5.51 C ATOM 505 CB GLU A 151 31.796 −4.464 22.555 1.00 6.19 C ATOM 508 CG GLU A 151 31.809 −2.948 22.701 1.00 7.98 C ATOM 511 CD GLU A 151 33.198 −2.358 22.605 1.00 9.90 C ATOM 512 OE1 GLU A 151 33.909 −2.350 23.625 1.00 11.04

ATOM 513 OE2 GLU A 151 33.570 −1.893 21.510 1.00 12.19

ATOM 514 C GLU A 151 30.408 −6.554 22.441 1.00 5.71

ATOM 515 O GLU A 151 31.357 −7.117 21.909 1.00 5.94

ATOM 516 N ARG A 152 29.336 −7.208 22.872 1.00 5.92

ATOM 518 CA ARG A 152 29.271 −8.663 22.846 1.00 6.09

ATOM 520 CB ARG A 152 29.723 −9.216 24.206 1.00 6.65

ATOM 523 CG ARG A 152 29.715 −10.730 24.288 1.00 7.72

ATOM 526 CD ARG A 152 30.177 −11.289 25.644 1.00 9.71

ATOM 529 NE ARG A 152 30.019 −12.741 25.683 1.00 11.70

ATOM 531 CZ ARG A 152 31.007 −13.605 25.870 1.00 13.50

ATOM 532 NH1 ARG A 152 32.247 −13.183 26.085 1.00 14.88

ATOM 535 NH2 ARG A 152 30.753 −14.906 25.867 1.00 14.21

ATOM 538 C ARG A 152 27.870 −9.156 22.530 1.00 5.87

ATOM 539 O ARG A 152 27.682 −9.962 21.623 1.00 6.13

ATOM 540 N THR A 153 26.890 −8.686 23.291 1.00 5.66

ATOM 542 CA THR A 153 25.507 −9.066 23.066 1.00 5.27

ATOM 544 CB THR A 153 24.656 −8.749 24.274 1.00 5.42

ATOM 546 OG1 THR A 153 25.280 −9.288 25.445 1.00 6.02

ATOM 548 CG2 THR A 153 23.311 −9.467 24.197 1.00 5.91

ATOM 552 C THR A 153 24.984 −8.289 21.884 1.00 5.05

ATOM 553 O THR A 153 25.111 −7.060 21.842 1.00 4.35

ATOM 554 N ALA A 154 24.373 −9.010 20.947 1.00 4.76

ATOM 556 CA ALA A 154 23.892 −8.413 19.723 1.00 4.85

ATOM 558 CB ALA A 154 24.885 −8.678 18.600 1.00 4.69

ATOM 562 C ALA A 154 22.514 −8.935 19.326 1.00 4.90

ATOM 563 O ALA A 154 22.090 −10.016 19.740 1.00 5.00

ATOM 564 N LEU A 155 21.838 −8.137 18.508 1.00 5.04

ATOM 566 CA LEU A 155 20.543 −8.475 17.934 1.00 4.96

ATOM 568 CB LEU A 155 19.488 −7.453 18.363 1.00 4.60

ATOM 571 CG LEU A 155 19.311 −7.227 19.871 1.00 4.30

ATOM 573 CD1 LEU A 155 18.176 −6.271 20.143 1.00 4.42

ATOM 577 CD2 LEU A 155 19.082 −8.530 20.607 1.00 3.93

ATOM 581 C LEU A 155 20.792 −8.437 16.420 1.00 5.23

ATOM 582 O LEU A 155 20.928 −7.370 15.836 1.00 5.43

ATOM 583 N TYR A 156 20.866 −9.613 15.805 1.00 5.87

ATOM 585 CA TYR A 156 21.312 −9.782 14.422 1.00 6.34

ATOM 587 CB TYR A 156 22.454 −10.815 14.445 1.00 6.89

ATOM 590 CG TYR A 156 23.081 −11.169 13.117 1.00 8.47

ATOM 591 CD1 TYR A 156 24.005 −10.336 12.519 1.00 9.81

ATOM 593 CE1 TYR A 156 24.604 −10.665 11.332 1.00 9.89

ATOM 595 CZ TYR A 156 24.300 −11.848 10.728 1.00 10.98

ATOM 596 OH TYR A 156 24.892 −12.163 9.533 1.00 11.95

ATOM 598 CE2 TYR A 156 23.380 −12.703 11.297 1.00 11.43

ATOM 600 CD2 TYR A 156 22.790 −12.368 12.495 1.00 10.67

ATOM 602 C TYR A 156 20.205 −10.268 13.497 1.00 6.17

ATOM 603 O TYR A 156 19.532 −11.251 13.798 1.00 5.91

ATOM 604 N GLY A 157 20.027 −9.588 12.362 1.00 5.92

ATOM 606 CA GLY A 157 19.010 −9.977 11.407 1.00 6.02

ATOM 609 C GLY A 157 18.607 −8.857 10.467 1.00 5.97

ATOM 610 O GLY A 157 19.444 −8.093 9.979 1.00 5.47

ATOM 611 N LYS A 158 17.304 −8.754 10.251 1.00 6.58

ATOM 613 CA LYS A 158 16.730 −7.820 9.289 1.00 6.79

ATOM 615 CB LYS A 158 15.383 −8.366 8.800 1.00 7.28

ATOM 618 CG LYS A 158 14.762 −7.570 7.673 1.00 8.22

ATOM 621 CD LYS A 158 13.496 −8.225 7.123 1.00 9.35

ATOM 624 CE LYS A 158 12.982 −7.512 5.882 1.00 10.69

ATOM 627 NZ LYS A 158 14.055 −7.155 4.906 1.00 11.82

ATOM 631 C LYS A 158 16.539 −6.421 9.862 1.00 6.67

ATOM 632 O LYS A 158 15.893 −6.245 10.888 1.00 7.00

ATOM 633 N PHE A 159 17.132 −5.435 9.199 1.00 6.57

ATOM 635 CA PHE A 159 16.961 −4.033 9.558 1.00 6.42

ATOM 637 CB PHE A 159 18.244 −3.424 10.113 1.00 6.39

ATOM 640 CG PHE A 159 18.557 −3.810 11.527 1.00 6.21

ATOM 641 CD1 PHE A 159 18.938 −5.105 11.834 1.00 6.41

ATOM 643 CE1 PHE A 159 19.258 −5.462 13.124 1.00 7.30

ATOM 645 CZ PHE A 159 19.205 −4.522 14.141 1.00 7.03

ATOM 647 CE2 PHE A 159 18.840 −3.225 13.861 1.00 6.65

ATOM 649 CD2 PHE A 159 18.510 −2.865 12.549 1.00 6.66

ATOM 651 C PHE A 159 16.630 −3.272 8.288 1.00 6.42

ATOM 652 O PHE A 159 17.075 −3.655 7.206 1.00 6.21

ATOM 653 N ILE A 160 15.872 −2.189 8.423 1.00 6.70

ATOM 655 CA ILE A 160 15.584 −1.310 7.295 1.00 6.91

ATOM 657 CB ILE A 160 14.128 −1.421 6.841 1.00 6.96

ATOM 659 CG1 ILE A 160 13.857 −2.802 6.238 1.00 6.91

ATOM 662 CD1 ILE A 160 12.379 −3.105 6.032 1.00 7.38

ATOM 666 CG2 ILE A 160 13.854 −0.364 5.804 1.00 6.76

ATOM 670 C ILE A 160 15.891 0.123 7.731 1.00 7.39

ATOM 671 O ILE A 160 15.271 0.635 8.663 1.00 7.44

ATOM 672 N ASP A 161 16.870 0.747 7.084 1.00 7.95

ATOM 674 CA ASP A 161 17.286 2.105 7.420 1.00 8.37

ATOM 676 CB ASP A 161 16.195 3.102 7.053 1.00 8.59

ATOM 679 CG ASP A 161 16.708 4.528 6.967 1.00 10.23

ATOM 680 OD1 ASP A 161 17.935 4.715 6.802 1.00 11.11

ATOM 681 OD2 ASP A 161 15.951 5.527 7.038 1.00 11.88

ATOM 682 C ASP A 161 17.607 2.256 8.905 1.00 8.18

ATOM 683 O ASP A 161 17.222 3.248 9.508 1.00 8.44

ATOM 684 N GLY A 162 18.292 1.272 9.486 1.00 8.28

ATOM 686 CA GLY A 162 18.703 1.321 10.888 1.00 7.95

ATOM 689 C GLY A 162 17.660 0.834 11.883 1.00 7.65

ATOM 690 O GLY A 162 17.938 0.718 13.080 1.00 7.80

ATOM 691 N GLU A 163 16.464 0.540 11.390 1.00 7.22

ATOM 693 CA GLU A 163 15.357 0.112 12.228 1.00 7.06

ATOM 695 CB GLU A 163 14.042 0.667 11.683 1.00 7.80

ATOM 698 CG GLU A 163 12.835 0.348 12.546 1.00 9.55

ATOM 701 CD GLU A 163 11.566 0.978 12.014 1.00 12.39 C ATOM 702 OE1 GLU A 163 10.581 0.247 11.786 1.00 13.95 O ATOM 703 OE2 GLU A 163 11.561 2.208 11.819 1.00 15.05 O ATOM 704 C GLU A 163 15.312 −1.408 12.280 1.00 6.25 C ATOM 705 O GLU A 163 15.342 −2.067 11.245 1.00 6.04 O ATOM 706 N MET A 164 15.232 −1.956 13.488 1.00 4.98 N ATOM 708 CA MET A 164 15.210 −3.396 13.688 1.00 4.77 C ATOM 710 CB MET A 164 15.531 −3.723 15.143 1.00 4.72 C ATOM 713 CG MET A 164 15.774 −5.202 15.382 1.00 4.94 C ATOM 716 SD MET A 164 16.451 −5.533 17.027 1.00 5.80 S ATOM 717 CE MET A 164 15.147 −4.981 17.997 1.00 5.96 C ATOM 721 C MET A 164 13.870 −4.029 13.329 1.00 4.84 C ATOM 722 O MET A 164 12.851 −3.766 13.969 1.00 4.40 O ATOM 723 N ILE A 165 13.880 −4.863 12.296 1.00 5.00 N ATOM 725 CA ILE A 165 12.671 −5.558 11.875 1.00 4.95 C ATOM 727 CB ILE A 165 12.608 −5.633 10.341 1.00 5.00 C ATOM 729 CG1 ILE A 165 12.742 −4.223 9.744 1.00 4.62 C ATOM 732 CD1 ILE A 165 11.748 −3.208 10.282 1.00 4.68 C ATOM 736 CG2 ILE A 165 11.329 −6.307 9.929 1.00 5.38 C ATOM 740 C ILE A 165 12.592 −6.946 12.525 1.00 5.29 C ATOM 741 O ILE A 165 11.558 −7.315 13.093 1.00 4.78 O ATOM 742 N GLU A 166 13.686 −7.705 12.446 1.00 6.00 N ATOM 744 CA GLU A 166 13.785 −9.017 13.085 1.00 6.87 C ATOM 746 CB GLU A 166 13.403 −10.149 12.137 1.00 7.63 C ATOM 749 CG GLU A 166 13.470 −11.533 12.779 1.00 9.02 C ATOM 752 CD GLU A 166 13.503 −12.667 11.766 1.00 12.97 C ATOM 753 OE1 GLU A 166 13.377 −12.407 10.552 1.00 15.93 C ATOM 754 OE2 GLU A 166 13.626 −13.836 12.185 1.00 14.80

ATOM 755 C GLU A 166 15.217 −9.261 13.538 1.00 6.98

ATOM 756 O GLU A 166 16.045 −9.709 12.749 1.00 6.92

ATOM 757 N GLY A 167 15.508 −8.980 14.803 1.00 7.29

ATOM 759 CA GLY A 167 16.842 −9.203 15.325 1.00 7.20

ATOM 762 C GLY A 167 16.852 −10.404 16.256 1.00 7.48

ATOM 763 O GLY A 167 16.056 −10.456 17.191 1.00 7.66

ATOM 764 N LYS A 168 17.728 −11.373 15.984 1.00 7.23

ATOM 766 CA LYS A 168 17.818 −12.587 16.781 1.00 7.09

ATOM 768 CB LYS A 168 18.026 −13.814 15.888 1.00 7.16

ATOM 771 CG LYS A 168 16.896 −14.045 14.883 1.00 8.66

ATOM 774 CD LYS A 168 17.128 −15.294 14.041 1.00 10.94

ATOM 777 CE LYS A 168 16.025 −15.488 13.017 1.00 12.79

ATOM 780 NZ LYS A 168 16.093 −16.800 12.293 1.00 15.02

ATOM 784 C LYS A 168 18.996 −12.428 17.710 1.00 6.71

ATOM 785 O LYS A 168 19.983 −11.812 17.337 1.00 6.28

ATOM 786 N LEU A 169 18.878 −12.976 18.916 1.00 6.73

ATOM 788 CA LEU A 169 19.933 −12.900 19.902 1.00 6.40

ATOM 790 CB LEU A 169 19.498 −13.607 21.186 1.00 7.01

ATOM 793 CG LEU A 169 20.474 −13.428 22.350 1.00 8.27

ATOM 795 CD1 LEU A 169 20.640 −11.955 22.716 1.00 9.19

ATOM 799 CD2 LEU A 169 20.033 −14.232 23.569 1.00 9.49

ATOM 803 C LEU A 169 21.217 −13.531 19.363 1.00 5.72

ATOM 804 O LEU A 169 21.198 −14.661 18.882 1.00 5.15

ATOM 805 N ALA A 170 22.333 −12.815 19.490 1.00 5.12

ATOM 807 CA ALA A 170 23.604 −13.270 18.952 1.00 4.79

ATOM 809 CB ALA A 170 23.813 −12.705 17.565 1.00 4.78

ATOM 813 C ALA A 170 24.731 −12.807 19.849 1.00 4.58

ATOM 814 O ALA A 170 24.512 −12.012 20.759 1.00 4.70

ATOM 815 N THR A 171 25.933 −13.309 19.581 1.00 4.52

ATOM 817 CA THR A 171 27.131 −12.873 20.290 1.00 4.42

ATOM 819 CB THR A 171 27.756 −14.026 21.085 1.00 4.30

ATOM 821 OG1 THR A 171 26.837 −14.497 22.083 1.00 4.54

ATOM 823 CG2 THR A 171 28.977 −13.555 21.899 1.00 3.98

ATOM 827 C THR A 171 28.120 −12.395 19.236 1.00 4.51

ATOM 828 O THR A 171 28.397 −13.116 18.278 1.00 4.13

ATOM 829 N LEU A 172 28.636 −11.184 19.406 1.00 5.15

ATOM 831 CA LEU A 172 29.680 −10.673 18.541 1.00 5.83

ATOM 833 CB LEU A 172 29.805 −9.159 18.697 1.00 6.13

ATOM 836 CG LEU A 172 31.000 −8.525 17.977 1.00 6.72

ATOM 838 CD1 LEU A 172 30.994 −8.877 16.496 1.00 7.77

ATOM 842 CD2 LEU A 172 30.991 −7.020 18.167 1.00 7.70

ATOM 846 C LEU A 172 30.973 −11.365 18.989 1.00 6.16

ATOM 847 O LEU A 172 31.430 −11.155 20.111 1.00 6.30

ATOM 848 N MET A 173 31.553 −12.201 18.136 1.00 6.57

ATOM 850 CA MET A 173 32.750 −12.965 18.519 1.00 7.57

ATOM 852 CB MET A 173 32.727 −14.331 17.850 1.00 7.41

ATOM 855 CG MET A 173 31.674 −15.243 18.433 1.00 7.25

ATOM 858 SD MET A 173 31.804 −16.910 17.822 1.00 7.63

ATOM 859 CE MET A 173 31.392 −16.676 16.148 1.00 8.74

ATOM 863 C MET A 173 34.060 −12.277 18.188 1.00 8.46

ATOM 864 O MET A 173 34.958 −12.176 19.035 1.00 9.38

ATOM 865 N SER A 174 34.182 −11.841 16.943 1.00 9.51

ATOM 867 CA SER A 174 35.395 −11.198 16.472 1.00 9.87

ATOM 869 CB SER A 174 36.388 −12.243 15.965 1.00 10.03

ATOM 872 OG SER A 174 35.897 −12.880 14.801 1.00 10.72

ATOM 874 C SER A 174 35.028 −10.268 15.331 1.00 10.19

ATOM 875 O SER A 174 33.887 −10.262 14.863 1.00 9.74

ATOM 876 N THR A 175 36.002 −9.477 14.899 1.00 10.64

ATOM 878 CA THR A 175 35.841 −8.599 13.752 1.00 11.10

ATOM 880 CB THR A 175 35.735 −7.125 14.184 1.00 11.03

ATOM 882 OG1 THR A 175 34.539 −6.915 14.949 1.00 10.19

ATOM 884 CG2 THR A 175 35.544 −6.209 12.996 1.00 11.00

ATOM 888 C THR A 175 37.079 −8.797 12.894 1.00 11.71

ATOM 889 O THR A 175 38.192 −8.951 13.420 1.00 11.93

ATOM 890 N GLU A 176 36.884 −8.814 11.584 1.00 12.23

ATOM 892 CA GLU A 176 37.970 −8.970 10.629 1.00 12.70

ATOM 894 CB GLU A 176 37.824 −10.291 9.873 1.00 13.24

ATOM 897 CG GLU A 176 38.742 −11.388 10.361 1.00 14.72

ATOM 900 CD GLU A 176 40.202 −11.034 10.166 1.00 16.74

ATOM 901 OE1 GLU A 176 40.678 −11.080 9.006 1.00 18.24

ATOM 902 OE2 GLU A 176 40.868 −10.699 11.167 1.00 17.70

ATOM 903 C GLU A 176 37.920 −7.818 9.635 1.00 12.62

ATOM 904 O GLU A 176 36.996 −7.741 8.824 1.00 12.20

ATOM 905 N GLU A 177 38.905 −6.924 9.702 1.00 12.51

ATOM 907 CA GLU A 177 38.963 −5.770 8.805 1.00 12.61

ATOM 909 CB GLU A 177 39.451 −6.189 7.408 1.00 12.77

ATOM 912 CG GLU A 177 40.878 −6.739 7.442 1.00 13.92

ATOM 915 CD GLU A 177 41.661 −6.565 6.147 1.00 15.14

ATOM 916 OE1 GLU A 177 41.102 −6.076 5.141 1.00 15.39

ATOM 917 OE2 GLU A 177 42.865 −6.919 6.154 1.00 15.99

ATOM 918 C GLU A 177 37.611 −5.035 8.763 1.00 12.30

ATOM 919 O GLU A 177 37.070 −4.742 7.689 1.00 12.20

ATOM 920 N GLY A 178 37.061 −4.764 9.948 1.00 11.92

ATOM 922 CA GLY A 178 35.806 −4.044 10.081 1.00 11.82

ATOM 925 C GLY A 178 34.565 −4.927 10.041 1.00 11.59

ATOM 926 O GLY A 178 33.496 −4.517 10.489 1.00 11.30

ATOM 927 N ARG A 179 34.710 −6.143 9.526 1.00 11.63

ATOM 929 CA ARG A 179 33.580 −7.061 9.384 1.00 11.85

ATOM 931 CB ARG A 179 33.790 −7.952 8.166 1.00 12.01

ATOM 934 CG ARG A 179 34.275 −7.169 6.958 1.00 13.17

ATOM 937 CD ARG A 179 34.204 −7.922 5.656 1.00 14.87

ATOM 940 NE ARG A 179 34.631 −7.092 4.533 1.00 16.33

ATOM 942 CZ ARG A 179 34.270 −7.297 3.276 1.00 18.07

ATOM 943 NH1 ARG A 179 33.464 −8.308 2.968 1.00 18.99

ATOM 946 NH2 ARG A 179 34.708 −6.485 2.318 1.00 18.61

ATOM 949 C ARG A 179 33.403 −7.917 10.632 1.00 11.75

ATOM 950 O ARG A 179 34.311 −8.634 11.031 1.00 11.24

ATOM 951 N PRO A 180 32.221 −7.865 11.232 1.00 11.83

ATOM 952 CA PRO A 180 31.961 −8.617 12.453 1.00 11.75

ATOM 954 CB PRO A 180 30.799 −7.855 13.092 1.00 11.88

ATOM 957 CG PRO A 180 30.346 −6.837 12.066 1.00 12.63

ATOM 960 CD PRO A 180 31.036 −7.111 10.800 1.00 11.88

ATOM 963 C PRO A 180 31.523 −10.035 12.171 1.00 11.47

ATOM 964 O PRO A 180 30.967 −10.320 11.112 1.00 11.35

ATOM 965 N HIS A 181 31.752 −10.908 13.140 1.00 10.99

ATOM 967 CA HIS A 181 31.373 −12.301 13.021 1.00 10.98

ATOM 969 CB HIS A 181 32.644 −13.124 12.855 1.00 11.41

ATOM 972 CG HIS A 181 33.479 −12.601 11.733 1.00 12.68

ATOM 973 ND1 HIS A 181 33.096 −12.732 10.413 1.00 14.33

ATOM 975 CE1 HIS A 181 33.967 −12.106 9.642 1.00 14.59

ATOM 977 NE2 HIS A 181 34.878 −11.542 10.417 1.00 14.53

ATOM 979 CD2 HIS A 181 34.573 −11.806 11.730 1.00 13.34

ATOM 981 C HIS A 181 30.538 −12.655 14.237 1.00 10.32

ATOM 982 O HIS A 181 30.976 −12.486 15.378 1.00 10.37

ATOM 983 N PHE A 182 29.315 −13.102 13.977 1.00 9.47

ATOM 985 CA PHE A 182 28.364 −13.389 15.037 1.00 8.95

ATOM 987 CB PHE A 182 27.026 −12.691 14.756 1.00 8.73

ATOM 990 CG PHE A 182 27.112 −11.193 14.743 1.00 9.26

ATOM 991 CD1 PHE A 182 27.259 −10.506 13.551 1.00 9.46

ATOM 993 CE1 PHE A 182 27.338 −9.131 13.540 1.00 10.19

ATOM 995 CZ PHE A 182 27.284 −8.423 14.722 1.00 11.01

ATOM 997 CE2 PHE A 182 27.142 −9.092 15.921 1.00 10.72

ATOM 999 CD2 PHE A 182 27.053 −10.472 15.926 1.00 10.44

ATOM 1001 C PHE A 182 28.094 −14.868 15.172 1.00 8.41

ATOM 1002 O PHE A 182 28.181 −15.608 14.200 1.00 7.90

ATOM 1003 N GLU A 183 27.779 −15.294 16.390 1.00 7.69

ATOM 1005 CA GLU A 183 27.266 −16.632 16.599 1.00 7.89

ATOM 1007 CB GLU A 183 28.026 −17.388 17.694 1.00 8.44

ATOM 1010 CG GLU A 183 27.883 −16.811 19.074 1.00 9.36

ATOM 1013 CD GLU A 183 28.444 −17.736 20.144 1.00 9.99

ATOM 1014 OE1 GLU A 183 29.224 −18.651 19.813 1.00 11.50

ATOM 1015 OE2 GLU A 183 28.089 −17.561 21.314 1.00 10.33

ATOM 1016 C GLU A 183 25.798 −16.403 16.965 1.00 7.71

ATOM 1017 O GLU A 183 25.499 −15.538 17.783 1.00 6.70

ATOM 1018 N LEU A 184 24.882 −17.106 16.300 1.00 7.86

ATOM 1020 CA LEU A 184 23.455 −16.996 16.617 1.00 8.53

ATOM 1022 CB LEU A 184 22.575 −17.474 15.455 1.00 8.98

ATOM 1025 CG LEU A 184 21.860 −16.417 14.596 1.00 10.69

ATOM 1027 CD1 LEU A 184 20.916 −17.109 13.631 1.00 11.63

ATOM 1031 CD2 LEU A 184 21.077 −15.394 15.406 1.00 11.85

ATOM 1035 C LEU A 184 23.182 −17.842 17.847 1.00 8.40

ATOM 1036 O LEU A 184 23.577 −19.002 17.892 1.00 8.35

ATOM 1037 N MET A 185 22.524 −17.268 18.847 1.00 8.65

ATOM 1039 CA MET A 185 22.274 −17.994 20.092 1.00 9.49

ATOM 1041 CB MET A 185 22.166 −17.032 21.277 1.00 9.31

ATOM 1044 CG MET A 185 23.331 −16.044 21.374 1.00 9.03

ATOM 1047 SD MET A 185 24.981 −16.799 21.366 1.00 8.67

ATOM 1048 CE MET A 185 24.996 −17.487 22.988 1.00 8.51

ATOM 1052 C MET A 185 21.012 −18.834 19.948 1.00 10.44

ATOM 1053 O MET A 185 20.171 −18.555 19.085 1.00 10.33

ATOM 1054 N PRO A 186 20.881 −19.871 20.767 1.00 11.73

ATOM 1055 CA PRO A 186 19.702 −20.733 20.721 1.00 12.82

ATOM 1057 CB PRO A 186 20.089 −21.907 21.625 1.00 12.75

ATOM 1060 CG PRO A 186 21.528 −21.764 21.891 1.00 12.45

ATOM 1063 CD PRO A 186 21.842 −20.322 21.783 1.00 12.03

ATOM 1066 C PRO A 186 18.468 −20.025 21.262 1.00 13.67

ATOM 1067 O PRO A 186 18.585 −18.993 21.920 1.00 14.31

ATOM 1068 N GLY A 187 17.302 −20.592 21.002 1.00 14.68

ATOM 1070 CA GLY A 187 16.051 −19.982 21.411 1.00 15.36

ATOM 1073 C GLY A 187 15.353 −19.478 20.158 1.00 15.85

ATOM 1074 O GLY A 187 15.922 −19.536 19.066 1.00 16.33

ATOM 1075 N ASN A 188 14.126 −18.993 20.295 1.00 16.29

ATOM 1077 CA ASN A 188 13.382 −18.491 19.142 1.00 16.60

ATOM 1079 CB ASN A 188 12.224 −19.425 18.800 1.00 16.84

ATOM 1082 CG ASN A 188 12.685 −20.693 18.107 1.00 17.32

ATOM 1083 OD1 ASN A 188 12.476 −20.872 16.903 1.00 17.36

ATOM 1084 ND2 ASN A 188 13.311 −21.584 18.869 1.00 17.33

ATOM 1087 C ASN A 188 12.851 −17.074 19.338 1.00 16.40

ATOM 1088 O ASN A 188 12.059 −16.586 18.529 1.00 16.84

ATOM 1089 N SER A 189 13.274 −16.423 20.413 1.00 15.95

ATOM 1091 CA SER A 189 12.832 −15.063 20.697 1.00 15.52

ATOM 1093 CB SER A 189 13.246 −14.644 22.106 1.00 15.67

ATOM 1096 OG SER A 189 12.480 −15.339 23.080 1.00 16.44

ATOM 1098 C SER A 189 13.394 −14.078 19.677 1.00 14.61

ATOM 1099 O SER A 189 14.597 −13.968 19.484 1.00 15.04

ATOM 1100 N VAL A 190 12.501 −13.380 18.998 1.00 13.84

ATOM 1102 CA VAL A 190 12.926 −12.357 18.061 1.00 12.46

ATOM 1104 CB VAL A 190 12.127 −12.417 16.747 1.00 12.81

ATOM 1106 CG1 VAL A 190 12.524 −13.627 15.919 1.00 13.83

ATOM 1110 CG2 VAL A 190 10.629 −12.440 17.024 1.00 13.36

ATOM 1114 C VAL A 190 12.671 −11.017 18.737 1.00 10.30

ATOM 1115 O VAL A 190 11.856 −10.935 19.651 1.00 9.90

ATOM 1116 N TYR A 191 13.365 −9.978 18.297 1.00 7.89

ATOM 1118 CA TYR A 191 13.065 −8.632 18.748 1.00 6.57

ATOM 1120 CB TYR A 191 14.196 −8.097 19.599 1.00 6.34

ATOM 1123 CG TYR A 191 14.589 −9.048 20.680 1.00 5.06

ATOM 1124 CD1 TYR A 191 15.581 −9.990 20.460 1.00 5.67

ATOM 1126 CE1 TYR A 191 15.982 −10.870 21.483 1.00 4.58

ATOM 1128 CZ TYR A 191 15.358 −10.831 22.705 1.00 3.98

ATOM 1129 OH TYR A 191 15.770 −11.722 23.688 1.00 5.42

ATOM 1131 CE2 TYR A 191 14.374 −9.904 22.956 1.00 3.96

ATOM 1133 CD2 TYR A 191 13.976 −9.015 21.936 1.00 4.68

ATOM 1135 C TYR A 191 12.867 −7.717 17.548 1.00 5.86

ATOM 1136 O TYR A 191 13.442 −7.941 16.490 1.00 5.27

ATOM 1137 N HIS A 192 12.064 −6.680 17.733 1.00 5.52

ATOM 1139 CA HIS A 192 11.834 −5.683 16.695 1.00 5.42

ATOM 1141 CB HIS A 192 10.640 −6.082 15.840 1.00 5.81

ATOM 1144 CG HIS A 192 9.337 −6.131 16.581 1.00 7.52

ATOM 1145 ND1 HIS A 192 8.968 −7.201 17.368 1.00 8.54

ATOM 1147 CE1 HIS A 192 7.767 −6.981 17.874 1.00 8.22

ATOM 1149 NE2 HIS A 192 7.340 −5.810 17.439 1.00 8.91

ATOM 1151 CD2 HIS A 192 8.297 −5.263 16.618 1.00 8.65

ATOM 1153 C HIS A 192 11.604 −4.308 17.310 1.00 4.59

ATOM 1154 O HIS A 192 11.297 −4.196 18.500 1.00 4.80

ATOM 1155 N PHE A 193 11.814 −3.269 16.514 1.00 3.78

ATOM 1157 CA PHE A 193 11.499 −1.910 16.920 1.00 4.00

ATOM 1159 CB PHE A 193 11.713 −0.937 15.762 1.00 3.98

ATOM 1162 CG PHE A 193 11.543 0.513 16.132 1.00 4.65

ATOM 1163 CD1 PHE A 193 12.275 1.085 17.162 1.00 5.34

ATOM 1165 CE1 PHE A 193 12.114 2.427 17.484 1.00 5.11

ATOM 1167 CZ PHE A 193 11.224 3.201 16.773 1.00 6.20

ATOM 1169 CE2 PHE A 193 10.492 2.641 15.759 1.00 6.35

ATOM 1171 CD2 PHE A 193 10.654 1.307 15.440 1.00 6.00

ATOM 1173 C PHE A 193 10.043 −1.917 17.354 1.00 4.11

ATOM 1174 O PHE A 193 9.153 −2.237 16.552 1.00 3.97

ATOM 1175 N ASP A 194 9.794 −1.561 18.607 1.00 4.35

ATOM 1177 CA ASP A 194 8.458 −1.645 19.176 1.00 4.97

ATOM 1179 CB ASP A 194 8.290 −3.008 19.861 1.00 5.31

ATOM 1182 CG ASP A 194 6.876 −3.264 20.360 1.00 4.89

ATOM 1183 OD1 ASP A 194 6.731 −3.777 21.498 1.00 4.65

ATOM 1184 OD2 ASP A 194 5.855 −2.991 19.698 1.00 6.48

ATOM 1185 C ASP A 194 8.249 −0.494 20.162 1.00 5.45

ATOM 1186 O ASP A 194 8.101 −0.711 21.369 1.00 5.31

ATOM 1187 N LYS A 195 8.246 0.728 19.634 1.00 5.95

ATOM 1189 CA LYS A 195 8.067 1.932 20.444 1.00 6.42

ATOM 1191 CB LYS A 195 8.163 3.173 19.549 1.00 6.85

ATOM 1194 CG LYS A 195 8.499 4.463 20.274 1.00 7.53

ATOM 1197 CD LYS A 195 8.571 5.668 19.330 1.00 9.24

ATOM 1200 CE LYS A 195 8.671 6.977 20.117 1.00 10.07

ATOM 1203 NZ LYS A 195 8.535 8.203 19.303 1.00 10.82

ATOM 1207 C LYS A 195 6.718 1.897 21.167 1.00 6.73

ATOM 1208 O LYS A 195 5.701 1.507 20.582 1.00 5.99

ATOM 1209 N SER A 196 6.697 2.294 22.438 1.00 6.97

ATOM 1211 CA SER A 196 5.443 2.313 23.210 1.00 7.85

ATOM 1213 CB SER A 196 5.741 2.699 24.653 1.00 7.66

ATOM 1216 OG SER A 196 6.188 4.036 24.712 1.00 7.51

ATOM 1218 C SER A 196 4.375 3.286 22.654 1.00 8.71

ATOM 1219 O SER A 196 4.719 4.256 21.987 1.00 8.40

ATOM 1220 N THR A 197 3.100 3.017 22.971 1.00 10.30

ATOM 1222 CA THR A 197 1.936 3.843 22.568 1.00 11.43

ATOM 1224 CB THR A 197 1.071 3.161 21.458 1.00 11.80

ATOM 1226 OG1 THR A 197 0.256 2.116 22.010 1.00 12.85

ATOM 1228 CG2 THR A 197 1.933 2.464 20.416 1.00 11.59

ATOM 1232 C THR A 197 1.075 4.129 23.811 1.00 12.45

ATOM 1233 O THR A 197 1.409 3.702 24.907 1.00 12.65

ATOM 1234 N SER A 198 −0.051 4.818 23.658 1.00 13.61

ATOM 1236 CA SER A 198 −0.866 5.162 24.829 1.00 14.55

ATOM 1238 CB SER A 198 −1.735 6.376 24.549 1.00 14.51

ATOM 1241 OG SER A 198 −2.410 6.197 23.325 1.00 13.76

ATOM 1243 C SER A 198 −1.754 3.982 25.168 1.00 15.46

ATOM 1244 O SER A 198 −2.209 3.819 26.297 1.00 16.73

ATOM 1245 N SER A 199 −2.002 3.166 24.158 1.00 15.77

ATOM 1247 CA SER A 199 −2.797 1.972 24.318 1.00 16.24

ATOM 1249 CB SER A 199 −3.745 1.838 23.130 1.00 16.54

ATOM 1252 OG SER A 199 −3.053 1.414 21.970 1.00 17.04

ATOM 1254 C SER A 199 −1.869 0.749 24.425 1.00 16.21

ATOM 1255 O SER A 199 −2.332 −0.385 24.516 1.00 16.42

ATOM 1256 N CYS A 200 −0.559 0.976 24.438 1.00 15.86

ATOM 1258 CA CYS A 200 0.386 −0.137 24.428 1.00 15.68

ATOM 1260 CB CYS A 200 0.453 −0.723 23.012 1.00 15.84

ATOM 1263 SG CYS A 200 1.110 −2.412 22.884 1.00 17.21

ATOM 1264 C CYS A 200 1.799 0.229 24.868 1.00 14.77

ATOM 1265 O CYS A 200 2.528 0.896 24.140 1.00 15.85

ATOM 1266 N ILE A 201 2.199 −0.229 26.052 1.00 13.28

ATOM 1268 CA ILE A 201 3.565 −0.032 26.518 1.00 11.96

ATOM 1270 CB ILE A 201 3.689 −0.385 28.025 1.00 12.01

ATOM 1272 CG1 ILE A 201 5.108 −0.137 28.534 1.00 12.80

ATOM 1275 CD1 ILE A 201 5.162 0.134 30.028 1.00 13.95

ATOM 1279 CG2 ILE A 201 3.284 −1.817 28.271 1.00 11.38

ATOM 1283 C ILE A 201 4.519 −0.889 25.680 1.00 10.34

ATOM 1284 O ILE A 201 5.630 −0.469 25.380 1.00 9.68

ATOM 1285 N SER A 202 4.057 −2.075 25.284 1.00 9.04

ATOM 1287 CA SER A 202 4.859 −3.027 24.519 1.00 8.50

ATOM 1289 CB SER A 202 5.929 −3.672 25.431 1.00 8.52

ATOM 1292 OG SER A 202 6.646 −4.704 24.774 1.00 6.90

ATOM 1294 C SER A 202 3.958 −4.114 23.917 1.00 8.85

ATOM 1295 O SER A 202 2.965 −4.520 24.529 1.00 8.96

ATOM 1296 N THR A 203 4.282 −4.557 22.703 1.00 8.53

ATOM 1298 CA THR A 203 3.553 −5.638 22.063 1.00 7.99

ATOM 1300 CB THR A 203 4.000 −5.799 20.604 1.00 8.51

ATOM 1302 OG1 THR A 203 3.927 −4.539 19.917 1.00 9.13

ATOM 1304 CG2 THR A 203 3.031 −6.653 19.837 1.00 9.16

ATOM 1308 C THR A 203 3.802 −6.953 22.780 1.00 7.35

ATOM 1309 O THR A 203 2.964 −7.850 22.759 1.00 6.77

ATOM 1310 N ASN A 204 4.983 −7.072 23.388 1.00 6.67

ATOM 1312 CA ASN A 204 5.358 −8.269 24.108 1.00 6.32

ATOM 1314 CB ASN A 204 6.430 −9.031 23.340 1.00 7.02

ATOM 1317 CG ASN A 204 6.076 −9.229 21.901 1.00 9.04

ATOM 1318 OD1 ASN A 204 5.442 −10.222 21.545 1.00 12.06

ATOM 1319 ND2 ASN A 204 6.473 −8.285 21.050 1.00 10.74

ATOM 1322 C ASN A 204 5.896 −7.849 25.476 1.00 5.34

ATOM 1323 O ASN A 204 7.112 −7.902 25.712 1.00 4.91

ATOM 1324 N ALA A 205 4.991 −7.414 26.355 1.00 4.25

ATOM 1326 CA ALA A 205 5.353 −6.895 27.687 1.00 4.45

ATOM 1328 CB ALA A 205 4.103 −6.433 28.415 1.00 4.36

ATOM 1332 C ALA A 205 6.107 −7.869 28.578 1.00 4.02

ATOM 1333 O ALA A 205 6.748 −7.445 29.545 1.00 4.26

ATOM 1334 N LEU A 206 5.996 −9.163 28.293 1.00 4.13

ATOM 1336 CA LEU A 206 6.639 −10.193 29.127 1.00 4.05

ATOM 1338 CB LEU A 206 5.651 −11.310 29.467 1.00 4.39

ATOM 1341 CG LEU A 206 4.540 −10.873 30.442 1.00 5.48

ATOM 1343 CD1 LEU A 206 3.623 −12.031 30.791 1.00 6.08

ATOM 1347 CD2 LEU A 206 5.105 −10.247 31.717 1.00 6.03

ATOM 1351 C LEU A 206 7.883 −10.780 28.476 1.00 3.35

ATOM 1352 O LEU A 206 8.445 −11.755 28.972 1.00 3.40

ATOM 1353 N LEU A 207 8.298 −10.190 27.363 1.00 2.61

ATOM 1355 CA LEU A 207 9.509 −10.600 26.677 1.00 2.48

ATOM 1357 CB LEU A 207 9.370 −10.388 25.167 1.00 2.30

ATOM 1360 CG LEU A 207 10.658 −10.610 24.363 1.00 2.38

ATOM 1362 CD1 LEU A 207 11.119 −12.048 24.473 1.00 2.94

ATOM 1366 CD2 LEU A 207 10.491 −10.235 22.889 1.00 2.26

ATOM 1370 C LEU A 207 10.639 −9.727 27.221 1.00 2.20

ATOM 1371 O LEU A 207 10.736 −8.557 26.881 1.00 2.36

ATOM 1372 N PRO A 208 11.487 −10.266 28.082 1.00 2.31

ATOM 1373 CA PRO A 208 12.541 −9.447 28.692 1.00 2.22

ATOM 1375 CB PRO A 208 13.158 −10.383 29.746 1.00 2.19

ATOM 1378 CG PRO A 208 12.238 −11.522 29.864 1.00 2.61

ATOM 1381 CD PRO A 208 11.525 −11.654 28.555 1.00 2.13

ATOM 1384 C PRO A 208 13.622 −9.002 27.729 1.00 2.17

ATOM 1385 O PRO A 208 13.744 −9.544 26.634 1.00 2.75

ATOM 1386 N ASP A 209 14.382 −7.993 28.133 1.00 2.07

ATOM 1388 CA ASP A 209 15.537 −7.558 27.370 1.00 2.07

ATOM 1390 CB ASP A 209 15.873 −6.108 27.671 1.00 2.16

ATOM 1393 CG ASP A 209 17.092 −5.642 26.921 1.00 2.83

ATOM 1394 OD1 ASP A 209 18.215 −5.970 27.366 1.00 2.00

ATOM 1395 OD2 ASP A 209 17.026 −4.987 25.858 1.00 3.37

ATOM 1396 C ASP A 209 16.696 −8.488 27.758 1.00 2.08

ATOM 1397 O ASP A 209 16.986 −8.667 28.940 1.00 2.17

ATOM 1398 N PRO A 210 17.378 −9.050 26.770 1.00 2.13

ATOM 1399 CA PRO A 210 18.411 −10.064 27.006 1.00 2.49

ATOM 1401 CB PRO A 210 18.719 −10.589 25.599 1.00 2.35

ATOM 1404 CG PRO A 210 18.212 −9.574 24.665 1.00 2.21

ATOM 1407 CD PRO A 210 17.258 −8.704 25.352 1.00 2.18

ATOM 1410 C PRO A 210 19.684 −9.538 27.651 1.00 2.93

ATOM 1411 O PRO A 210 20.321 −10.299 28.361 1.00 2.79

ATOM 1412 N TYR A 211 20.043 −8.283 27.398 1.00 3.18

ATOM 1414 CA TYR A 211 21.242 −7.682 27.950 1.00 3.33

ATOM 1416 CB TYR A 211 21.570 −6.388 27.200 1.00 3.46

ATOM 1419 CG TYR A 211 22.666 −5.539 27.817 1.00 2.30

ATOM 1420 CD1 TYR A 211 23.995 −5.687 27.428 1.00 2.58

ATOM 1422 CE1 TYR A 211 25.015 −4.900 28.010 1.00 2.00

ATOM 1424 CZ TYR A 211 24.685 −3.963 28.967 1.00 2.27

ATOM 1425 OH TYR A 211 25.673 −3.168 29.545 1.00 2.08

ATOM 1427 CE2 TYR A 211 23.356 −3.791 29.346 1.00 2.01

ATOM 1429 CD2 TYR A 211 22.371 −4.583 28.785 1.00 2.29

ATOM 1431 C TYR A 211 20.962 −7.403 29.419 1.00 3.70

ATOM 1432 O TYR A 211 21.770 −7.707 30.297 1.00 4.00

ATOM 1433 N GLU A 212 19.782 −6.845 29.670 1.00 3.95

ATOM 1435 CA GLU A 212 19.348 −6.519 31.018 1.00 4.61

ATOM 1437 CB GLU A 212 18.024 −5.773 30.929 1.00 4.52

ATOM 1440 CG GLU A 212 17.515 −5.155 32.202 1.00 4.94

ATOM 1443 CD GLU A 212 16.226 −4.392 31.966 1.00 4.99

ATOM 1444 OE1 GLU A 212 15.347 −4.950 31.280 1.00 5.00

ATOM 1445 OE2 GLU A 212 16.086 −3.249 32.445 1.00 5.13

ATOM 1446 C GLU A 212 19.214 −7.802 31.846 1.00 5.07

ATOM 1447 O GLU A 212 19.640 −7.862 33.002 1.00 4.83

ATOM 1448 N SER A 213 18.638 −8.830 31.228 1.00 5.54

ATOM 1450 CA SER A 213 18.421 −10.135 31.850 1.00 6.29

ATOM 1452 CB SER A 213 17.821 −11.080 30.797 1.00 6.89

ATOM 1455 OG SER A 213 17.892 −12.428 31.216 1.00 9.71

ATOM 1457 C SER A 213 19.702 −10.733 32.444 1.00 6.29

ATOM 1458 O SER A 213 19.665 −11.412 33.479 1.00 6.32

ATOM 1459 N GLU A 214 20.832 −10.472 31.796 1.00 6.12

ATOM 1461 CA GLU A 214 22.120 −10.969 32.278 1.00 5.99

ATOM 1463 CB GLU A 214 23.164 −10.915 31.166 1.00 6.73

ATOM 1466 CG GLU A 214 22.949 −11.904 30.036 1.00 9.30

ATOM 1469 CD GLU A 214 24.057 −11.830 28.999 1.00 12.66

ATOM 1470 OE1 GLU A 214 24.949 −10.962 29.143 1.00 14.58

ATOM 1471 OE2 GLU A 214 24.032 −12.631 28.041 1.00 14.18

ATOM 1472 C GLU A 214 22.679 −10.174 33.454 1.00 5.39

ATOM 1473 O GLU A 214 23.514 −10.687 34.206 1.00 4.38

ATOM 1474 N ARG A 215 22.222 −8.937 33.610 1.00 4.75

ATOM 1476 CA ARG A 215 22.830 −8.018 34.578 1.00 4.90

ATOM 1478 CB ARG A 215 23.306 −6.746 33.853 1.00 5.24

ATOM 1481 CG ARG A 215 24.713 −6.896 33.276 1.00 8.07

ATOM 1484 CD ARG A 215 25.145 −5.883 32.213 1.00 10.65

ATOM 1487 NE ARG A 215 24.801 −6.383 30.908 1.00 14.29

ATOM 1489 CZ ARG A 215 25.577 −7.088 30.089 1.00 15.26

ATOM 1490 NH1 ARG A 215 26.820 −7.388 30.367 1.00 15.54

ATOM 1493 NH2 ARG A 215 25.065 −7.491 28.943 1.00 17.12

ATOM 1496 C ARG A 215 21.957 −7.671 35.791 1.00 4.12

ATOM 1497 O ARG A 215 22.487 −7.282 36.806 1.00 3.33

ATOM 1498 N VAL A 216 20.629 −7.807 35.709 1.00 3.09

ATOM 1500 CA VAL A 216 19.809 −7.429 36.873 1.00 2.91

ATOM 1502 CB VAL A 216 19.230 −6.002 36.738 1.00 2.96

ATOM 1504 CG1 VAL A 216 20.332 −4.974 36.602 1.00 3.75

ATOM 1508 CG2 VAL A 216 18.252 −5.921 35.551 1.00 2.83

ATOM 1512 C VAL A 216 18.647 −8.355 37.189 1.00 2.98

ATOM 1513 O VAL A 216 18.168 −9.109 36.331 1.00 2.44

ATOM 1514 N TYR A 217 18.199 −8.289 38.440 1.00 2.76

ATOM 1516 CA TYR A 217 17.009 −9.020 38.865 1.00 2.74

ATOM 1518 CB TYR A 217 17.341 −10.412 39.382 1.00 2.54

ATOM 1521 CG TYR A 217 18.125 −10.454 40.662 1.00 2.38

ATOM 1522 CD1 TYR A 217 17.486 −10.645 41.874 1.00 2.54

ATOM 1524 CE1 TYR A 217 18.183 −10.712 43.040 1.00 2.32

ATOM 1526 CZ TYR A 217 19.553 −10.587 43.022 1.00 2.27

ATOM 1527 OH TYR A 217 20.236 −10.656 44.219 1.00 2.99

ATOM 1529 CE2 TYR A 217 20.220 −10.409 41.826 1.00 2.26

ATOM 1531 CD2 TYR A 217 19.507 −10.339 40.657 1.00 2.43

ATOM 1533 C TYR A 217 16.202 −8.208 39.881 1.00 2.77

ATOM 1534 O TYR A 217 16.737 −7.327 40.557 1.00 3.00

ATOM 1535 N VAL A 218 14.908 −8.497 39.961 1.00 2.44

ATOM 1537 CA VAL A 218 14.014 −7.831 40.890 1.00 2.69

ATOM 1539 CB VAL A 218 12.632 −7.579 40.228 1.00 3.00

ATOM 1541 CG1 VAL A 218 11.610 −7.097 41.245 1.00 3.76

ATOM 1545 CG2 VAL A 218 12.778 −6.577 39.140 1.00 3.43

ATOM 1549 C VAL A 218 13.833 −8.702 42.120 1.00 2.66

ATOM 1550 O VAL A 218 13.617 −9.907 42.005 1.00 3.28

ATOM 1551 N ALA A 219 13.917 −8.091 43.296 1.00 2.57

ATOM 1553 CA ALA A 219 13.739 −8.791 44.555 1.00 2.48

ATOM 1555 CB ALA A 219 15.054 −9.468 45.000 1.00 2.68

ATOM 1559 C ALA A 219 13.301 −7.758 45.585 1.00 2.60

ATOM 1560 O ALA A 219 13.221 −6.571 45.284 1.00 2.69

ATOM 1561 N GLU A 220 13.021 −8.204 46.800 1.00 2.80

ATOM 1563 CA GLU A 220 12.644 −7.286 47.867 1.00 3.50

ATOM 1565 CB GLU A 220 12.332 −8.043 49.165 1.00 4.18

ATOM 1568 CG GLU A 220 12.052 −7.104 50.330 1.00 5.43

ATOM 1571 CD GLU A 220 11.359 −7.774 51.506 1.00 7.31

ATOM 1572 OE1 GLU A 220 11.761 −8.899 51.879 1.00 9.83

ATOM 1573 OE2 GLU A 220 10.420 −7.163 52.069 1.00 6.12

ATOM 1574 C GLU A 220 13.792 −6.321 48.138 1.00 3.30

ATOM 1575 O GLU A 220 14.942 −6.747 48.291 1.00 3.39

ATOM 1576 N SER A 221 13.485 −5.032 48.215 1.00 3.07

ATOM 1578 CA SER A 221 14.500 −4.024 48.513 1.00 3.25

ATOM 1580 CB SER A 221 13.896 −2.637 48.422 1.00 3.15

ATOM 1583 OG SER A 221 14.888 −1.657 48.617 1.00 3.60

ATOM 1585 C SER A 221 15.103 −4.174 49.913 1.00 3.41

ATOM 1586 O SER A 221 14.425 −4.601 50.853 1.00 2.86

ATOM 1587 N LEU A 222 16.375 −3.790 50.034 1.00 3.90

ATOM 1589 CA LEU A 222 17.070 −3.766 51.321 1.00 4.56

ATOM 1591 CB LEU A 222 18.588 −3.834 51.130 1.00 5.30

ATOM 1594 CG LEU A 222 19.097 −4.976 50.249 1.00 7.15

ATOM 1596 CD1 LEU A 222 20.607 −4.964 50.183 1.00 9.23

ATOM 1600 CD2 LEU A 222 18.609 −6.315 50.772 1.00 8.38

ATOM 1604 C LEU A 222 16.723 −2.480 52.059 1.00 4.29

ATOM 1605 O LEU A 222 17.001 −2.343 53.254 1.00 4.06

ATOM 1606 N ILE A 223 16.138 −1.527 51.343 1.00 3.99

ATOM 1608 CA ILE A 223 15.724 −0.267 51.944 1.00 4.02

ATOM 1610 CB ILE A 223 15.547 0.816 50.886 1.00 3.79

ATOM 1612 CG1 ILE A 223 16.865 1.041 50.150 1.00 5.03

ATOM 1615 CD1 ILE A 223 16.706 1.847 48.893 1.00 4.83

ATOM 1619 CG2 ILE A 223 15.073 2.118 51.527 1.00 3.14

ATOM 1623 C ILE A 223 14.411 −0.511 52.669 1.00 3.87

ATOM 1624 O ILE A 223 13.503 −1.110 52.119 1.00 2.80

ATOM 1625 N SER A 224 14.343 −0.082 53.923 1.00 3.63

ATOM 1627 CA SER A 224 13.162 −0.286 54.758 1.00 3.85

ATOM 1629 CB SER A 224 13.353 0.467 56.075 1.00 4.59

ATOM 1632 OG SER A 224 12.305 0.153 56.970 1.00 6.66

ATOM 1634 C SER A 224 11.834 0.150 54.131 1.00 3.32

ATOM 1635 O SER A 224 11.658 1.317 53.811 1.00 2.78

ATOM 1636 N SER A 225 10.913 −0.801 53.972 1.00 3.00

ATOM 1638 CA SER A 225 9.545 −0.514 53.494 1.00 3.09

ATOM 1640 CB SER A 225 8.874 0.469 54.462 1.00 2.88

ATOM 1643 OG SER A 225 8.729 −0.106 55.745 1.00 3.17

ATOM 1645 C SER A 225 9.470 0.031 52.068 1.00 3.22

ATOM 1646 O SER A 225 8.407 0.502 51.627 1.00 3.34

ATOM 1647 N ALA A 226 10.572 −0.066 51.331 1.00 3.38

ATOM 1649 CA ALA A 226 10.683 0.493 49.987 1.00 3.48

ATOM 1651 CB ALA A 226 12.139 0.766 49.672 1.00 3.48

ATOM 1655 C ALA A 226 10.060 −0.368 48.879 1.00 3.36

ATOM 1656 O ALA A 226 10.057 0.036 47.717 1.00 3.94

ATOM 1657 N GLY A 227 9.531 −1.534 49.244 1.00 3.22

ATOM 1659 CA GLY A 227 8.911 −2.445 48.299 1.00 2.87

ATOM 1662 C GLY A 227 9.944 −3.293 47.583 1.00 2.64

ATOM 1663 O GLY A 227 10.914 −3.763 48.189 1.00 2.43

ATOM 1664 N GLU A 228 9.747 −3.486 46.281 1.00 2.32

ATOM 1666 CA GLU A 228 10.693 −4.244 45.484 1.00 2.34

ATOM 1668 CB GLU A 228 10.039 −4.814 44.223 1.00 2.52

ATOM 1671 CG GLU A 228 8.887 −5.768 44.488 1.00 3.17

ATOM 1674 CD GLU A 228 8.461 −6.522 43.236 1.00 4.92

ATOM 1675 OE1 GLU A 228 8.462 −5.922 42.145 1.00 5.91

ATOM 1676 OE2 GLU A 228 8.141 −7.722 43.344 1.00 6.16

ATOM 1677 C GLU A 228 11.825 −3.310 45.083 1.00 2.31

ATOM 1678 O GLU A 228 11.652 −2.099 45.062 1.00 2.49

ATOM 1679 N GLY A 229 12.980 −3.887 44.771 1.00 2.30

ATOM 1681 CA GLY A 229 14.119 −3.135 44.286 1.00 2.20

ATOM 1684 C GLY A 229 14.778 −3.869 43.125 1.00 2.15

ATOM 1685 O GLY A 229 14.360 −4.973 42.754 1.00 2.15

ATOM 1686 N LEU A 230 15.812 −3.254 42.561 1.00 2.22

ATOM 1688 CA LEU A 230 16.549 −3.802 41.435 1.00 2.13

ATOM 1690 CB LEU A 230 16.623 −2.757 40.328 1.00 2.21

ATOM 1693 CG LEU A 230 17.162 −3.248 38.983 1.00 2.18

ATOM 1695 CD1 LEU A 230 16.210 −4.268 38.363 1.00 2.50

ATOM 1699 CD2 LEU A 230 17.388 −2.068 38.043 1.00 2.60

ATOM 1703 C LEU A 230 17.956 −4.182 41.901 1.00 2.15

ATOM 1704 O LEU A 230 18.621 −3.385 42.549 1.00 2.20

ATOM 1705 N PHE A 231 18.396 −5.394 41.580 1.00 2.05

ATOM 1707 CA PHE A 231 19.697 −5.875 42.041 1.00 2.38

ATOM 1709 CB PHE A 231 19.507 −7.041 43.007 1.00 2.23

ATOM 1712 CG PHE A 231 18.813 −6.666 44.269 1.00 2.69

ATOM 1713 CD1 PHE A 231 17.443 −6.483 44.302 1.00 3.21

ATOM 1715 CE1 PHE A 231 16.807 −6.139 45.480 1.00 3.94

ATOM 1717 CZ PHE A 231 17.542 −5.970 46.633 1.00 2.72

ATOM 1719 CE2 PHE A 231 18.900 −6.141 46.607 1.00 3.21

ATOM 1721 CD2 PHE A 231 19.534 −6.486 45.434 1.00 2.54

ATOM 1723 C PHE A 231 20.609 −6.336 40.921 1.00 2.43

ATOM 1724 O PHE A 231 20.168 −6.832 39.910 1.00 2.42

ATOM 1725 N SER A 232 21.909 −6.195 41.130 1.00 2.69

ATOM 1727 CA SER A 232 22.862 −6.677 40.158 1.00 3.10

ATOM 1729 CB SER A 232 24.242 −6.068 40.413 1.00 2.95

ATOM 1732 OG ASER A 232 24.570 −6.073 41.799 0.50 5.29

ATOM 1733 OG BSER A 232 25.105 −6.433 39.353 0.50 4.49

ATOM 1736 C SER A 232 22.989 −8.182 40.259 1.00 2.97

ATOM 1737 O SER A 232 23.054 −8.736 41.364 1.00 2.99

ATOM 1738 N LYS A 233 23.064 −8.838 39.106 1.00 3.09

ATOM 1740 CA LYS A 233 23.294 −10.273 39.050 1.00 3.64

ATOM 1742 CB LYS A 233 22.732 −10.849 37.748 1.00 3.60

ATOM 1745 CG LYS A 233 21.288 −11.149 37.782 1.00 4.20

ATOM 1748 CD LYS A 233 20.904 −12.027 36.601 1.00 4.67

ATOM 1751 CE LYS A 233 19.415 −12.173 36.504 1.00 4.71

ATOM 1754 NZ LYS A 233 19.004 −13.209 35.517 1.00 4.85

ATOM 1758 C LYS A 233 24.779 −10.585 39.057 1.00 3.83

ATOM 1759 O LYS A 233 25.189 −11.681 39.419 1.00 4.11

ATOM 1760 N VAL A 234 25.584 −9.607 38.657 1.00 4.42

ATOM 1762 CA VAL A 234 26.996 −9.819 38.406 1.00 4.40

ATOM 1764 CB VAL A 234 27.223 −10.020 36.886 1.00 4.65

ATOM 1766 CG1 VAL A 234 26.545 −11.304 36.402 1.00 4.93

ATOM 1770 CG2 VAL A 234 26.683 −8.840 36.103 1.00 4.52

ATOM 1774 C VAL A 234 27.836 −8.636 38.870 1.00 4.50

ATOM 1775 O VAL A 234 27.306 −7.553 39.115 1.00 4.51

ATOM 1776 N ALA A 235 29.141 −8.860 39.022 1.00 4.24

ATOM 1778 CA ALA A 235 30.074 −7.799 39.364 1.00 3.86

ATOM 1780 CB ALA A 235 31.387 −8.386 39.903 1.00 4.11

ATOM 1784 C ALA A 235 30.358 −6.973 38.120 1.00 3.50

ATOM 1785 O ALA A 235 30.673 −7.530 37.077 1.00 3.56

ATOM 1786 N VAL A 236 30.255 −5.653 38.235 1.00 3.07

ATOM 1788 CA VAL A 236 30.572 −4.751 37.131 1.00 2.74

ATOM 1790 CB VAL A 236 29.286 −4.217 36.449 1.00 2.68

ATOM 1792 CG1 VAL A 236 28.513 −5.360 35.863 1.00 3.61

ATOM 1796 CG2 VAL A 236 28.426 −3.439 37.437 1.00 2.43

ATOM 1800 C VAL A 236 31.426 −3.575 37.609 1.00 2.65

ATOM 1801 O VAL A 236 31.505 −3.284 38.807 1.00 2.46

ATOM 1802 N GLY A 237 32.080 −2.916 36.668 1.00 2.33

ATOM 1804 CA GLY A 237 32.831 −1.722 36.973 1.00 2.18

ATOM 1807 C GLY A 237 31.965 −0.487 36.807 1.00 2.29

ATOM 1808 O GLY A 237 30.770 −0.572 36.490 1.00 2.08

ATOM 1809 N PRO A 238 32.567 0.675 37.015 1.00 2.31

ATOM 1810 CA PRO A 238 31.876 1.948 36.840 1.00 2.21

ATOM 1812 CB PRO A 238 32.944 2.981 37.223 1.00 2.41

ATOM 1815 CG PRO A 238 34.019 2.248 37.840 1.00 2.81

ATOM 1818 CD PRO A 238 33.965 0.853 37.409 1.00 2.49

ATOM 1821 C PRO A 238 31.507 2.156 35.382 1.00 2.28

ATOM 1822 O PRO A 238 32.095 1.500 34.535 1.00 2.08

ATOM 1823 N ASN A 239 30.549 3.042 35.111 1.00 2.48

ATOM 1825 CA ASN A 239 30.204 3.416 33.749 1.00 2.91

ATOM 1827 CB ASN A 239 31.457 3.843 32.981 1.00 3.61

ATOM 1830 CG ASN A 239 31.214 5.010 32.013 1.00 7.42

ATOM 1831 OD1 ASN A 239 30.074 5.447 31.779 1.00 10.92

ATOM 1832 ND2 ASN A 239 32.302 5.510 31.430 1.00 11.07

ATOM 1835 C ASN A 239 29.508 2.279 32.992 1.00 2.43

ATOM 1836 O ASN A 239 29.484 2.301 31.763 1.00 2.65

ATOM 1837 N THR A 240 28.933 1.315 33.708 1.00 2.07

ATOM 1839 CA THR A 240 28.302 0.157 33.059 1.00 2.01

ATOM 1841 CB THR A 240 28.632 −1.143 33.799 1.00 2.12

ATOM 1843 OG1 THR A 240 30.051 −1.268 33.983 1.00 2.28

ATOM 1845 CG2 THR A 240 28.262 −2.351 32.948 1.00 2.11

ATOM 1849 C THR A 240 26.777 0.275 32.950 1.00 2.04

ATOM 1850 O THR A 240 26.073 0.443 33.935 1.00 2.06

ATOM 1851 N VAL A 241 26.262 0.166 31.738 1.00 2.00

ATOM 1853 CA VAL A 241 24.815 0.177 31.570 1.00 2.01

ATOM 1855 CB VAL A 241 24.419 0.335 30.105 1.00 2.05

ATOM 1857 CG1 VAL A 241 22.902 0.169 29.941 1.00 2.07

ATOM 1861 CG2 VAL A 241 24.863 1.684 29.579 1.00 2.18

ATOM 1865 C VAL A 241 24.262 −1.130 32.134 1.00 2.16

ATOM 1866 O VAL A 241 24.753 −2.217 31.809 1.00 2.29

ATOM 1867 N MET A 242 23.224 −1.036 32.958 1.00 2.59

ATOM 1869 CA MET A 242 22.672 −2.226 33.615 1.00 2.76

ATOM 1871 CB MET A 242 22.756 −2.078 35.126 1.00 2.81

ATOM 1874 CG MET A 242 24.163 −1.918 35.634 1.00 3.09

ATOM 1877 SD MET A 242 25.119 −3.426 35.424 1.00 3.66

ATOM 1878 CE MET A 242 24.649 −4.347 36.888 1.00 3.91

ATOM 1882 C MET A 242 21.224 −2.534 33.297 1.00 2.34

ATOM 1883 O MET A 242 20.839 −3.689 33.299 1.00 2.18

ATOM 1884 N SER A 243 20.428 −1.493 33.089 1.00 2.43

ATOM 1886 CA SER A 243 18.988 −1.644 32.937 1.00 2.80

ATOM 1888 CB SER A 243 18.353 −1.584 34.332 1.00 2.79

ATOM 1891 OG SER A 243 16.985 −1.910 34.357 1.00 3.90

ATOM 1893 C SER A 243 18.430 −0.532 32.059 1.00 2.74

ATOM 1894 O SER A 243 19.043 0.516 31.890 1.00 3.19

ATOM 1895 N PHE A 244 17.249 −0.764 31.516 1.00 2.66

ATOM 1897 CA PHE A 244 16.602 0.200 30.632 1.00 2.43

ATOM 1899 CB PHE A 244 16.358 −0.446 29.280 1.00 2.19

ATOM 1902 CG PHE A 244 17.611 −0.977 28.664 1.00 2.28

ATOM 1903 CD1 PHE A 244 17.793 −2.334 28.481 1.00 2.21

ATOM 1905 CE1 PHE A 244 18.984 −2.818 27.945 1.00 2.25

ATOM 1907 CZ PHE A 244 19.985 −1.948 27.588 1.00 2.16

ATOM 1909 CE2 PHE A 244 19.814 −0.595 27.763 1.00 2.45

ATOM 1911 CD2 PHE A 244 18.628 −0.111 28.298 1.00 2.35

ATOM 1913 C PHE A 244 15.324 0.716 31.253 1.00 2.17

ATOM 1914 O PHE A 244 14.640 −0.013 31.958 1.00 2.24

ATOM 1915 N TYR A 245 15.035 1.991 31.009 1.00 2.18

ATOM 1917 CA TYR A 245 13.862 2.651 31.560 1.00 2.15

ATOM 1919 CB TYR A 245 14.256 3.924 32.353 1.00 2.20

ATOM 1922 CG TYR A 245 13.301 4.321 33.471 1.00 2.00

ATOM 1923 CD1 TYR A 245 13.712 4.344 34.795 1.00 2.00

ATOM 1925 CE1 TYR A 245 12.848 4.708 35.812 1.00 2.07

ATOM 1927 CZ TYR A 245 11.548 5.070 35.516 1.00 2.37

ATOM 1928 OH TYR A 245 10.675 5.430 36.522 1.00 2.32

ATOM 1930 CE2 TYR A 245 11.121 5.048 34.214 1.00 2.16

ATOM 1932 CD2 TYR A 245 11.988 4.684 33.201 1.00 2.44

ATOM 1934 C TYR A 245 12.932 2.994 30.402 1.00 2.45

ATOM 1935 O TYR A 245 12.892 4.136 29.945 1.00 2.43

ATOM 1936 N ASN A 246 12.238 1.977 29.890 1.00 2.77

ATOM 1938 CA ASN A 246 11.219 2.175 28.862 1.00 3.04

ATOM 1940 CB ASN A 246 11.057 0.938 27.976 1.00 2.93

ATOM 1943 CG ASN A 246 10.037 1.154 26.861 1.00 2.79

ATOM 1944 OD1 ASN A 246 10.093 2.157 26.148 1.00 2.29

ATOM 1945 ND2 ASN A 246 9.086 0.220 26.721 1.00 2.93

ATOM 1948 C ASN A 246 9.895 2.460 29.556 1.00 3.31

ATOM 1949 O ASN A 246 9.744 2.209 30.747 1.00 3.44

ATOM 1950 N GLY A 247 8.944 3.003 28.814 1.00 3.66

ATOM 1952 CA GLY A 247 7.616 3.268 29.336 1.00 3.80

ATOM 1955 C GLY A 247 6.799 4.017 28.309 1.00 4.27

ATOM 1956 O GLY A 247 7.253 4.225 27.178 1.00 4.28

ATOM 1957 N VAL A 248 5.584 4.396 28.697 1.00 4.32

ATOM 1959 CA VAL A 248 4.708 5.179 27.852 1.00 4.50

ATOM 1961 CB VAL A 248 3.233 5.103 28.304 1.00 4.48

ATOM 1963 CG1 VAL A 248 2.745 3.670 28.288 1.00 5.63

ATOM 1967 CG2 VAL A 248 3.023 5.702 29.664 1.00 4.96

ATOM 1971 C VAL A 248 5.195 6.620 27.881 1.00 4.37

ATOM 1972 O VAL A 248 5.774 7.068 28.864 1.00 4.09

ATOM 1973 N ARG A 249 4.974 7.348 26.795 1.00 4.02

ATOM 1975 CA ARG A 249 5.419 8.733 26.726 1.00 4.38

ATOM 1977 CB ARG A 249 6.013 9.022 25.353 1.00 5.06

ATOM 1980 CG ARG A 249 7.450 8.604 25.238 1.00 6.52

ATOM 1983 CD ARG A 249 7.815 7.997 23.918 1.00 9.42

ATOM 1986 NE ARG A 249 8.843 6.985 24.094 1.00 11.70

ATOM 1988 CZ ARG A 249 10.093 7.116 23.696 1.00 13.30

ATOM 1989 NH1 ARG A 249 10.475 8.216 23.070 1.00 15.18

ATOM 1992 NH2 ARG A 249 10.965 6.143 23.922 1.00 13.35

ATOM 1995 C ARG A 249 4.248 9.675 26.983 1.00 4.18

ATOM 1996 O ARG A 249 3.199 9.560 26.346 1.00 3.34

ATOM 1997 N ILE A 250 4.429 10.615 27.902 1.00 3.39

ATOM 1999 CA ILE A 250 3.389 11.580 28.226 1.00 3.73

ATOM 2001 CB ILE A 250 2.611 11.120 29.460 1.00 4.31

ATOM 2003 CG1 ILE A 250 3.553 10.933 30.639 1.00 4.63

ATOM 2006 CD1 ILE A 250 2.844 10.570 31.927 1.00 5.32

ATOM 2010 CG2 ILE A 250 1.887 9.813 29.164 1.00 5.16

ATOM 2014 C ILE A 250 3.992 12.972 28.438 1.00 3.77

ATOM 2015 O ILE A 250 5.213 13.161 28.334 1.00 3.89

ATOM 2016 N THR A 251 3.148 13.951 28.740 1.00 3.68

ATOM 2018 CA THR A 251 3.637 15.312 28.956 1.00 3.84

ATOM 2020 CB THR A 251 2.637 16.325 28.398 1.00 3.91

ATOM 2022 OG1 THR A 251 1.476 16.366 29.245 1.00 2.98

ATOM 2024 CG2 THR A 251 2.135 15.916 27.032 1.00 3.69

ATOM 2028 C THR A 251 3.874 15.648 30.430 1.00 4.23

ATOM 2029 O THR A 251 3.304 15.034 31.329 1.00 3.85

ATOM 2030 N HIS A 252 4.724 16.644 30.656 1.00 4.92

ATOM 2032 CA HIS A 252 4.997 17.135 31.987 1.00 5.37

ATOM 2034 CB HIS A 252 6.129 18.167 31.939 1.00 5.54

ATOM 2037 CG HIS A 252 7.471 17.579 31.608 1.00 5.74

ATOM 2038 ND1 HIS A 252 8.365 17.169 32.572 1.00 6.59

ATOM 2040 CE1 HIS A 252 9.454 16.699 31.990 1.00 5.78

ATOM 2042 NE2 HIS A 252 9.301 16.796 30.683 1.00 6.87

ATOM 2044 CD2 HIS A 252 8.066 17.336 30.417 1.00 6.09

ATOM 2046 C HIS A 252 3.730 17.755 32.590 1.00 5.91

ATOM 2047 O HIS A 252 3.529 17.740 33.783 1.00 6.19

ATOM 2048 N GLN A 253 2.858 18.287 31.748 1.00 6.66

ATOM 2050 CA GLN A 253 1.646 18.938 32.236 1.00 7.22

ATOM 2052 CB GLN A 253 0.923 19.618 31.094 1.00 7.93

ATOM 2055 CG GLN A 253 1.585 20.884 30.621 1.00 9.76

ATOM 2058 CD GLN A 253 2.804 20.650 29.728 1.00 11.24

ATOM 2059 OE1 GLN A 253 3.202 21.534 28.981 1.00 12.89

ATOM 2060 NE2 GLN A 253 3.384 19.472 29.800 1.00 13.47

ATOM 2063 C GLN A 253 0.683 17.970 32.877 1.00 6.97

ATOM 2064 O GLN A 253 0.187 18.204 33.982 1.00 7.62

ATOM 2065 N GLU A 254 0.418 16.887 32.168 1.00 6.45

ATOM 2067 CA GLU A 254 −0.470 15.849 32.654 1.00 7.11

ATOM 2069 CB GLU A 254 −0.530 14.696 31.648 1.00 7.42

ATOM 2072 CG GLU A 254 −1.409 13.521 32.075 1.00 9.67

ATOM 2075 CD GLU A 254 −1.514 12.426 31.008 1.00 12.85

ATOM 2076 OE1 GLU A 254 −0.897 12.561 29.925 1.00 12.24

ATOM 2077 OE2 GLU A 254 −2.230 11.423 31.249 1.00 15.26

ATOM 2078 C GLU A 254 0.045 15.333 33.988 1.00 6.48

ATOM 2079 O GLU A 254 −0.725 15.114 34.913 1.00 6.44

ATOM 2080 N VAL A 255 1.364 15.155 34.075 1.00 6.59

ATOM 2082 CA VAL A 255 2.005 14.650 35.278 1.00 6.49

ATOM 2084 CB VAL A 255 3.505 14.345 35.012 1.00 6.42

ATOM 2086 CG1 VAL A 255 4.236 14.063 36.290 1.00 6.18

ATOM 2090 CG2 VAL A 255 3.647 13.158 34.066 1.00 5.96

ATOM 2094 C VAL A 255 1.853 15.651 36.439 1.00 6.75

ATOM 2095 O VAL A 255 1.463 15.273 37.531 1.00 6.38

ATOM 2096 N ASP A 256 2.126 16.929 36.181 1.00 7.52

ATOM 2098 CA ASP A 256 2.012 17.982 37.199 1.00 8.01

ATOM 2100 CB ASP A 256 2.583 19.306 36.678 1.00 8.71

ATOM 2103 CG ASP A 256 4.066 19.221 36.343 1.00 10.13

ATOM 2104 OD1 ASP A 256 4.731 18.286 36.812 1.00 11.21

ATOM 2105 OD2 ASP A 256 4.660 20.027 35.596 1.00 13.23

ATOM 2106 C ASP A 256 0.565 18.216 37.629 1.00 7.94

ATOM 2107 O ASP A 256 0.317 18.769 38.702 1.00 8.89

ATOM 2108 N SER A 257 −0.382 17.788 36.802 1.00 7.19

ATOM 2110 CA SER A 257 −1.799 17.999 37.086 1.00 6.69

ATOM 2112 CB SER A 257 −2.549 18.295 35.789 1.00 6.90

ATOM 2115 OG SER A 257 −2.974 17.081 35.197 1.00 7.47

ATOM 2117 C SER A 257 −2.443 16.794 37.772 1.00 6.14

ATOM 2118 O SER A 257 −3.653 16.773 37.998 1.00 6.30

ATOM 2119 N ARG A 258 −1.650 15.783 38.113 1.00 5.33

ATOM 2121 CA ARG A 258 −2.224 14.601 38.751 1.00 4.73

ATOM 2123 CB ARG A 258 −2.178 13.397 37.822 1.00 4.74

ATOM 2126 CG ARG A 258 −0.801 12.948 37.443 1.00 4.66

ATOM 2129 CD ARG A 258 −0.806 11.964 36.291 1.00 4.23

ATOM 2132 NE ARG A 258 0.439 11.225 36.181 1.00 3.76

ATOM 2134 CZ ARG A 258 0.678 10.280 35.288 1.00 3.91

ATOM 2135 NH1 ARG A 258 −0.253 9.948 34.393 1.00 3.83

ATOM 2138 NH2 ARG A 258 1.857 9.672 35.282 1.00 4.26

ATOM 2141 C ARG A 258 −1.551 14.266 40.077 1.00 4.32

ATOM 2142 O ARG A 258 −0.455 14.729 40.356 1.00 3.68

ATOM 2143 N ASP A 259 −2.254 13.461 40.868 1.00 4.17

ATOM 2145 CA ASP A 259 −1.831 13.025 42.202 1.00 3.92

ATOM 2147 CB ASP A 259 −2.930 12.122 42.753 1.00 4.24

ATOM 2150 CG ASP A 259 −2.800 11.847 44.221 1.00 5.85

ATOM 2151 OD1 ASP A 259 −1.852 11.160 44.626 1.00 6.94

ATOM 2152 OD2 ASP A 259 −3.658 12.248 45.031 1.00 9.13

ATOM 2153 C ASP A 259 −0.514 12.255 42.188 1.00 3.64

ATOM 2154 O ASP A 259 −0.214 11.522 41.245 1.00 3.11

ATOM 2155 N TRP A 260 0.269 12.394 43.259 1.00 3.86

ATOM 2157 CA TRP A 260 1.550 11.696 43.325 1.00 3.80

ATOM 2159 CB TRP A 260 2.322 12.060 44.581 1.00 4.34

ATOM 2162 CG TRP A 260 3.204 13.248 44.416 1.00 5.06

ATOM 2163 CD1 TRP A 260 2.993 14.485 44.936 1.00 5.61

ATOM 2165 NE1 TRP A 260 4.011 15.332 44.573 1.00 5.32

ATOM 2167 CE2 TRP A 260 4.916 14.639 43.812 1.00 5.59

ATOM 2168 CD2 TRP A 260 4.443 13.320 43.695 1.00 4.92

ATOM 2169 CE3 TRP A 260 5.196 12.406 42.945 1.00 5.71

ATOM 2171 CZ3 TRP A 260 6.383 12.839 42.357 1.00 6.16

ATOM 2173 CH2 TRP A 260 6.822 14.155 42.506 1.00 5.94

ATOM 2175 CZ2 TRP A 260 6.103 15.066 43.222 1.00 6.33

ATOM 2177 C TRP A 260 1.374 10.193 43.279 1.00 3.37

ATOM 2178 O TRP A 260 2.280 9.476 42.883 1.00 4.00

ATOM 2179 N ALA A 261 0.215 9.715 43.702 1.00 2.79

ATOM 2181 CA ALA A 261 −0.050 8.292 43.691 1.00 2.81

ATOM 2183 CB ALA A 261 −1.418 8.005 44.207 1.00 3.00

ATOM 2187 C ALA A 261 0.115 7.752 42.270 1.00 2.68

ATOM 2188 O ALA A 261 0.342 6.565 42.093 1.00 2.83

ATOM 2189 N LEU A 262 0.022 8.633 41.270 1.00 2.70

ATOM 2191 CA LEU A 262 0.198 8.252 39.866 1.00 2.95

ATOM 2193 CB LEU A 262 −0.841 8.985 38.993 1.00 2.95

ATOM 2196 CG LEU A 262 −2.312 8.808 39.386 1.00 3.70

ATOM 2198 CD1 LEU A 262 −3.220 9.716 38.576 1.00 4.17

ATOM 2202 CD2 LEU A 262 −2.738 7.384 39.178 1.00 4.22

ATOM 2206 C LEU A 262 1.582 8.582 39.304 1.00 3.18

ATOM 2207 O LEU A 262 1.877 8.216 38.161 1.00 3.23

ATOM 2208 N ASN A 263 2.427 9.247 40.098 1.00 3.18

ATOM 2210 CA ASN A 263 3.719 9.748 39.623 1.00 3.19

ATOM 2212 CB ASN A 263 3.757 11.274 39.771 1.00 3.19

ATOM 2215 CG ASN A 263 2.767 11.976 38.847 1.00 3.20

ATOM 2216 OD1 ASN A 263 2.454 11.479 37.762 1.00 3.60

ATOM 2217 ND2 ASN A 263 2.263 13.132 39.273 1.00 2.78

ATOM 2220 C ASN A 263 4.956 9.112 40.279 1.00 3.27

ATOM 2221 O ASN A 263 6.022 9.740 40.386 1.00 3.08

ATOM 2222 N GLY A 264 4.821 7.874 40.742 1.00 3.23

ATOM 2224 CA GLY A 264 5.955 7.159 41.309 1.00 2.91

ATOM 2227 C GLY A 264 7.028 6.781 40.291 1.00 2.93

ATOM 2228 O GLY A 264 8.228 6.724 40.628 1.00 3.18

ATOM 2229 N ASN A 265 6.612 6.529 39.044 1.00 2.70

ATOM 2231 CA ASN A 265 7.515 6.059 37.998 1.00 2.83

ATOM 2233 CB ASN A 265 6.995 4.736 37.440 1.00 3.16

ATOM 2236 CG ASN A 265 7.070 3.609 38.466 1.00 4.64

ATOM 2237 OD1 ASN A 265 7.723 3.733 39.519 1.00 6.97

ATOM 2238 ND2 ASN A 265 6.423 2.499 38.158 1.00 5.90

ATOM 2241 C ASN A 265 7.782 7.030 36.854 1.00 2.63

ATOM 2242 O ASN A 265 8.411 6.670 35.868 1.00 3.13

ATOM 2243 N THR A 266 7.312 8.260 36.975 1.00 2.76

ATOM 2245 CA THR A 266 7.534 9.243 35.928 1.00 2.53

ATOM 2247 CB THR A 266 6.657 10.449 36.156 1.00 2.58

ATOM 2249 OG1 THR A 266 6.755 10.851 37.536 1.00 2.28

ATOM 2251 CG2 THR A 266 5.182 10.097 35.948 1.00 2.42

ATOM 2255 C THR A 266 8.988 9.687 35.950 1.00 2.81

ATOM 2256 O THR A 266 9.516 10.009 37.015 1.00 3.23

ATOM 2257 N LEU A 267 9.606 9.711 34.775 1.00 2.94

ATOM 2259 CA LEU A 267 10.987 10.109 34.596 1.00 3.68

ATOM 2261 CB LEU A 267 11.856 8.890 34.312 1.00 3.83

ATOM 2264 CG LEU A 267 13.291 9.198 33.862 1.00 3.83

ATOM 2266 CD1 LEU A 267 14.115 9.914 34.943 1.00 4.78

ATOM 2270 CD2 LEU A 267 13.946 7.910 33.437 1.00 4.52

ATOM 2274 C LEU A 267 11.056 11.061 33.421 1.00 4.61

ATOM 2275 O LEU A 267 10.514 10.764 32.334 1.00 3.96

ATOM 2276 N SER A 268 11.692 12.210 33.629 1.00 5.56

ATOM 2278 CA SER A 268 11.786 13.203 32.563 1.00 6.81

ATOM 2280 CB SER A 268 12.141 14.598 33.129 1.00 6.96

ATOM 2283 OG ASER A 268 11.251 14.979 34.133 0.50 7.90

ATOM 2284 OG BSER A 268 12.920 15.273 32.173 0.50 7.34

ATOM 2287 C SER A 268 12.801 12.694 31.527 1.00 7.87

ATOM 2288 O SER A 268 13.968 12.392 31.860 1.00 8.21

ATOM 2289 N LEU A 269 12.345 12.574 30.289 1.00 9.28

ATOM 2291 CA LEU A 269 13.168 12.087 29.190 1.00 10.67

ATOM 2293 CB LEU A 269 12.292 11.404 28.140 1.00 10.48

ATOM 2296 CG LEU A 269 12.909 10.303 27.274 1.00 11.51

ATOM 2298 CD1 LEU A 269 12.263 10.333 25.897 1.00 11.38

ATOM 2302 CD2 LEU A 269 14.419 10.399 27.144 1.00 12.54

ATOM 2306 C LEU A 269 13.918 13.255 28.554 1.00 11.61

ATOM 2307 O LEU A 269 15.148 13.263 28.471 1.00 11.86

ATOM 2308 N ASP A 270 13.152 14.239 28.114 1.00 12.80

ATOM 2310 CA ASP A 270 13.676 15.440 27.491 1.00 13.69

ATOM 2312 CB ASP A 270 13.689 15.311 25.962 1.00 13.95

ATOM 2315 CG ASP A 270 12.311 15.213 25.376 1.00 14.89

ATOM 2316 OD1 ASP A 270 11.368 15.718 26.018 1.00 14.96

ATOM 2317 OD2 ASP A 270 12.061 14.665 24.267 1.00 17.09

ATOM 2318 C ASP A 270 12.755 16.571 27.958 1.00 14.07

ATOM 2319 O ASP A 270 11.871 16.357 28.794 1.00 14.20

ATOM 2320 N GLU A 271 12.948 17.763 27.416 1.00 14.31

ATOM 2322 CA GLU A 271 12.154 18.915 27.816 1.00 14.56

ATOM 2324 CB GLU A 271 12.632 20.138 27.034 1.00 15.14

ATOM 2327 CG GLU A 271 12.577 21.432 27.821 1.00 16.67

ATOM 2330 CD GLU A 271 13.173 22.603 27.053 1.00 18.56

ATOM 2331 OE1 GLU A 271 13.233 22.537 25.801 1.00 19.69

ATOM 2332 OE2 GLU A 271 13.584 23.591 27.702 1.00 19.35

ATOM 2333 C GLU A 271 10.656 18.705 27.566 1.00 14.24

ATOM 2334 O GLU A 271 9.811 19.220 28.306 1.00 14.58

ATOM 2335 N GLU A 272 10.339 17.938 26.530 1.00 13.41

ATOM 2337 CA GLU A 272 8.964 17.740 26.095 1.00 12.91

ATOM 2339 CB GLU A 272 8.919 17.825 24.564 1.00 13.45

ATOM 2342 CG GLU A 272 7.646 17.287 23.930 1.00 15.09

ATOM 2345 CD GLU A 272 6.425 18.139 24.229 1.00 17.47

ATOM 2346 OE1 GLU A 272 6.010 18.937 23.354 1.00 17.98

ATOM 2347 OE2 GLU A 272 5.871 17.995 25.343 1.00 19.19

ATOM 2348 C GLU A 272 8.329 16.421 26.530 1.00 11.55

ATOM 2349 O GLU A 272 7.108 16.284 26.498 1.00 11.51

ATOM 2350 N THR A 273 9.134 15.452 26.944 1.00 9.75

ATOM 2352 CA THR A 273 8.585 14.129 27.218 1.00 8.69

ATOM 2354 CB THR A 273 9.075 13.153 26.159 1.00 8.76

ATOM 2356 OG1 TER A 273 9.047 13.781 24.869 1.00 9.12

ATOM 2358 CG2 THR A 273 8.126 11.978 26.041 1.00 9.77

ATOM 2362 C THR A 273 8.942 13.528 28.565 1.00 7.33

ATOM 2363 O THR A 273 10.073 13.621 29.005 1.00 7.19

ATOM 2364 N VAL A 274 7.953 12.863 29.151 1.00 6.08

ATOM 2366 CA VAL A 274 8.077 12.124 30.390 1.00 5.63

ATOM 2368 CB VAL A 274 7.038 12.603 31.427 1.00 5.35

ATOM 2370 CG1 VAL A 274 7.064 11.752 32.668 1.00 5.23

ATOM 2374 CG2 VAL A 274 7.260 14.059 31.782 1.00 6.17

ATOM 2378 C VAL A 274 7.804 10.658 30.066 1.00 5.28

ATOM 2379 O VAL A 274 6.843 10.333 29.349 1.00 4.93

ATOM 2380 N ILE A 275 8.673 9.779 30.545 1.00 4.74

ATOM 2382 CA ILE A 275 8.492 8.345 30.395 1.00 5.25

ATOM 2384 CB ILE A 275 9.845 7.644 30.146 1.00 6.00

ATOM 2386 CG1 ILE A 275 10.254 7.791 28.685 1.00 7.09

ATOM 2389 CD1 ILE A 275 9.124 7.536 27.688 1.00 8.89

ATOM 2393 CG2 ILE A 275 9.778 6.160 30.517 1.00 6.24

ATOM 2397 C ILE A 275 7.843 7.847 31.682 1.00 5.16

ATOM 2398 O ILE A 275 8.244 8.252 32.778 1.00 4.51

ATOM 2399 N ASP A 276 6.821 7.003 31.550 1.00 4.93

ATOM 2401 CA ASP A 276 6.097 6.499 32.712 1.00 4.99

ATOM 2403 CB ASP A 276 4.781 7.268 32.855 1.00 5.23

ATOM 2406 CG ASP A 276 4.056 6.983 34.159 1.00 5.97

ATOM 2407 OD1 ASP A 276 4.721 6.607 35.154 1.00 7.19

ATOM 2408 OD2 ASP A 276 2.818 7.146 34.273 1.00 6.97

ATOM 2409 C ASP A 276 5.813 5.004 32.610 1.00 5.08

ATOM 2410 O ASP A 276 5.674 4.459 31.522 1.00 4.61

ATOM 2411 N VAL A 277 5.758 4.335 33.761 1.00 5.26

ATOM 2413 CA VAL A 277 5.382 2.928 33.811 1.00 5.55

ATOM 2415 CB VAL A 277 6.506 2.054 34.354 1.00 6.07

ATOM 2417 CG1 VAL A 277 6.110 0.589 34.321 1.00 6.33

ATOM 2421 CG2 VAL A 277 7.767 2.265 33.537 1.00 6.87

ATOM 2425 C VAL A 277 4.143 2.842 34.703 1.00 5.75

ATOM 2426 O VAL A 277 4.226 2.531 35.888 1.00 5.17

ATOM 2427 N PRO A 278 2.995 3.165 34.130 1.00 5.68

ATOM 2428 CA PRO A 278 1.717 3.192 34.842 1.00 6.20

ATOM 2430 CB PRO A 278 0.738 3.734 33.780 1.00 6.37

ATOM 2433 CG PRO A 278 1.493 3.937 32.561 1.00 6.28

ATOM 2436 CD PRO A 278 2.853 3.518 32.708 1.00 5.79

ATOM 2439 C PRO A 278 1.214 1.820 35.278 1.00 6.95

ATOM 2440 O PRO A 278 1.647 0.810 34.733 1.00 6.97

ATOM 2441 N GLU A 279 0.314 1.794 36.259 1.00 7.70

ATOM 2443 CA GLU A 279 −0.341 0.559 36.691 1.00 8.29

ATOM 2445 CB GLU A 279 −1.627 0.928 37.450 1.00 8.86

ATOM 2448 CG GLU A 279 −1.592 0.943 38.965 1.00 10.55

ATOM 2451 CD GLU A 279 −0.797 −0.198 39.546 1.00 11.50

ATOM 2452 OE1 GLU A 279 −0.096 0.024 40.564 1.00 12.98

ATOM 2453 OE2 GLU A 279 −0.874 −1.317 38.996 1.00 12.19

ATOM 2454 C GLU A 279 −0.786 −0.106 35.394 1.00 8.23

ATOM 2455 O GLU A 279 −1.127 0.658 34.486 1.00 8.51

ATOM 2456 N PRO A 280 −0.849 −1.424 35.159 1.00 8.03

ATOM 2457 CA PRO A 280 −0.438 −2.620 35.910 1.00 7.65

ATOM 2459 CB PRO A 280 −1.239 −3.753 35.191 1.00 7.99

ATOM 2462 CG PRO A 280 −1.963 −3.141 34.091 1.00 8.12

ATOM 2465 CD PRO A 280 −1.524 −1.783 33.914 1.00 8.30

ATOM 2468 C PRO A 280 1.043 −2.900 35.695 1.00 6.68

ATOM 2469 O PRO A 280 1.691 −3.577 36.482 1.00 7.93

ATOM 2470 N TYR A 281 1.575 −2.321 34.628 1.00 5.83

ATOM 2472 CA TYR A 281 2.948 −2.492 34.168 1.00 4.98

ATOM 2474 CB TYR A 281 3.143 −1.626 32.932 1.00 4.93

ATOM 2477 CG TYR A 281 1.998 −1.853 31.958 1.00 5.13

ATOM 2478 CD1 TYR A 281 1.142 −0.824 31.599 1.00 6.00

ATOM 2480 CE1 TYR A 281 0.082 −1.048 30.733 1.00 6.35

ATOM 2482 CZ TYR A 281 −0.126 −2.314 30.231 1.00 6.60

ATOM 2483 OH TYR A 281 −1.168 −2.555 29.374 1.00 7.98

ATOM 2485 CE2 TYR A 281 0.697 −3.351 30.583 1.00 6.56

ATOM 2487 CD2 TYR A 281 1.748 −3.119 31.445 1.00 5.49

ATOM 2489 C TYR A 281 4.061 −2.236 35.181 1.00 4.34

ATOM 2490 O TYR A 281 5.201 −2.564 34.898 1.00 4.10

ATOM 2491 N ASN A 282 3.744 −1.655 36.335 1.00 3.78

ATOM 2493 CA ASN A 282 4.756 −1.474 37.377 1.00 3.97

ATOM 2495 CB ASN A 282 4.402 −0.340 38.344 1.00 4.11

ATOM 2498 CG ASN A 282 3.066 −0.537 39.012 1.00 5.03

ATOM 2499 OD1 ASN A 282 2.065 −0.819 38.361 1.00 5.68

ATOM 2500 ND2 ASN A 282 3.043 −0.379 40.325 1.00 5.45 N ATOM 2503 C ASN A 282 4.962 −2.793 38.130 1.00 3.55

ATOM 2504 O ASN A 282 5.766 −2.876 39.063 1.00 3.50

ATOM 2505 N HIS A 283 4.218 −3.820 37.729 1.00 3.14 N ATOM 2507 CA HIS A 283 4.330 −5.155 38.302 1.00 2.99

ATOM 2509 CB HIS A 283 2.958 −5.680 38.729 1.00 3.26

ATOM 2512 CG HIS A 283 2.198 −4.747 39.619 1.00 3.72

ATOM 2513 ND1 HIS A 283 2.212 −4.855 40.997 1.00 5.84 N ATOM 2515 CE1 HIS A 283 1.466 −3.896 41.517 1.00 5.78

ATOM 2517 NE2 HIS A 283 0.967 −3.175 40.527 1.00 5.04 N ATOM 2519 CD2 HIS A 283 1.427 −3.673 39.336 1.00 4.01

ATOM 2521 C HIS A 283 4.959 −6.077 37.250 1.00 3.18

ATOM 2522 O HIS A 283 4.542 −6.077 36.083 1.00 2.66

ATOM 2523 N VAL A 284 5.962 −6.852 37.664 1.00 3.38 N ATOM 2525 CA VAL A 284 6.691 −7.754 36.772 1.00 3.93

ATOM 2527 CB VAL A 284 7.902 −8.397 37.522 1.00 4.61

ATOM 2529 CG1 VAL A 284 8.480 −9.561 36.733 1.00 6.36

ATOM 2533 CG2 VAL A 284 8.951 −7.367 37.765 1.00 5.28

ATOM 2537 C VAL A 284 5.793 −8.835 36.177 1.00 3.60

ATOM 2538 O VAL A 284 6.077 −9.374 35.102 1.00 3.80

ATOM 2539 N SER A 285 4.690 −9.129 36.857 1.00 3.21 N ATOM 2541 CA SER A 285 3.729 −10.112 36.374 1.00 3.59

ATOM 2543 CB SER A 285 2.665 −10.381 37.441 1.00 3.57

ATOM 2546 OG SER A 285 2.080 −9.175 37.898 1.00 3.13

ATOM 2548 C SER A 285 3.053 −9.624 35.091 1.00 3.14

ATOM 2549 O SER A 285 2.489 −10.423 34.338 1.00 4.00

ATOM 2550 N LYS A 286 3.093 −8.313 34.853 1.00 3.10 N ATOM 2552 CA LYS A 286 2.439 −7.702 33.678 1.00 3.42

ATOM 2554 CB LYS A 286 1.438 −6.633 34.123 1.00 3.77

ATOM 2557 CG LYS A 286 0.123 −7.194 34.685 1.00 6.06

ATOM 2560 CD LYS A 286 −0.724 −7.896 33.666 1.00 8.22

ATOM 2563 CE LYS A 286 −1.925 −8.600 34.311 1.00 9.47

ATOM 2566 NZ LYS A 286 −2.793 −9.261 33.296 1.00 11.77

ATOM 2570 C LYS A 286 3.405 −7.077 32.670 1.00 3.19

ATOM 2571 O LYS A 286 3.067 −6.937 31.484 1.00 3.19

ATOM 2572 N TYR A 287 4.591 −6.686 33.135 1.00 3.08

ATOM 2574 CA TYR A 287 5.581 −6.043 32.283 1.00 2.92

ATOM 2576 CB TYR A 287 5.327 −4.534 32.227 1.00 3.01

ATOM 2579 CG TYR A 287 6.346 −3.785 31.403 1.00 2.82

ATOM 2580 CD1 TYR A 287 6.227 −3.716 30.020 1.00 2.65

ATOM 2582 CE1 TYR A 287 7.154 −3.039 29.258 1.00 3.46

ATOM 2584 CZ TYR A 287 8.239 −2.428 29.883 1.00 3.19

ATOM 2585 OH TYR A 287 9.179 −1.762 29.138 1.00 3.19

ATOM 2587 CE2 TYR A 287 8.375 −2.474 31.262 1.00 3.12

ATOM 2589 CD2 TYR A 287 7.438 −3.153 32.008 1.00 2.85

ATOM 2591 C TYR A 287 6.994 −6.291 32.781 1.00 3.16

ATOM 2592 O TYR A 287 7.328 −5.923 33.904 1.00 2.77

ATOM 2593 N CYS A 288 7.825 −6.899 31.943 1.00 3.14

ATOM 2595 CA CYS A 288 9.210 −7.146 32.319 1.00 3.38

ATOM 2597 CB CYS A 288 9.379 −8.530 32.957 1.00 3.55

ATOM 2600 SG CYS A 288 9.045 −9.938 31.904 1.00 4.82

ATOM 2601 C CYS A 288 10.167 −6.940 31.143 1.00 3.21

ATOM 2602 O CYS A 288 11.324 −7.371 31.199 1.00 3.03

ATOM 2603 N ALA A 289 9.694 −6.258 30.100 1.00 2.71

ATOM 2605 CA ALA A 289 10.523 −5.935 28.941 1.00 2.80

ATOM 2607 CB ALA A 289 9.680 −5.275 27.818 1.00 2.83

ATOM 2611 C ALA A 289 11.691 −5.033 29.332 1.00 3.28

ATOM 2612 O ALA A 289 12.757 −5.100 28.732 1.00 4.23

ATOM 2613 N SER A 290 11.496 −4.204 30.354 1.00 3.41

ATOM 2615 CA SER A 290 12.558 −3.353 30.882 1.00 3.17

ATOM 2617 CB SER A 290 12.535 −1.959 30.266 1.00 3.30

ATOM 2620 OG SER A 290 11.322 −1.293 30.525 1.00 2.87

ATOM 2622 C SER A 290 12.317 −3.286 32.377 1.00 3.07

ATOM 2623 O SER A 290 11.195 −3.478 32.823 1.00 2.76

ATOM 2624 N LEU A 291 13.349 −2.993 33.159 1.00 2.85

ATOM 2626 CA LEU A 291 13.206 −3.042 34.601 1.00 2.89

ATOM 2628 CB LEU A 291 13.931 −4.286 35.143 1.00 2.91

ATOM 2631 CG LEU A 291 13.374 −5.624 34.631 1.00 2.88

ATOM 2633 CD1 LEU A 291 14.284 −6.783 34.977 1.00 3.99

ATOM 2637 CD2 LEU A 291 11.955 −5.886 35.147 1.00 2.41

ATOM 2641 C LEU A 291 13.712 −1.810 35.332 1.00 2.94

ATOM 2642 O LEU A 291 13.742 −1.805 36.562 1.00 2.78

ATOM 2643 N GLY A 292 14.073 −0.766 34.587 1.00 2.64

ATOM 2645 CA GLY A 292 14.630 0.449 35.169 1.00 2.69

ATOM 2648 C GLY A 292 13.795 1.106 36.250 1.00 2.65

ATOM 2649 O GLY A 292 14.336 1.707 37.187 1.00 2.68

ATOM 2650 N HIS A 293 12.478 0.991 36.126 1.00 2.35

ATOM 2652 CA HIS A 293 11.550 1.619 37.055 1.00 2.26

ATOM 2654 CB HIS A 293 10.148 1.602 36.437 1.00 2.29

ATOM 2657 CG HIS A 293 9.712 0.229 36.055 1.00 2.25

ATOM 2658 ND1 HIS A 293 10.181 −0.403 34.926 1.00 2.25

ATOM 2660 CE1 HIS A 293 9.648 −1.609 34.848 1.00 2.36

ATOM 2662 NE2 HIS A 293 8.885 −1.797 35.910 1.00 2.79

ATOM 2664 CD2 HIS A 293 8.918 −0.666 36.690 1.00 2.34

ATOM 2666 C HIS A 293 11.504 0.929 38.421 1.00 2.56

ATOM 2667 O HIS A 293 10.796 1.395 39.313 1.00 2.98

ATOM 2668 N LYS A 294 12.240 −0.172 38.582 1.00 2.27

ATOM 2670 CA LYS A 294 12.264 −0.919 39.839 1.00 2.63

ATOM 2672 CB LYS A 294 12.376 −2.421 39.565 1.00 2.92

ATOM 2675 CG LYS A 294 11.067 −3.031 39.101 1.00 3.32

ATOM 2678 CD LYS A 294 10.086 −3.141 40.258 1.00 4.06

ATOM 2681 CE LYS A 294 8.697 −3.522 39.807 1.00 4.08

ATOM 2684 NZ LYS A 294 7.734 −3.623 40.939 1.00 4.41

ATOM 2688 C LYS A 294 13.399 −0.470 40.746 1.00 2.51

ATOM 2689 O LYS A 294 13.471 −0.868 41.922 1.00 2.44

ATOM 2690 N ALA A 295 14.293 0.366 40.230 1.00 2.47

ATOM 2692 CA ALA A 295 15.431 0.814 41.054 1.00 2.22

ATOM 2694 CB ALA A 295 16.548 1.337 40.185 1.00 2.36

ATOM 2698 C ALA A 295 14.970 1.893 42.034 1.00 2.25

ATOM 2699 O ALA A 295 14.358 2.889 41.637 1.00 2.76

ATOM 2700 N ASN A 296 15.253 1.682 43.313 1.00 2.13

ATOM 2702 CA ASN A 296 14.860 2.615 44.361 1.00 2.29

ATOM 2704 CB ASN A 296 14.725 1.873 45.678 1.00 2.09

ATOM 2707 CG ASN A 296 13.486 1.028 45.711 1.00 2.28

ATOM 2708 OD1 ASN A 296 12.422 1.486 45.279 1.00 2.81

ATOM 2709 ND2 ASN A 296 13.615 −0.221 46.121 1.00 2.55

ATOM 2712 C ASN A 296 15.786 3.816 44.496 1.00 2.15

ATOM 2713 O ASN A 296 16.853 3.860 43.893 1.00 2.45

ATOM 2714 N HIS A 297 15.344 4.798 45.271 1.00 2.20

ATOM 2716 CA HIS A 297 16.080 6.034 45.450 1.00 2.13

ATOM 2718 CB HIS A 297 15.121 7.173 45.807 1.00 2.21

ATOM 2721 CG HIS A 297 15.829 8.394 46.302 1.00 2.34

ATOM 2722 ND1 HIS A 297 16.462 9.281 45.458 1.00 2.56

ATOM 2724 CE1 HIS A 297 17.037 10.232 46.173 1.00 2.82

ATOM 2726 NE2 HIS A 297 16.815 9.984 47.451 1.00 2.94

ATOM 2728 CD2 HIS A 297 16.066 8.838 47.561 1.00 2.18

ATOM 2730 C HIS A 297 17.130 5.980 46.554 1.00 2.15

ATOM 2731 O HIS A 297 16.948 5.305 47.551 1.00 2.33

ATOM 2732 N SER A 298 18.216 6.721 46.364 1.00 2.19

ATOM 2734 CA SER A 298 19.215 6.914 47.405 1.00 2.49

ATOM 2736 CB SER A 298 20.243 5.783 47.431 1.00 2.80

ATOM 2739 OG SER A 298 21.287 6.091 48.325 1.00 2.20

ATOM 2741 C SER A 298 19.911 8.241 47.136 1.00 2.39

ATOM 2742 O SER A 298 20.109 8.615 45.982 1.00 2.37

ATOM 2743 N PHE A 299 20.277 8.943 48.207 1.00 2.46

ATOM 2745 CA PHE A 299 21.037 10.186 48.092 1.00 2.65

ATOM 2747 CB PHE A 299 20.745 11.104 49.279 1.00 2.42

ATOM 2750 CG PHE A 299 19.338 11.659 49.286 1.00 2.34

ATOM 2751 CD1 PHE A 299 18.416 11.245 50.231 1.00 2.37

ATOM 2753 CE1 PHE A 299 17.133 11.763 50.240 1.00 2.97

ATOM 2755 CZ PHE A 299 16.752 12.697 49.297 1.00 2.88

ATOM 2757 CE2 PHE A 299 17.657 13.115 48.345 1.00 3.21

ATOM 2759 CD2 PHE A 299 18.945 12.599 48.341 1.00 2.74

ATOM 2761 C PHE A 299 22.543 9.873 47.963 1.00 2.90

ATOM 2762 O PHE A 299 23.370 10.764 47.722 1.00 3.44

ATOM 2763 N THR A 300 22.901 8.605 48.151 1.00 2.84

ATOM 2765 CA THR A 300 24.260 8.135 47.903 1.00 2.81

ATOM 2767 CB THR A 300 24.960 7.752 49.219 1.00 3.19

ATOM 2769 OG1 THR A 300 24.282 6.645 49.839 1.00 3.63

ATOM 2771 CG2 THR A 300 24.845 8.865 50.233 1.00 3.94

ATOM 2775 C THR A 300 24.177 6.940 46.941 1.00 2.44

ATOM 2776 O THR A 300 24.554 5.827 47.265 1.00 2.31

ATOM 2777 N PRO A 301 23.657 7.180 45.737 1.00 2.43

ATOM 2778 CA PRO A 301 23.378 6.110 44.781 1.00 2.16

ATOM 2780 CB PRO A 301 22.571 6.820 43.687 1.00 2.48

ATOM 2783 CG PRO A 301 22.859 8.261 43.848 1.00 2.59

ATOM 2786 CD PRO A 301 23.355 8.504 45.187 1.00 2.30

ATOM 2789 C PRO A 301 24.612 5.508 44.146 1.00 2.19

ATOM 2790 O PRO A 301 25.667 6.142 44.118 1.00 2.11

ATOM 2791 N ASN A 302 24.473 4.280 43.663 1.00 2.08

ATOM 2793 CA ASN A 302 25.544 3.631 42.923 1.00 2.30

ATOM 2795 CB ASN A 302 25.760 2.176 43.368 1.00 2.54

ATOM 2798 CG ASN A 302 24.503 1.347 43.345 1.00 2.93

ATOM 2799 OD1 ASN A 302 23.527 1.646 42.642 1.00 2.27

ATOM 2800 ND2 ASN A 302 24.524 0.276 44.126 1.00 2.69

ATOM 2803 C ASN A 302 25.305 3.719 41.414 1.00 2.18

ATOM 2804 O ASN A 302 26.127 3.272 40.629 1.00 2.31

ATOM 2805 N CYS A 303 24.182 4.317 41.022 1.00 2.27

ATOM 2807 CA CYS A 303 23.833 4.451 39.602 1.00 2.49

ATOM 2809 CB CYS A 303 22.792 3.396 39.210 1.00 2.78

ATOM 2812 SG CYS A 303 23.339 1.693 39.246 1.00 3.80

ATOM 2813 C CYS A 303 23.254 5.829 39.291 1.00 2.73

ATOM 2814 O CYS A 303 22.880 6.575 40.195 1.00 2.38

ATOM 2815 N ILE A 304 23.175 6.144 37.997 1.00 3.20

ATOM 2817 CA ILE A 304 22.551 7.362 37.507 1.00 4.01

ATOM 2819 CB ILE A 304 23.589 8.352 36.962 1.00 4.63

ATOM 2821 CG1 ILE A 304 22.900 9.662 36.546 1.00 6.24

ATOM 2824 CD1 ILE A 304 23.714 10.929 36.824 1.00 7.94

ATOM 2828 CG2 ILE A 304 24.294 7.762 35.735 1.00 3.91

ATOM 2832 C ILE A 304 21.615 7.005 36.356 1.00 3.90

ATOM 2833 O ILE A 304 21.779 5.967 35.706 1.00 3.61

ATOM 2834 N TYR A 305 20.620 7.851 36.115 1.00 4.27

ATOM 2836 CA TYR A 305 19.811 7.719 34.905 1.00 4.17

ATOM 2838 CB TYR A 305 18.446 8.396 35.049 1.00 4.27

ATOM 2841 CG TYR A 305 17.518 7.784 36.075 1.00 4.35

ATOM 2842 CD1 TYR A 305 16.969 8.561 37.079 1.00 3.85

ATOM 2844 CE1 TYR A 305 16.088 8.031 37.989 1.00 3.52

ATOM 2846 CZ TYR A 305 15.742 6.705 37.916 1.00 2.97

ATOM 2847 OH TYR A 305 14.899 6.178 38.864 1.00 3.40

ATOM 2849 CE2 TYR A 305 16.272 5.905 36.938 1.00 3.18

ATOM 2851 CD2 TYR A 305 17.145 6.445 36.009 1.00 3.93

ATOM 2853 C TYR A 305 20.594 8.424 33.793 1.00 4.33

ATOM 2854 O TYR A 305 21.046 9.556 33.979 1.00 4.86

ATOM 2855 N ASP A 306 20.757 7.766 32.646 1.00 4.34

ATOM 2857 CA ASP A 306 21.513 8.308 31.529 1.00 4.40

ATOM 2859 CB ASP A 306 22.849 7.584 31.422 1.00 4.75

ATOM 2862 CG ASP A 306 23.936 8.435 30.780 1.00 7.01

ATOM 2863 OD1 ASP A 306 25.078 7.942 30.676 1.00 9.18

ATOM 2864 OD2 ASP A 306 23.753 9.599 30.359 1.00 8.97

ATOM 2865 C ASP A 306 20.724 8.051 30.246 1.00 4.09

ATOM 2866 O ASP A 306 19.871 7.178 30.213 1.00 4.07

ATOM 2867 N MET A 307 21.019 8.816 29.205 1.00 4.07

ATOM 2869 CA MET A 307 20.347 8.664 27.912 1.00 4.21

ATOM 2871 CB MET A 307 20.783 9.786 26.977 1.00 5.32

ATOM 2874 CG MET A 307 20.489 11.178 27.519 1.00 8.07

ATOM 2877 SD MET A 307 18.720 11.457 27.739 1.00 14.04

ATOM 2878 CE MET A 307 18.218 11.779 26.162 1.00 13.82

ATOM 2882 C MET A 307 20.701 7.330 27.284 1.00 3.48

ATOM 2883 O MET A 307 21.779 6.778 27.512 1.00 3.03

ATOM 2884 N PHE A 308 19.800 6.798 26.472 1.00 2.95

ATOM 2886 CA PHE A 308 20.089 5.560 25.787 1.00 2.68

ATOM 2888 CB PHE A 308 19.816 4.342 26.658 1.00 2.48

ATOM 2891 CG PHE A 308 20.525 3.109 26.175 1.00 2.58

ATOM 2892 CD1 PHE A 308 21.838 2.872 26.533 1.00 2.38

ATOM 2894 CE1 PHE A 308 22.506 1.749 26.081 1.00 2.34

ATOM 2896 CZ PHE A 308 21.861 0.859 25.233 1.00 2.21

ATOM 2898 CE2 PHE A 308 20.561 1.091 24.864 1.00 2.27

ATOM 2900 CD2 PHE A 308 19.899 2.213 25.323 1.00 2.69

ATOM 2902 C PHE A 308 19.247 5.463 24.556 1.00 2.59

ATOM 2903 O PHE A 308 18.077 5.819 24.590 1.00 2.93

ATOM 2904 N VAL A 309 19.846 4.997 23.470 1.00 2.55

ATOM 2906 CA VAL A 309 19.084 4.741 22.238 1.00 2.34

ATOM 2908 CB VAL A 309 19.779 5.286 20.996 1.00 2.39

ATOM 2910 CG1 VAL A 309 18.970 4.927 19.749 1.00 3.20

ATOM 2914 CG2 VAL A 309 19.947 6.783 21.101 1.00 2.94

ATOM 2918 C VAL A 309 18.929 3.234 22.085 1.00 2.29

ATOM 2919 O VAL A 309 19.908 2.537 21.784 1.00 2.81

ATOM 2920 N HIS A 310 17.708 2.735 22.288 1.00 2.05

ATOM 2922 CA HIS A 310 17.437 1.302 22.283 1.00 2.05

ATOM 2924 CB HIS A 310 16.515 0.970 23.451 1.00 2.06

ATOM 2927 CG HIS A 310 16.542 −0.468 23.854 1.00 2.16

ATOM 2928 ND1 HIS A 310 15.910 −1.456 23.133 1.00 2.24

ATOM 2930 CE1 HIS A 310 16.094 −2.620 23.729 1.00 2.24

ATOM 2932 NE2 HIS A 310 16.841 −2.424 24.804 1.00 2.07

ATOM 2934 CD2 HIS A 310 17.129 −1.087 24.907 1.00 2.11

ATOM 2936 C HIS A 310 16.780 0.859 20.978 1.00 2.02

ATOM 2937 O HIS A 310 15.853 1.516 20.508 1.00 2.15

ATOM 2938 N PRO A 311 17.236 −0.253 20.404 1.00 2.00

ATOM 2939 CA PRO A 311 16.729 −0.708 19.113 1.00 2.03

ATOM 2941 CB PRO A 311 17.679 −1.853 18.779 1.00 2.05

ATOM 2944 CG PRO A 311 18.002 −2.396 20.074 1.00 2.00

ATOM 2947 CD PRO A 311 18.269 −1.178 20.901 1.00 2.25

ATOM 2950 C PRO A 311 15.305 −1.227 19.166 1.00 2.06

ATOM 2951 O PRO A 311 14.682 −1.344 18.121 1.00 2.04

ATOM 2952 N ARG A 312 14.825 −1.556 20.363 1.00 2.07

ATOM 2954 CA ARG A 312 13.457 −2.019 20.544 1.00 2.05

ATOM 2956 CB ARG A 312 13.451 −3.193 21.520 1.00 2.11

ATOM 2959 CG ARG A 312 12.081 −3.729 21.869 1.00 2.61

ATOM 2962 CD ARG A 312 12.183 −4.845 22.888 1.00 2.59

ATOM 2965 NE ARG A 312 10.909 −5.399 23.321 1.00 2.54

ATOM 2967 CZ ARG A 312 10.809 −6.309 24.281 1.00 2.35

ATOM 2968 NH1 ARG A 312 11.910 −6.750 24.882 1.00 2.09

ATOM 2971 NH2 ARG A 312 9.633 −6.785 24.651 1.00 2.21

ATOM 2974 C ARG A 312 12.555 −0.906 21.079 1.00 2.01

ATOM 2975 O ARG A 312 11.441 −0.707 20.585 1.00 2.03

ATOM 2976 N PHE A 313 13.048 −0.180 22.082 1.00 2.06

ATOM 2978 CA PHE A 313 12.272 0.852 22.768 1.00 2.15

ATOM 2980 CB PHE A 313 12.646 0.908 24.252 1.00 2.09

ATOM 2983 CG PHE A 313 12.593 −0.422 24.940 1.00 2.49

ATOM 2984 CD1 PHE A 313 13.706 −0.932 25.595 1.00 2.43

ATOM 2986 CE1 PHE A 313 13.649 −2.151 26.218 1.00 2.71

ATOM 2988 CZ PHE A 313 12.476 −2.890 26.186 1.00 3.14

ATOM 2990 CE2 PHE A 313 11.374 −2.388 25.543 1.00 3.93

ATOM 2992 CD2 PHE A 313 11.432 −1.170 24.924 1.00 3.07

ATOM 2994 C PHE A 313 12.411 2.260 22.202 1.00 2.21

ATOM 2995 O PHE A 313 11.577 3.113 22.496 1.00 2.40

ATOM 2996 N GLY A 314 13.465 2.515 21.430 1.00 2.22

ATOM 2998 CA GLY A 314 13.703 3.846 20.898 1.00 2.38

ATOM 3001 C GLY A 314 14.504 4.673 21.888 1.00 2.42

ATOM 3002 O GLY A 314 15.170 4.117 22.771 1.00 2.50

ATOM 3003 N PRO A 315 14.474 5.995 21.752 1.00 2.39

ATOM 3004 CA PRO A 315 15.205 6.863 22.682 1.00 2.53

ATOM 3006 CB PRO A 315 15.125 8.244 22.017 1.00 2.53

ATOM 3009 CG PRO A 315 14.561 8.011 20.631 1.00 2.82

ATOM 3012 CD PRO A 315 13.766 6.768 20.718 1.00 2.60

ATOM 3015 C PRO A 315 14.553 6.856 24.064 1.00 2.29

ATOM 3016 O PRO A 315 13.414 7.277 24.218 1.00 2.54

ATOM 3017 N ILE A 316 15.279 6.371 25.065 1.00 2.65

ATOM 3019 CA ILE A 316 14.766 6.267 26.421 1.00 2.47

ATOM 3021 CB ILE A 316 14.346 4.822 26.706 1.00 2.35

ATOM 3023 CG1 ILE A 316 15.497 3.870 26.375 1.00 2.33

ATOM 3026 CD1 ILE A 316 15.293 2.446 26.877 1.00 2.49

ATOM 3030 CG2 ILE A 316 13.104 4.465 25.901 1.00 3.20

ATOM 3034 C ILE A 316 15.879 6.678 27.374 1.00 2.60

ATOM 3035 O ILE A 316 16.785 7.397 26.977 1.00 2.71

ATOM 3036 N LYS A 317 15.811 6.223 28.622 1.00 3.12

ATOM 3038 CA LYS A 317 16.918 6.422 29.560 1.00 3.53

ATOM 3040 CB LYS A 317 16.561 7.348 30.733 1.00 4.01

ATOM 3043 CG LYS A 317 16.618 8.849 30.330 1.00 5.08

ATOM 3046 CD LYS A 317 16.663 9.811 31.503 1.00 5.59

ATOM 3049 CE LYS A 317 16.792 11.261 31.003 1.00 5.93

ATOM 3052 NZ LYS A 317 16.702 12.281 32.080 1.00 5.69

ATOM 3056 C LYS A 317 17.334 5.033 30.034 1.00 3.26

ATOM 3057 O LYS A 317 16.600 4.056 29.832 1.00 3.14

ATOM 3058 N CYS A 318 18.520 4.937 30.615 1.00 3.10

ATOM 3060 CA CYS A 318 19.029 3.676 31.146 1.00 2.84

ATOM 3062 CB CYS A 318 20.146 3.121 30.260 1.00 2.61

ATOM 3065 SG CYS A 318 21.710 4.019 30.351 1.00 3.58

ATOM 3066 C CYS A 318 19.546 3.909 32.557 1.00 2.89

ATOM 3067 O CYS A 318 19.564 5.043 33.031 1.00 2.65

ATOM 3068 N ILE A 319 19.941 2.826 33.223 1.00 2.82

ATOM 3070 CA ILE A 319 20.562 2.902 34.537 1.00 3.48

ATOM 3072 CB ILE A 319 19.903 1.905 35.512 1.00 3.96

ATOM 3074 CG1 ILE A 319 18.398 2.176 35.628 1.00 5.82

ATOM 3077 CD1 ILE A 319 18.023 3.175 36.621 1.00 7.54

ATOM 3081 CG2 ILE A 319 20.612 1.932 36.846 1.00 4.63

ATOM 3085 C ILE A 319 22.012 2.515 34.311 1.00 2.77

ATOM 3086 O ILE A 319 22.282 1.418 33.815 1.00 2.85

ATOM 3087 N ARG A 320 22.930 3.417 34.653 1.00 2.38

ATOM 3089 CA ARG A 320 24.357 3.199 34.461 1.00 2.26

ATOM 3091 CB ARG A 320 24.902 4.228 33.482 1.00 2.37

ATOM 3094 CG ARG A 320 26.360 4.064 33.145 1.00 2.44

ATOM 3097 CD ARG A 320 26.901 5.216 32.313 1.00 2.34

ATOM 3100 NE ARG A 320 26.315 5.275 30.983 1.00 2.76

ATOM 3102 CZ ARG A 320 26.774 4.615 29.933 1.00 2.66

ATOM 3103 NH1 ARG A 320 27.827 3.820 30.046 1.00 2.29

ATOM 3106 NH2 ARG A 320 26.164 4.746 28.761 1.00 2.49

ATOM 3109 C ARG A 320 25.070 3.362 35.792 1.00 2.24

ATOM 3110 O ARG A 320 24.845 4.335 36.511 1.00 2.42

ATOM 3111 N THR A 321 25.943 2.419 36.115 1.00 2.12

ATOM 3113 CA THR A 321 26.667 2.490 37.390 1.00 2.25

ATOM 3115 CB THR A 321 27.462 1.218 37.665 1.00 2.06

ATOM 3117 OG1 THR A 321 28.545 1.097 36.736 1.00 2.59

ATOM 3119 CG2 THR A 321 26.650 −0.039 37.490 1.00 2.06

ATOM 3123 C THR A 321 27.605 3.696 37.421 1.00 2.65

ATOM 3124 O THR A 321 28.131 4.132 36.388 1.00 2.48

ATOM 3125 N LEU A 322 27.791 4.227 38.628 1.00 3.11

ATOM 3127 CA LEU A 322 28.667 5.360 38.890 1.00 3.87

ATOM 3129 CB LEU A 322 28.016 6.264 39.937 1.00 4.48

ATOM 3132 CG LEU A 322 27.290 7.518 39.498 1.00 6.27

ATOM 3134 CD1 LEU A 322 26.431 7.277 38.300 1.00 9.03

ATOM 3138 CD2 LEU A 322 26.468 7.993 40.693 1.00 6.96

ATOM 3142 C LEU A 322 29.987 4.870 39.476 1.00 4.18

ATOM 3143 O LEU A 322 30.979 5.597 39.508 1.00 4.32

ATOM 3144 N ARG A 323 29.970 3.649 39.985 1.00 4.39

ATOM 3146 CA ARG A 323 31.132 3.070 40.646 1.00 4.63

ATOM 3148 CB ARG A 323 31.080 3.375 42.146 1.00 4.87

ATOM 3151 CG ARG A 323 29.824 2.867 42.875 1.00 6.06

ATOM 3154 CD ARG A 323 29.726 3.355 44.329 1.00 8.55

ATOM 3157 NE ARG A 323 28.606 2.801 45.088 1.00 10.17

ATOM 3159 CZ ARG A 323 27.802 3.516 45.885 1.00 12.22

ATOM 3160 NH1 ARG A 323 27.966 4.828 46.029 1.00 11.79

ATOM 3163 NH2 ARG A 323 26.815 2.918 46.539 1.00 14.22

ATOM 3166 C ARG A 323 31.090 1.571 40.424 1.00 4.50

ATOM 3167 O ARG A 323 30.161 1.064 39.814 1.00 5.16

ATOM 3168 N ALA A 324 32.084 0.846 40.915 1.00 4.31

ATOM 3170 CA ALA A 324 32.033 −0.602 40.779 1.00 4.08

ATOM 3172 CB ALA A 324 33.333 −1.223 41.129 1.00 3.70

ATOM 3176 C ALA A 324 30.902 −1.132 41.665 1.00 4.02

ATOM 3177 O ALA A 324 30.613 −0.573 42.718 1.00 3.97

ATOM 3178 N VAL A 325 30.235 −2.184 41.204 1.00 4.41

ATOM 3180 CA VAL A 325 29.097 −2.754 41.907 1.00 4.52

ATOM 3182 CB VAL A 325 27.782 −2.415 41.193 1.00 4.82

ATOM 3184 CG1 VAL A 325 26.624 −3.204 41.766 1.00 5.53

ATOM 3188 CG2 VAL A 325 27.496 −0.917 41.274 1.00 5.10

ATOM 3192 C VAL A 325 29.304 −4.263 41.968 1.00 4.28

ATOM 3193 O VAL A 325 29.699 −4.874 40.979 1.00 4.13

ATOM 3194 N GLU A 326 29.071 −4.862 43.130 1.00 4.39

ATOM 3196 CA GLU A 326 29.232 −6.304 43.270 1.00 4.62

ATOM 3198 CB GLU A 326 29.656 −6.670 44.685 1.00 5.39

ATOM 3201 CG GLU A 326 31.133 −7.007 44.791 1.00 6.97

ATOM 3204 CD GLU A 326 31.551 −8.095 43.807 1.00 9.48

ATOM 3205 OE1 GLU A 326 30.686 −8.907 43.347 1.00 8.95

ATOM 3206 OE2 GLU A 326 32.753 −8.133 43.478 1.00 11.36

ATOM 3207 C GLU A 326 27.952 −7.052 42.956 1.00 4.33

ATOM 3208 O GLU A 326 26.871 −6.472 42.948 1.00 4.21

ATOM 3209 N ALA A 327 28.089 −8.355 42.734 1.00 3.98

ATOM 3211 CA ALA A 327 26.940 −9.226 42.518 1.00 3.84

ATOM 3213 CB ALA A 327 27.418 −10.657 42.330 1.00 3.86

ATOM 3217 C ALA A 327 25.998 −9.155 43.719 1.00 3.85

ATOM 3218 O ALA A 327 26.454 −9.146 44.870 1.00 3.06

ATOM 3219 N ASP A 328 24.697 −9.120 43.453 1.00 3.85

ATOM 3221 CA ASP A 328 23.662 −9.100 44.490 1.00 4.37

ATOM 3223 CB ASP A 328 23.813 −10.313 45.399 1.00 4.71

ATOM 3226 CG ASP A 328 23.611 −11.610 44.651 1.00 4.46

ATOM 3227 OD1 ASP A 328 24.460 −12.518 44.789 1.00 4.47

ATOM 3228 OD2 ASP A 328 22.646 −11.801 43.882 1.00 5.41

ATOM 3229 C ASP A 328 23.600 −7.799 45.295 1.00 4.84

ATOM 3230 O ASP A 328 22.965 −7.740 46.351 1.00 5.11

ATOM 3231 N GLU A 329 24.256 −6.757 44.797 1.00 4.98

ATOM 3233 CA GLU A 329 24.176 −5.439 45.411 1.00 4.94

ATOM 3235 CB GLU A 329 25.431 −4.620 45.086 1.00 5.24

ATOM 3238 CG GLU A 329 25.329 −3.153 45.470 1.00 6.22

ATOM 3241 CD GLU A 329 26.680 −2.439 45.501 1.00 7.84

ATOM 3242 OE1 GLU A 329 27.745 −3.107 45.497 1.00 6.56

ATOM 3243 OE2 GLU A 329 26.659 −1.189 45.515 1.00 9.56

ATOM 3244 C GLU A 329 22.908 −4.745 44.876 1.00 4.42

ATOM 3245 O GLU A 329 22.546 −4.900 43.698 1.00 4.27

ATOM 3246 N GLU A 330 22.204 −4.002 45.723 1.00 3.90

ATOM 3248 CA GLU A 330 21.009 −3.293 45.234 1.00 3.66

ATOM 3250 CB GLU A 330 20.079 −2.861 46.373 1.00 3.79

ATOM 3253 CG GLU A 330 18.758 −2.288 45.866 1.00 3.60

ATOM 3256 CD GLU A 330 17.722 −2.054 46.950 1.00 4.19

ATOM 3257 OE1 GLU A 330 18.039 −2.252 48.125 1.00 4.83

ATOM 3258 OE2 GLU A 330 16.567 −1.680 46.626 1.00 4.44

ATOM 3259 C GLU A 330 21.439 −2.076 44.415 1.00 3.53

ATOM 3260 O GLU A 330 22.347 −1.328 44.822 1.00 3.55

ATOM 3261 N LEU A 331 20.796 −1.891 43.264 1.00 3.45

ATOM 3263 CA LEU A 331 21.040 −0.743 42.397 1.00 3.33

ATOM 3265 CB LEU A 331 20.753 −1.077 40.938 1.00 3.49

ATOM 3268 CG LEU A 331 21.633 −2.168 40.332 1.00 4.45

ATOM 3270 CD1 LEU A 331 21.415 −2.275 38.821 1.00 4.93

ATOM 3274 CD2 LEU A 331 23.105 −1.933 40.668 1.00 4.93

ATOM 3278 C LEU A 331 20.149 0.400 42.838 1.00 2.89

ATOM 3279 O LEU A 331 18.930 0.239 42.968 1.00 2.74

ATOM 3280 N THR A 332 20.752 1.552 43.089 1.00 2.38

ATOM 3282 CA THR A 332 19.992 2.721 43.498 1.00 2.55

ATOM 3284 CB THR A 332 20.241 3.074 44.958 1.00 2.23

ATOM 3286 OG1 THR A 332 21.648 3.262 45.174 1.00 3.52

ATOM 3288 CG2 THR A 332 19.851 1.934 45.860 1.00 2.12

ATOM 3292 C THR A 332 20.363 3.913 42.642 1.00 2.57

ATOM 3293 O THR A 332 21.450 3.969 42.082 1.00 2.47

ATOM 3294 N VAL A 333 19.447 4.871 42.560 1.00 2.89

ATOM 3296 CA VAL A 333 19.650 6.071 41.761 1.00 3.37

ATOM 3298 CB VAL A 333 18.935 5.964 40.381 1.00 3.63

ATOM 3300 CG1 VAL A 333 19.195 7.192 39.540 1.00 4.18

ATOM 3304 CG2 VAL A 333 19.375 4.712 39.631 1.00 4.44

ATOM 3308 C VAL A 333 19.063 7.272 42.494 1.00 3.05

ATOM 3309 O VAL A 333 18.110 7.138 43.250 1.00 2.77

ATOM 3310 N ALA A 334 19.626 8.448 42.258 1.00 2.99

ATOM 3312 CA ALA A 334 19.081 9.671 42.831 1.00 2.93

ATOM 3314 CB ALA A 334 20.136 10.765 42.851 1.00 3.06

ATOM 3318 C ALA A 334 17.890 10.075 41.973 1.00 2.63

ATOM 3319 O ALA A 334 18.049 10.352 40.787 1.00 3.30

ATOM 3320 N TYR A 335 16.695 10.076 42.547 1.00 2.12

ATOM 3322 CA TYR A 335 15.488 10.421 41.772 1.00 2.13

ATOM 3324 CB TYR A 335 14.226 10.153 42.591 1.00 2.12

ATOM 3327 CG TYR A 335 13.822 8.679 42.649 1.00 2.19

ATOM 3328 CD1 TYR A 335 14.659 7.669 42.172 1.00 2.05

ATOM 3330 CE1 TYR A 335 14.288 6.333 42.253 1.00 2.13

ATOM 3332 CZ TYR A 335 13.062 6.001 42.802 1.00 2.11

ATOM 3333 OH TYR A 335 12.679 4.679 42.880 1.00 2.37

ATOM 3335 CE2 TYR A 335 12.227 6.983 43.280 1.00 2.00

ATOM 3337 CD2 TYR A 335 12.605 8.302 43.201 1.00 2.00

ATOM 3339 C TYR A 335 15.537 11.863 41.250 1.00 2.06

ATOM 3340 O TYR A 335 14.941 12.187 40.210 1.00 2.37

ATOM 3341 N GLY A 336 16.249 12.730 41.965 1.00 2.07

ATOM 3343 CA GLY A 336 16.435 14.105 41.538 1.00 2.14

ATOM 3346 C GLY A 336 15.197 14.964 41.409 1.00 2.34

ATOM 3347 O GLY A 336 15.019 15.632 40.396 1.00 2.51

ATOM 3348 N TYR A 337 14.344 14.964 42.425 1.00 2.25

ATOM 3350 CA TYR A 337 13.200 15.861 42.424 1.00 2.45

ATOM 3352 CB TYR A 337 12.150 15.412 43.440 1.00 2.38

ATOM 3355 CG TYR A 337 11.528 14.084 43.097 1.00 2.24

ATOM 3356 CD1 TYR A 337 11.490 13.046 44.013 1.00 2.21

ATOM 3358 CE1 TYR A 337 10.916 11.828 43.694 1.00 2.44

ATOM 3360 CZ TYR A 337 10.367 11.648 42.449 1.00 2.60

ATOM 3361 OH TYR A 337 9.790 10.446 42.091 1.00 2.91

ATOM 3363 CE2 TYR A 337 10.396 12.668 41.530 1.00 2.55

ATOM 3365 CD2 TYR A 337 10.963 13.867 41.847 1.00 2.67

ATOM 3367 C TYR A 337 13.721 17.255 42.754 1.00 2.50

ATOM 3368 O TYR A 337 14.841 17.394 43.269 1.00 2.54

ATOM 3369 N ASP A 338 12.922 18.275 42.463 1.00 2.61

ATOM 3371 CA ASP A 338 13.279 19.658 42.726 1.00 3.24

ATOM 3373 CB ASP A 338 12.413 20.600 41.906 1.00 3.78

ATOM 3376 CG ASP A 338 12.916 22.029 41.916 1.00 4.73

ATOM 3377 OD1 ASP A 338 13.709 22.399 42.804 1.00 4.71

ATOM 3378 OD2 ASP A 338 12.539 22.873 41.070 1.00 6.96

ATOM 3379 C ASP A 338 13.128 19.964 44.214 1.00 3.59

ATOM 3380 O ASP A 338 12.020 19.993 44.750 1.00 3.63

ATOM 3381 N HIS A 339 14.262 20.207 44.865 1.00 3.16

ATOM 3383 CA HIS A 339 14.304 20.488 46.296 1.00 3.75

ATOM 3385 CB HIS A 339 15.695 20.166 46.843 1.00 3.35

ATOM 3388 CG HIS A 339 16.044 18.711 46.790 1.00 3.17

ATOM 3389 ND1 HIS A 339 17.254 18.223 47.230 1.00 2.63

ATOM 3391 CE1 HIS A 339 17.288 16.915 47.057 1.00 2.70

ATOM 3393 NE2 HIS A 339 16.143 16.534 46.522 1.00 2.61

ATOM 3395 CD2 HIS A 339 15.350 17.639 46.338 1.00 2.29

ATOM 3397 C HIS A 339 13.972 21.931 46.640 1.00 4.29

ATOM 3398 O HIS A 339 13.708 22.237 47.799 1.00 4.47

ATOM 3399 N SER A 340 13.989 22.813 45.642 1.00 4.86

ATOM 3401 CA SER A 340 13.725 24.228 45.875 1.00 5.67

ATOM 3403 CB SER A 340 15.034 24.966 46.119 1.00 5.47

ATOM 3406 OG SER A 340 14.765 26.299 46.505 1.00 5.21

ATOM 3408 C SER A 340 12.992 24.922 44.726 1.00 6.73

ATOM 3409 O SER A 340 13.558 25.757 44.031 1.00 6.15

ATOM 3410 N PRO A 341 11.735 24.570 44.514 1.00 8.49

ATOM 3411 CA PRO A 341 10.935 25.205 43.464 1.00 9.84

ATOM 3413 CB PRO A 341 9.548 24.564 43.621 1.00 9.67

ATOM 3416 CG PRO A 341 9.663 23.509 44.656 1.00 9.19

ATOM 3419 CD PRO A 341 11.008 23.538 45.251 1.00 8.47

ATOM 3422 C PRO A 341 10.906 26.729 43.636 1.00 11.40

ATOM 3423 O PRO A 341 11.054 27.212 44.752 1.00 11.46

ATOM 3424 N PRO A 342 10.702 27.460 42.539 1.00 13.36

ATOM 3425 CA PRO A 342 10.795 28.924 42.514 1.00 14.64

ATOM 3427 CB PRO A 342 10.413 29.298 41.083 1.00 14.54

ATOM 3430 CG PRO A 342 10.091 28.070 40.386 1.00 14.08

ATOM 3433 CD PRO A 342 10.255 26.912 41.264 1.00 13.41

ATOM 3436 C PRO A 342 9.692 29.343 43.362 1.00 15.96

ATOM 3437 O PRO A 342 9.633 30.393 44.022 1.00 16.30

ATOM 3438 N GLY A 343 8.735 28.442 43.240 1.00 17.38

ATOM 3440 CA GLY A 343 7.569 28.478 44.029 1.00 18.23

ATOM 3443 C GLY A 343 8.228 28.995 45.268 1.00 18.94

ATOM 3444 O GLY A 343 9.434 29.246 45.343 1.00 19.46

ATOM 3445 N LYS A 344 7.428 29.144 46.274 1.00 19.60

ATOM 3447 CA LYS A 344 7.914 29.735 47.463 1.00 20.09

ATOM 3449 CB LYS A 344 6.668 30.125 48.244 1.00 20.41

ATOM 3452 CG LYS A 344 6.315 29.099 49.302 1.00 21.21

ATOM 3455 CD LYS A 344 5.275 29.602 50.247 1.00 22.19

ATOM 3458 CE LYS A 344 4.668 28.474 51.058 1.00 22.78

ATOM 3461 NZ LYS A 344 3.561 28.978 51.917 1.00 22.97

ATOM 3465 C LYS A 344 8.632 28.654 48.255 1.00 20.09

ATOM 3466 O LYS A 344 9.787 28.762 48.682 1.00 20.34

ATOM 3467 N SER A 345 7.861 27.577 48.261 1.00 19.82

ATOM 3469 CA SER A 345 7.728 26.467 49.184 1.00 19.48

ATOM 3471 CB SER A 345 6.371 26.002 48.682 1.00 19.59

ATOM 3474 OG SER A 345 6.417 26.059 47.251 1.00 20.84

ATOM 3476 C SER A 345 8.360 25.117 49.402 1.00 18.72

ATOM 3477 O SER A 345 7.650 24.234 49.879 1.00 19.17

ATOM 3478 N GLY A 346 9.612 24.864 49.135 1.00 17.45

ATOM 3480 CA GLY A 346 10.055 23.530 49.496 1.00 16.41

ATOM 3483 C GLY A 346 9.892 22.517 48.382 1.00 15.40

ATOM 3484 O GLY A 346 9.197 22.747 47.397 1.00 15.23

ATOM 3485 N PRO A 347 10.529 21.369 48.560 1.00 14.06

ATOM 3486 CA PRO A 347 10.630 20.358 47.508 1.00 13.20

ATOM 3488 CB PRO A 347 11.447 19.236 48.160 1.00 13.19

ATOM 3491 CG PRO A 347 11.825 19.687 49.517 1.00 13.71

ATOM 3494 CD PRO A 347 11.199 20.970 49.801 1.00 14.23

ATOM 3497 C PRO A 347 9.322 19.797 46.988 1.00 12.24

ATOM 3498 O PRO A 347 8.428 19.461 47.754 1.00 12.46

ATOM 3499 N GLU A 348 9.227 19.698 45.669 1.00 11.28

ATOM 3501 CA GLU A 348 8.063 19.073 45.047 1.00 10.48

ATOM 3503 CB GLU A 348 7.728 19.695 43.700 1.00 11.42

ATOM 3506 CG GLU A 348 6.239 20.027 43.515 1.00 14.16

ATOM 3509 CD GLU A 348 5.301 19.258 44.447 1.00 17.81

ATOM 3510 OE1 GLU A 348 5.099 18.042 44.248 1.00 20.08

ATOM 3511 OE2 GLU A 348 4.749 19.879 45.386 1.00 19.94

ATOM 3512 C GLU A 348 8.448 17.609 44.902 1.00 8.57

ATOM 3513 O GLU A 348 9.138 17.214 43.968 1.00 7.67

ATOM 3514 N ALA A 349 8.041 16.810 45.874 1.00 7.53

ATOM 3516 CA ALA A 349 8.433 15.419 45.919 1.00 6.82

ATOM 3518 CB ALA A 349 9.829 15.300 46.541 1.00 6.96

ATOM 3522 C ALA A 349 7.430 14.658 46.753 1.00 6.14

ATOM 3523 O ALA A 349 6.677 15.252 47.524 1.00 5.39

ATOM 3524 N PRO A 350 7.427 13.339 46.618 1.00 6.01

ATOM 3525 CA PRO A 350 6.539 12.502 47.408 1.00 5.75

ATOM 3527 CB PRO A 350 6.814 11.089 46.884 1.00 6.19

ATOM 3530 CG PRO A 350 7.616 11.243 45.665 1.00 6.43

ATOM 3533 CD PRO A 350 8.290 12.542 45.737 1.00 6.39

ATOM 3536 C PRO A 350 6.958 12.613 48.865 1.00 5.09

ATOM 3537 O PRO A 350 8.127 12.904 49.136 1.00 4.77

ATOM 3538 N GLU A 351 6.025 12.392 49.777 1.00 4.61

ATOM 3540 CA GLU A 351 6.289 12.547 51.198 1.00 4.26

ATOM 3542 CB GLU A 351 5.007 12.350 52.004 1.00 4.18

ATOM 3545 CG GLU A 351 5.192 12.539 53.512 1.00 3.77

ATOM 3548 CD GLU A 351 5.700 13.918 53.922 1.00 3.90

ATOM 3549 OE1 GLU A 351 5.729 14.847 53.088 1.00 3.41

ATOM 3550 OE2 GLU A 351 6.079 14.078 55.111 1.00 4.18

ATOM 3551 C GLU A 351 7.399 11.637 51.723 1.00 3.94

ATOM 3552 O GLU A 351 8.212 12.067 52.542 1.00 3.91

ATOM 3553 N TRP A 352 7.439 10.386 51.268 1.00 3.48

ATOM 3555 CA TRP A 352 8.464 9.448 51.727 1.00 3.30

ATOM 3557 CB TRP A 352 8.244 8.051 51.132 1.00 3.23

ATOM 3560 CG TRP A 352 8.373 7.984 49.655 1.00 2.44

ATOM 3561 CD1 TRP A 352 7.354 7.966 48.734 1.00 2.73

ATOM 3563 NE1 TRP A 352 7.872 7.904 47.464 1.00 2.26

ATOM 3565 CE2 TRP A 352 9.242 7.885 47.545 1.00 2.19

ATOM 3566 CD2 TRP A 352 9.587 7.923 48.907 1.00 2.67

ATOM 3567 CE3 TRP A 352 10.950 7.919 49.251 1.00 2.00

ATOM 3569 CZ3 TRP A 352 11.888 7.860 48.247 1.00 2.01

ATOM 3571 CH2 TRP A 352 11.510 7.818 46.900 1.00 2.08

ATOM 3573 CZ2 TRP A 352 10.193 7.823 46.534 1.00 2.44

ATOM 3575 C TRP A 352 9.872 9.978 51.407 1.00 3.05

ATOM 3576 O TRP A 352 10.821 9.749 52.161 1.00 2.69

ATOM 3577 N TYR A 353 9.984 10.686 50.286 1.00 2.79

ATOM 3579 CA TYR A 353 11.239 11.243 49.798 1.00 2.97

ATOM 3581 CB TYR A 353 11.074 11.636 48.332 1.00 2.84

ATOM 3584 CG TYR A 353 12.258 12.302 47.667 1.00 2.38

ATOM 3585 CD1 TYR A 353 13.044 11.602 46.758 1.00 2.40

ATOM 3587 CE1 TYR A 353 14.092 12.210 46.110 1.00 2.38

ATOM 3589 CZ TYR A 353 14.346 13.539 46.339 1.00 2.34

ATOM 3590 OH TYR A 353 15.372 14.143 45.669 1.00 3.35

ATOM 3592 CE2 TYR A 353 13.561 14.265 47.205 1.00 2.14

ATOM 3594 CD2 TYR A 353 12.520 13.646 47.858 1.00 2.08

ATOM 3596 C TYR A 353 11.620 12.449 50.640 1.00 3.20

ATOM 3597 O TYR A 353 12.780 12.621 50.995 1.00 3.31

ATOM 3598 N GLN A 354 10.632 13.274 50.965 1.00 3.72

ATOM 3600 CA GLN A 354 10.862 14.427 51.829 1.00 4.18

ATOM 3602 CB GLN A 354 9.589 15.248 51.985 1.00 4.39

ATOM 3605 CG GLN A 354 9.064 15.734 50.649 1.00 5.35

ATOM 3608 CD GLN A 354 8.216 16.977 50.735 1.00 6.61

ATOM 3609 OE1 GLN A 354 8.524 17.899 51.485 1.00 8.35

ATOM 3610 NE2 GLN A 354 7.164 17.022 49.933 1.00 6.18

ATOM 3613 C GLN A 354 11.365 13.965 53.195 1.00 4.32

ATOM 3614 O GLN A 354 12.252 14.591 53.771 1.00 4.28

ATOM 3615 N VAL A 355 10.795 12.871 53.706 1.00 4.44

ATOM 3617 CA VAL A 355 11.211 12.316 55.001 1.00 4.83

ATOM 3619 CB VAL A 355 10.322 11.120 55.416 1.00 4.90

ATOM 3621 CG1 VAL A 355 10.953 10.366 56.603 1.00 5.07

ATOM 3625 CG2 VAL A 355 8.928 11.585 55.764 1.00 4.57

ATOM 3629 C VAL A 355 12.666 11.842 54.947 1.00 4.96

ATOM 3630 O VAL A 355 13.457 12.124 55.853 1.00 4.94

ATOM 3631 N GLU A 356 13.005 11.105 53.887 1.00 5.36

ATOM 3633 CA GLU A 356 14.367 10.585 53.709 1.00 5.54

ATOM 3635 CB GLU A 356 14.446 9.650 52.495 1.00 6.54

ATOM 3638 CG GLU A 356 15.780 8.917 52.429 1.00 9.22

ATOM 3641 CD GLU A 356 15.801 7.726 51.489 1.00 13.26

ATOM 3642 OE1 GLU A 356 16.176 7.917 50.315 1.00 15.69

ATOM 3643 OE2 GLU A 356 15.493 6.590 51.933 1.00 15.43

ATOM 3644 C GLU A 356 15.349 11.737 53.541 1.00 4.88

ATOM 3645 O GLU A 356 16.484 11.695 54.048 1.00 4.16

ATOM 3646 N LEU A 357 14.913 12.784 52.851 1.00 4.21

ATOM 3648 CA LEU A 357 15.751 13.967 52.671 1.00 4.57

ATOM 3650 CB LEU A 357 15.024 15.006 51.825 1.00 3.91

ATOM 3653 CG LEU A 357 15.813 16.279 51.499 1.00 3.60

ATOM 3655 CD1 LEU A 357 17.210 15.951 51.005 1.00 3.39

ATOM 3659 CD2 LEU A 357 15.093 17.144 50.480 1.00 4.35

ATOM 3663 C LEU A 357 16.112 14.579 54.032 1.00 4.95

ATOM 3664 O LEU A 357 17.270 14.937 54.294 1.00 5.53

ATOM 3665 N LYS A 358 15.108 14.694 54.897 1.00 5.80

ATOM 3667 CA LYS A 358 15.295 15.243 56.242 1.00 6.34

ATOM 3669 CB LYS A 358 13.954 15.311 56.986 1.00 6.79

ATOM 3672 CG LYS A 358 14.039 15.852 58.408 1.00 8.85

ATOM 3675 CD LYS A 358 12.667 15.963 59.081 1.00 11.56

ATOM 3678 CE LYS A 358 12.778 15.922 60.608 1.00 13.45

ATOM 3681 NZ LYS A 358 11.446 16.046 61.278 1.00 15.20

ATOM 3685 C LYS A 358 16.278 14.381 57.021 1.00 6.23

ATOM 3686 O LYS A 358 17.210 14.897 57.647 1.00 6.46

ATOM 3687 N ALA A 359 16.055 13.069 56.982 1.00 6.07

ATOM 3689 CA ALA A 359 16.879 12.101 57.687 1.00 6.00

ATOM 3691 CB ALA A 359 16.277 10.724 57.587 1.00 6.19

ATOM 3695 C ALA A 359 18.303 12.091 57.143 1.00 6.09

ATOM 3696 O ALA A 359 19.265 12.036 57.907 1.00 5.68

ATOM 3697 N PHE A 360 18.443 12.145 55.824 1.00 5.93

ATOM 3699 CA PHE A 360 19.774 12.143 55.219 1.00 6.25

ATOM 3701 CB PHE A 360 19.692 12.075 53.691 1.00 6.09

ATOM 3704 CG PHE A 360 21.035 12.164 53.015 1.00 5.08

ATOM 3705 CD1 PHE A 360 21.974 11.152 53.164 1.00 5.53

ATOM 3707 CE1 PHE A 360 23.222 11.241 52.557 1.00 5.05

ATOM 3709 CZ PHE A 360 23.541 12.349 51.800 1.00 5.36

ATOM 3711 CE2 PHE A 360 22.616 13.362 51.643 1.00 5.78

ATOM 3713 CD2 PHE A 360 21.371 13.270 52.258 1.00 5.37

ATOM 3715 C PHE A 360 20.549 13.395 55.642 1.00 6.88

ATOM 3716 O PHE A 360 21.688 13.311 56.106 1.00 7.37

ATOM 3717 N GLN A 361 19.913 14.553 55.504 1.00 7.57

ATOM 3719 CA GLN A 361 20.535 15.826 55.850 1.00 8.38

ATOM 3721 CB GLN A 361 19.603 16.971 55.489 1.00 7.94

ATOM 3724 CG GLN A 361 19.627 17.293 53.983 1.00 7.07

ATOM 3727 CD GLN A 361 21.036 17.618 53.478 1.00 5.92

ATOM 3728 OE1 GLN A 361 21.496 17.078 52.467 1.00 7.96

ATOM 3729 NE2 GLN A 361 21.702 18.503 54.166 1.00 3.18

ATOM 3732 C GLN A 361 20.932 15.897 57.325 1.00 9.69

ATOM 3733 O GLN A 361 21.821 16.664 57.692 1.00 9.62

ATOM 3734 N ALA A 362 20.273 15.099 58.159 1.00 11.55

ATOM 3736 CA ALA A 362 20.615 15.019 59.590 1.00 13.25

ATOM 3738 CB ALA A 362 19.511 14.306 60.361 1.00 13.47

ATOM 3742 C ALA A 362 21.944 14.302 59.788 1.00 14.65

ATOM 3743 O ALA A 362 22.567 14.414 60.852 1.00 15.14

ATOM 3744 N THR A 363 22.382 13.561 58.772 1.00 16.29

ATOM 3746 CA THR A 363 23.667 12.859 58.813 1.00 17.77

ATOM 3748 CB THR A 363 23.600 11.548 58.031 1.00 17.95

ATOM 3750 OG1 THR A 363 22.493 10.765 58.497 1.00 18.76

ATOM 3752 CG2 THR A 363 24.814 10.663 58.314 1.00 18.15

ATOM 3756 C THR A 363 24.732 13.750 58.195 1.00 18.76

ATOM 3757 O THR A 363 25.922 13.421 58.208 1.00 18.78

ATOM 3758 N GLN A 364 24.283 14.871 57.640 1.00 19.77

ATOM 3760 CA GLN A 364 25.158 15.851 57.022 1.00 20.96

ATOM 3762 CB GLN A 364 24.616 16.229 55.640 1.00 21.24

ATOM 3765 CG GLN A 364 25.490 15.801 54.446 1.00 22.43

ATOM 3768 CD GLN A 364 25.668 14.294 54.277 1.00 23.32

ATOM 3769 OE1 GLN A 364 25.472 13.516 55.210 1.00 23.46

ATOM 3770 NE2 GLN A 364 26.060 13.889 53.076 1.00 24.13

ATOM 3773 C GLN A 364 25.312 17.110 57.902 1.00 21.55

ATOM 3774 O GLN A 364 26.401 17.645 58.011 1.00 21.55

ATOM 3775 N GLN A 365 24.219 17.542 58.539 1.00 22.62

ATOM 3777 CA GLN A 365 24.114 18.807 59.294 1.00 23.44

ATOM 3779 CB GLN A 365 25.287 19.137 60.218 1.00 23.70

ATOM 3782 CG GLN A 365 24.879 19.207 61.721 1.00 24.10

ATOM 3785 CD GLN A 365 24.542 20.613 62.236 1.00 24.69

ATOM 3786 OE1 GLN A 365 23.620 21.268 61.738 1.00 25.16

ATOM 3787 NE2 GLN A 365 25.279 21.061 63.257 1.00 24.67

ATOM 3790 C GLN A 365 23.877 19.909 58.281 1.00 24.03

ATOM 3791 O GLN A 365 24.709 20.190 57.421 1.00 24.63

ATOM 3792 N LYS A 366 22.717 20.524 58.396 1.00 24.21

ATOM 3794 CA LYS A 366 22.284 21.522 57.454 1.00 24.37

ATOM 3796 CB LYS A 366 20.933 21.079 56.920 1.00 24.52

ATOM 3799 CG LYS A 366 20.046 20.537 58.053 1.00 24.53

ATOM 3802 CD LYS A 366 19.425 19.211 57.731 1.00 24.45

ATOM 3805 CE LYS A 366 18.536 18.713 58.859 1.00 24.03

ATOM 3808 NZ LYS A 366 17.310 18.004 58.315 1.00 23.21

ATOM 3812 C LYS A 366 22.183 22.861 58.160 1.00 24.51

ATOM 3813 O LYS A 366 22.939 23.126 59.107 1.00 24.62

ATOM 3814 O SAH E 501 8.297 −2.058 44.325 1.00 40.90

ATOM 3815 C SAH E 501 8.314 −0.968 43.757 1.00 41.24

ATOM 3816 CA SAH E 501 9.219 0.183 44.185 1.00 41.19

ATOM 3818 N SAH E 501 9.794 −0.121 45.501 1.00 41.18

ATOM 3819 CB SAH E 501 10.235 0.369 43.049 1.00 40.73

ATOM 3822 CG SAH E 501 10.669 1.774 42.642 1.00 40.21

ATOM 3825 SD SAH E 501 9.362 2.829 41.941 1.00 40.07

ATOM 3826 C5* SAH E 501 9.401 4.162 43.144 1.00 39.88

ATOM 3829 C4* SAH E 501 8.664 3.778 44.420 1.00 40.55

ATOM 3831 O4* SAH E 501 9.530 2.983 45.238 1.00 40.00

ATOM 3832 C1* SAH E 501 9.449 3.389 46.590 1.00 40.22

ATOM 3834 C2* SAH E 501 8.352 4.430 46.689 1.00 40.93

ATOM 3836 O2* SAH E 501 7.161 3.829 47.167 1.00 41.07

ATOM 3838 C3* SAH E 501 8.191 4.947 45.270 1.00 41.32

ATOM 3840 O3* SAH E 501 6.840 5.321 45.046 1.00 41.73

ATOM 3842 N9 SAH E 501 10.788 3.906 46.999 1.00 40.52

ATOM 3843 C8 SAH E 501 11.866 4.115 46.184 1.00 40.63

ATOM 3845 N7 SAH E 501 12.911 4.552 46.930 1.00 40.77

ATOM 3846 C5 SAH E 501 12.513 4.611 48.221 1.00 40.71

ATOM 3847 C6 SAH E 501 13.174 4.980 49.395 1.00 41.16

ATOM 3848 N6 SAH E 501 14.445 5.380 49.372 1.00 40.82

ATOM 3851 C4 SAH E 501 11.186 4.199 48.278 1.00 40.49

ATOM 3852 N3 SAH E 501 10.520 4.152 49.451 1.00 40.16

ATOM 3853 C2 SAH E 501 11.180 4.520 50.620 1.00 41.78

ATOM 3855 N1 SAH E 501 12.490 4.933 50.576 1.00 39.76

ATOM 3859 N ALA K 1 8.996 19.908 38.353 1.00 12.39

ATOM 3861 CA ALA K 1 8.059 18.939 37.729 1.00 12.32

ATOM 3863 CB ALA K 1 8.537 18.584 36.343 1.00 12.87

ATOM 3867 C ALA K 1 7.923 17.674 38.576 1.00 11.87

ATOM 3868 O ALA K 1 8.855 17.304 39.301 1.00 11.99

ATOM 3871 N ARG K 2 6.723 17.102 38.604 1.00 10.65

ATOM 3873 CA ARG K 2 6.470 15.840 39.291 1.00 10.19

ATOM 3875 CB ARG K 2 4.974 15.667 39.504 1.00 10.49

ATOM 3878 CG ARG K 2 4.415 16.668 40.510 1.00 11.49

ATOM 3881 CD ARG K 2 3.077 16.269 41.101 1.00 13.38

ATOM 3884 NE ARG K 2 2.519 17.280 41.994 1.00 14.59

ATOM 3886 CZ ARG K 2 1.339 17.177 42.589 1.00 16.21

ATOM 3887 NH1 ARG K 2 0.571 16.115 42.374 1.00 16.66

ATOM 3890 NH2 ARG K 2 0.918 18.135 43.406 1.00 17.20

ATOM 3893 C ARG K 2 7.094 14.579 38.700 1.00 9.34

ATOM 3894 O ARG K 2 6.421 13.555 38.530 1.00 8.70

ATOM 3895 N THR K 3 8.389 14.649 38.415 1.00 8.38

ATOM 3897 CA THR K 3 9.111 13.512 37.888 1.00 8.36

ATOM 3899 CB THR K 3 8.979 13.404 36.364 1.00 9.04

ATOM 3901 OG1 THR K 3 10.130 13.974 35.730 1.00 11.22

ATOM 3903 CG2 THR K 3 7.815 14.212 35.820 1.00 8.63

ATOM 3907 C THR K 3 10.587 13.644 38.268 1.00 7.71

ATOM 3908 O THR K 3 11.070 14.728 38.566 1.00 6.59

ATOM 3909 CM M1L K 4 11.009 5.204 39.930 1.00 2.73

ATOM 3910 NZ M1L K 4 11.719 6.209 39.159 1.00 2.32

ATOM 3911 CE M1L K 4 11.574 7.615 39.523 1.00 2.66

ATOM 3914 CD M1L K 4 12.364 8.512 38.589 1.00 2.45

ATOM 3917 CG M1L K 4 12.084 9.965 38.945 1.00 2.40

ATOM 3920 CB M1L K 4 12.904 10.873 38.053 1.00 2.54

ATOM 3923 CA M1L K 4 12.449 12.304 38.194 1.00 2.52

ATOM 3925 N M1L K 4 11.029 12.295 37.865 1.00 3.37

ATOM 3926 C M1L K 4 13.197 13.193 37.235 1.00 3.01

ATOM 3928 O M1L K 4 12.962 13.222 36.056 1.00 2.56

ATOM 3929 N GLN K 5 14.584 13.478 37.797 1.00 7.22

ATOM 3931 CA GLN K 5 15.450 14.271 36.884 1.00 8.17

ATOM 3933 CB GLN K 5 16.054 13.370 35.828 1.00 8.43

ATOM 3936 CG GLN K 5 16.970 12.351 36.383 1.00 8.88

ATOM 3939 CD GLN K 5 18.081 11.997 35.430 1.00 9.35

ATOM 3940 OE1 GLN K 5 17.869 11.885 34.227 1.00 8.97

ATOM 3941 NE2 GLN K 5 19.276 11.807 35.972 1.00 9.42

ATOM 3944 C GLN K 5 14.750 15.431 36.194 1.00 8.64

ATOM 3945 O GLN K 5 15.022 15.707 35.035 1.00 8.44

ATOM 3948 N THR K 6 13.745 15.998 36.835 1.00 9.60

ATOM 3950 CA THR K 6 13.138 17.229 36.381 1.00 10.73

ATOM 3952 CB THR K 6 12.040 17.631 37.363 1.00 10.90

ATOM 3954 OG1 THR K 6 11.316 18.746 36.833 1.00 12.28

ATOM 3956 CG2 THR K 6 12.600 18.116 38.676 1.00 11.76

ATOM 3960 C THR K 6 14.104 18.390 36.122 1.00 11.09

ATOM 3961 O THR K 6 14.998 18.679 36.930 1.00 10.66

ATOM 3962 N ALA K 7 13.884 19.030 34.973 1.00 11.81

ATOM 3964 CA ALA K 7 14.630 20.184 34.495 1.00 12.53

ATOM 3966 CB ALA K 7 14.059 20.649 33.157 1.00 12.47

ATOM 3970 C ALA K 7 14.556 21.319 35.484 1.00 13.22

ATOM 3971 O ALA K 7 13.501 21.601 36.053 1.00 13.11

ATOM 3972 N ARG K 8 15.686 21.985 35.664 1.00 14.21

ATOM 3974 CA ARG K 8 15.771 23.093 36.588 1.00 14.87

ATOM 3976 CB ARG K 8 17.199 23.225 37.085 1.00 15.34

ATOM 3979 CG ARG K 8 17.295 23.916 38.407 1.00 16.87

ATOM 3982 CD ARG K 8 18.715 24.179 38.833 1.00 18.48

ATOM 3985 NE ARG K 8 18.899 25.527 39.347 1.00 19.64

ATOM 3987 CZ ARG K 8 19.763 25.839 40.293 1.00 20.69

ATOM 3988 NH1 ARG K 8 20.502 24.888 40.845 1.00 21.86

ATOM 3991 NH2 ARG K 8 19.885 27.095 40.703 1.00 20.91

ATOM 3994 C ARG K 8 15.329 24.395 35.926 1.00 14.75

ATOM 3995 O ARG K 8 15.383 24.535 34.715 1.00 14.65

ATOM 3996 N LYS K 9 14.897 25.343 36.745 1.00 14.92

ATOM 3998 CA LYS K 9 14.466 26.644 36.275 1.00 14.95

ATOM 4000 CB LYS K 9 13.143 27.010 36.942 1.00 15.30

ATOM 4003 CG LYS K 9 12.515 28.277 36.408 1.00 15.99

ATOM 4006 CD LYS K 9 12.015 28.080 34.985 1.00 16.93

ATOM 4009 CE LYS K 9 11.418 29.347 34.407 1.00 17.56

ATOM 4012 NZ LYS K 9 10.839 29.172 33.040 1.00 18.06

ATOM 4016 C LYS K 9 15.529 27.676 36.635 1.00 14.60

ATOM 4017 O LYS K 9 16.025 27.681 37.755 1.00 14.59

ATOM 4018 N TYR K 10 15.874 28.546 35.689 1.00 14.19

ATOM 4020 CA TYR K 10 16.904 29.561 35.916 1.00 14.11

ATOM 4022 CB TYR K 10 18.127 29.273 35.050 1.00 13.87

ATOM 4025 CG TYR K 10 18.817 27.984 35.439 1.00 13.76

ATOM 4026 CD1 TYR K 10 18.440 26.775 34.878 1.00 13.67

ATOM 4028 CE1 TYR K 10 19.061 25.596 35.241 1.00 14.13

ATOM 4030 CZ TYR K 10 20.074 25.616 36.175 1.00 14.21

ATOM 4031 OH TYR K 10 20.694 24.442 36.532 1.00 15.41

ATOM 4033 CE2 TYR K 10 20.462 26.800 36.751 1.00 13.59

ATOM 4035 CD2 TYR K 10 19.836 27.976 36.386 1.00 13.60

ATOM 4037 C TYR K 10 16.349 30.958 35.649 1.00 14.14

ATOM 4038 O TYR K 10 15.294 31.125 35.050 1.00 14.51

ATOM 4039 OXT TYR K 10 16.895 31.990 36.032 1.00 14.07 

1. A crystal comprising at least a catalytically active portion of a SET 7/9 histone methyltransferase.
 2. A crystal according to claim 1, comprising at least residues 117-366, preferably residues 108-366, of SET 7/9.
 3. A crystal according to claim 1, comprising SET 7/9 in complex with a lysine-containing substrate peptide or protein and/or a cofactor.
 4. A crystal according to claim 3, comprising SET 7/9 in complex with a lysine-containing substrate peptide or protein and a cofactor, wherein the lysine of the substrate which interacts with the SET 7/9 active site is methylated and wherein cofactor is unmethylated at the site whence a methyl group is normally transferred to the substrate.
 5. A crystal in accordance with claim 1, having the atomic co-ordinates set out in Annex 1 or having a structure in which the atomic co-ordinates vary by less than 0.2 Å in any direction from those set out in Annex
 1. 6. A crystal in accordance with claim 1, comprising at least a catalytically active portion of SET 7/9 in complex with a lysine-containing substrate peptide or protein, wherein the complex comprises one or more of the following interactions: SET 7/9 Residue Relative Substrate Residue Trp 260 −3 His 252 −2 Asp 256 −2 Ser 268 −1 Thr 266 Lys O Ser 268 Lys O Ser 268 +1 Val 355 +1 Lys 317 +2


7. A method of selecting or designing a ligand for SET 7/9, which method comprises use of at least part of the atomic co-ordinate data contained in Annex 1 or data derivable therefrom.
 8. A method according to claim 7 comprising use of data relating to at least 50%, preferably 75% and most preferably 95% of the atoms detailed in Annex I, or data derivable therefrom, or data in which the atomic co-ordinates used vary by less than 0.2 Å (preferably less than 0.1 Å) in any direction from the co-ordinates given in Annex
 1. 9. A method according to claim 7, which involves the use of a computer system and/or computer readable medium.
 10. A method according to claim 7, which comprises at least use of the atomic co-ordinate data contained in Annex 1 in respect of some or all of the amino residues of the SET 7/9 domain selected from the group consisting of: Tyr 245, His 252, Asp 256, Asn 263, Gly 264, Thr 266, Leu 267, Ser 268, Gly 292, His 293, Ala 295, Tyr 305, Lys 317, Tyr 335, and Tyr
 337. 11. A method according to claim 7, comprising the step of testing in vitro the selected or designed ligand for ability to bind to SET 7/9, typically by contacting the ligand with SET 7/9 and measuring the amount of ligand, if any, bound to the SET 7/9.
 12. A method according to claim 7, comprising the step of testing in vitro the ability of the selected or designed ligand to modulate the methyltransferase activity of SET 7/9 HMT.
 13. A method according to claim 7, comprising the step of forming a complex comprising the selected or designed ligand and SET 7/9.
 14. A method according to claim 13, comprising the step of forming a crystal comprising the complex and subjecting the crystal to X-ray diffraction analysis to investigate the binding of the ligand to SET 7/9.
 15. A method according to claim 14, wherein the structure of the ligand is modified in view of the results of the X-ray diffraction analysis in order to optimise the characteristics of its binding to SET 7/9.
 16. A method according to claim 15, wherein the optimised ligand is retested in vitro for ability to bind to SET 7/9 and/or modulate methyltransferase activity of SET 7/9 HMT.
 17. A computer system and/or a computer readable medium comprising positional data relating to, or derivable form, at least part of the atomic co-ordinate data contained in Annex
 1. 18. A computer system and/or a computer readable medium according to claim 9, comprising at least atomic co-ordinate data from Annex 1 (or data derivable therefrom) in respect of some or all of the amino acid residues of SET 7/9 domain selected from the group consisting of: Tyr 245, His 252, Hsp 256, Asn 263, Gly 264, Thr 266, Leu 267, Ser 268, Gly 292, His 293, Ala 295, Tyr 305, Lys 317, Tyr 335, and Tyr
 337. 19. A method of forming a crystal comprising at least part of a SET 7/9 domain, the method comprising the steps of: forming a complex comprising at least a catalytically active portion of a SET 7/9 domain and a lysine-containing substrate peptide or protein; and crystallising the complex.
 20. A method according to claim 19, wherein the complex further comprises a cofactor.
 21. A method according to claim 20, wherein the lysine-containing substrate peptide or protein comprises a target lysine residue which has a methylated side chain and wherein the cofactor is unmethylated.
 22. A method of forming a crystal comprising at least part of a SET 7/9 domain, the method comprising the steps of: selecting or designing a ligand in accordance with claim 7; forming a complex comprising the ligand and at least a catalytically active portion of a SET 7/9 domain; and crystallising the complex.
 23. A method according to claim 19, wherein the complex comprises at least residues 117-366 of SET 7/9.
 24. A ligand for SET 7/9 selected or designed by the method of claim
 7. 25. A ligand for SET 7/9 conforming to general formula I or II:

wherein R¹, R² and R³ are, independently: H, alkyl, haloakyl, aralkyl, acyl, cycloalkyl, alkenyl, or oxa-alkyl and wherein n=0, 1 or
 2.

wherein R¹-R³ and are as in general formula I, and wherein R⁴ may be selected from any of the following: a linear, cyclic or branched alkyl group comprising 2 or more carbon atoms (preferably 2-6 carbon atoms, more preferably 2-5 carbon atoms); an alkenyl group having one or more double bonds; the alkyl or alkenyl group optionally being substituted at one or more positions (e.g. hydroxylated, halogenated, or aminated) and optionally comprising one or more oxa- aza- or thia-replacements of CH₂ groups.
 26. A ligand for SET 7/9 comprising a bis-bicyclooctane or a 1,4 diphenyl moiety.
 27. A ligand for SET 7/9 in accordance with the structure shown in FIG. 5 or FIG.
 6. 28. A ligand according to claim 24, comprising an analogue of AdoMet having a stabilised 5′ thioadenosine moiety, and optionally substituted at the 3′-OH of the ribosyl moiety and/or the —NH₂ group at position 4 of the adenyl moiety.
 29. A ligand for SET 7/9 according to claim 24 comprising a hydrophobic moiety which occupies the lysine access channel of SET 7/9, forming hydrophobic interactions with the amino acid residues of SET 7/9 which define the lysine access channel.
 30. A ligand according to claim 24, comprising a moiety which alkylates the terminal amino group the target lysine side chain of the histone substrate.
 31. A ligand according to claim 30, comprising a modified or unmodified 5′-aziridinyl adenosine alkylating agent.
 32. A ligand according to claim 24, which modulates the methyltransferase activity of SET 7/9 HMT.
 33. A pharmaceutical composition comprising a ligand according to claim 24, in admixture with a physiologically acceptable excipient, carrier or diluent.
 34. Use of a ligand in accordance with claim 24 to prepare a pharmaceutical composition for modulating the methylation of histones.
 35. A method of altering the substrate specificity of histone methyltransferases, the method comprising the steps of: obtaining a nucleotide sequence encoding at least a catalytically active portion of a SET HMT; and altering the nucleotide sequence so as to introduce a mutation at one or more residues selected from the group consisting of residue numbers; 245; 305; and
 335. 36. A method according to claim 35 for altering the substrate specificity of a SET 7/9 HMT, the method comprising the step of introducing at least one of the mutations selected from the group consisting of Y245>A; Y305>; and Y305>P.
 37. An SET HMT having altered substrate specificity as a result of alteration of the amino acid sequence of the protein by a method according to claim
 35. 